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 Résumé de la Thèse: 
 Les cryptophanes constituent une classe de composés macrocycliques uniques 
caractérisée par la présence d’une cavité lipophile dont la taille peut varier selon la nature du 
cryptophane. En solution, cette cavité est susceptible d’accueillir divers substrats comme de 
petites molécules ou des atomes (ions, gaz rare) dont les propriétés physiques s’en trouvent alors 
modifiées. Depuis la première description de ces composés en 1981 par André Collet, les 
cryptophanes ont connu un regain d’intérêt au début des années 2000 avec la mise en évidence de 
la complexation du xénon par des cryptophanes de petites tailles. Cette découverte a depuis été 
exploitée par plusieurs équipes internationales pour préparer des bio-sondes moléculaires pouvant 
présenter un intérêt en imagerie de résonance magnétique nucléaire (IRM) du xénon 
hyperpolarisé. Au contraire des autres techniques IRM développées jusqu’ici, l’IRM du xénon 
hyperpolarisé des complexes xénon-cryptophane repose sur une technique de détection basée sur 
le déplacement chimique. Les complexes xénon-cryptophane présentent ainsi une signature 
spécifique qui peut être facilement identifiée et exploitée pour produire une image IRM. La très 
grande sensibilité de la technique combinée aux propriétés exceptionnelles des complexes xénon-
cryptophanes rendent cette approche extrêmement intéressante pour concevoir de nouveaux 
traceurs pour l’imagerie RMN du xénon hyperpolarisé.   
 
 Ce travail nécessite toutefois de développer en amont de nouveaux cryptophanes 
présentant toutes les caractéristiques requises pour une utilisation optimale en milieu 
physiologique. La mise en œuvre de composés présentant une bonne solubilité est par exemple 
cruciale pour éviter les phénomènes d’agrégation pouvant se produire dans les milieux aqueux. 
Le greffage sélectif d’une tête de reconnaissance présentant une activité biologique prédéfinie 
constitue également un verrou important qu’il faut prendre en compte. Au cours de ces 20 
dernières années des résultats importants ont été rapportés dans la littérature et ont permis de 
démontrer l’intérêt de ces systèmes supramoléculaires pour l’imagerie RMN. Cependant, les 
systèmes développés jusqu’ici n’ont pas permis de résoudre de manière satisfaisante les deux 
points soulevés ci-dessus.   
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 Ce travail de thèse a pour objectif de développer de nouveaux cryptophanes hydrosolubles 
possédant une fonction organique unique permettant d’accrocher une tête de reconnaissance. 
Pour cela, un cryptophane de type [223] possédant une fonction réactive a été modifiée de façon à 
introduire de manière sélective une fonction acide carboxylique sur la chaîne dioxypropylene. 
Cette approche originale permet de tirer profit des six autres fonctions localisées sur les cycles 
aromatiques pour introduire des groupements hydrosolubles à une autre étape de la synthèse. 
Nous avons ainsi pour la première fois été capable de préparer de nouvelles plateformes 
organiques de type cryptophanes répondant à ce cahier des charges strict. L’intérêt de cette 
nouvelle approche réside également dans la très grande flexibilité de nos systèmes organiques 
puisqu’ils peuvent être très rapidement utilisés par d’autres pour y introduire de nouvelles 
fonctionnalités. Pour mettre en avant notre stratégie de synthèse nous avons développé un 
cryptophane capable de détecter les ions zinc et nickel en milieu physiologique. Les avantages et 
les inconvénients liés à notre approche sont discutés en détail dans ce mémoire.   
 
 La deuxième partie de ce mémoire est consacrée à l’étude des propriétés chiroptiques de 
cryptophanes donnant lieu à un phénomène d’auto-encapsulation lequel dépend de la nature du 
solvant. C’est la première fois que cet effet est observé avec ces composés macrocycliques. Pour 
mettre en évidence ce phénomène plusieurs techniques comme la spectroscopie RMN et 
Infrarouge (IR) ou encore les techniques chiroptiques de dichroïsme circulaire électronique 
(ECD) et vibrationnel (VCD) ont été utilisées. Celles-ci révèlent des modifications importantes 
en fonction de la nature et la taille du solvant. Cependant, une étude réalisée sur plusieurs 
composés montre clairement que seules les techniques RMN et IR permettent de mettre en 
évidence ce phénomène d’auto-encapsulation. Cet effet original apparaît donc comme un autre 
moyen pour ces composés macrocycliques de combler leur cavité sans faire intervenir d’autres 
changements conformationnels plus énergétiques.  
   
 
 
 
General Introduction
General Introduction 
Page | 14  
 
Cryptophanes are container-like molecular structures that have the ability to encapsulate 
various substrates in their lipophilic cavity. This structure, which is elegantly tailored, has offered 
different lessons in supramolecular chemistry especially in host-guest interactions. The high 
affinity of cryptophanes to xenon has been smartly exploited to design 129Xe-NMR/MRI sensors. 
Unlike the usual proton-based MRI tracers, 129Xe-cryptophane combination allows accessing 
smart MRI biosensors that are characterized by their fast response and high sensitivity. Since 
2001, a large number of hyperpolarized 129Xe-cryptophane biosensors has been reported for the 
detection of various physical and biological targets like pH, temperature, enzymatic activity and 
ionic analytes. The synthesis of these molecular structures remains challenging and this thesis is 
dedicated to develop a new strategy aimed at facilitating the elaboration of these cryptophanes 
based biosensors. 
The first part of this manuscript describes the synthesis of cryptophane platforms for biosensing 
applications. In the introductory chapter of this part, we gave a general view on cryptophane 
derivatives and their main features. Additionally, we delivered a non-exhaustive description of 
the new imaging and hyperpolarization techniques and the biosensors reported in literature. In a 
second chapter, we focused our attention on the synthesis and development of new cryptophane-
[223] platforms, characterized by their improved water solubility and easy functionalization via 
the two available reactive sites. The sensors elaborated from these new cages were studied by 
hyperpolarized 129Xe NMR spectroscopy and ITC experiments and the results are reported in the 
third chapter.  
A second part of this manuscript is dedicated to the synthesis and the characterization of 
cryptophane-[223] derivatives subjected to self-encapsulation. An introductory chapter of this 
part describes the synthesis of enantiopure cryptophanes and their characterization by different 
General Introduction 
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chiroptical tools. In the second chapter, we reported the main results that evidence the self-
encapsulation phenomenon and the corresponding chiroptical variations induced by it for a series 
of cryptophane-[223] derivatives. 
At the end of each part of this manuscript, we reported the detailed experimental procedures 
leading to the new derivatives and their corresponding characterizations. An additional part 
gathers the main compounds and their corresponding numbers in the text. This part is added to 
facilitate the reading of the thesis. The references are all gathered at the end of the manuscript.   
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Introduction 
The knowledge in biological systems’ chemistry is inevitably inspiring.1 Inspirited by natural 
processes, supramolecular chemistry or “the chemistry beyond the molecule” has emerged, as the 
study of the structure and function of intermolecular assemblies among molecules driven by weak 
non-covalent interactions.2 Supramolecular chemistry has served, to a great extent in a better 
understanding of biological processes, which are vastly governed by non-covalent bonds like 
hydrogen bonding, Van der Waals interactions, solvophobic effect and coulombic interactions.3 
From protein folding, enzyme-substrate assembly, genetic information storage, transcription, to 
the most complicated cells interaction, highly selective and delicate cascade of events takes place, 
starting from the selective recognition of a receptor or a “host” to a substrate or a “guest”.4,5,6 
This recognition is based on complementarity, the strength and kind of interactions and the extent 
of preorganization of the non-complexed species before the binding event.7 Exploiting this 
knowledge, Pedersen in 19678, Lehn and Sauvage in 19699 and Cram in 197310 have developed 
new families of structurally ion-selective complexes, establishing by this the foundations of the 
field. Greater complexity has been added to this field by introducing photo or electro-responsive 
motifs, making dynamic molecular assemblies, Figure 1.11  
 
Figure 1: earliest receptor crown ether by Pedersen, Cram's spherand, Lehn's macrobicylic cryptands and Stoddart's 
modern containers. 
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Among the vast majority of supramolecular designs, molecular containers possessing hollow, 
concave hydrophobic surfaces have gained special attention. Mimicking enzyme’s hydrophobic 
pocket, these containers can selectively recognize smaller convex molecules based on the size, 
shape and nature of the inner surface.12,13 The residency time of such complexes is strongly 
dependent on the host’s structure. For example, molecules with rigid enclosed spheres can 
permanently encapsulate guests and these are referred to as carcerands.14,15 Other structures 
possess dynamic portals16 allowing the exchange of the contained molecule with the bulk such as 
cavitands, deep cavitands,17 cryptophanes,18 hemicarcerands,19 cyclodextrins,20 
hemicryptophanes,21 and calixarenes,22 Figure 2. Once the complex formed, a change in the guest 
behavior is expected, due to the change in the surrounding environment. These include physical, 
mainly magnetic properties, which are well characterized by NMR spectroscopy, conformational 
and catalytic properties.12 This effect is especially important because it paves the way for many 
applications such as catalysis, stabilization of highly reactive intermediates, sensors, nano-scale 
molecular reactors and separation agents.23, 24 ,21  
 
Figure 2: examples of cavity-containing macrocycles like cyclodextrins A, calixarenes B, cavitand C and 
hemicryptophane D. 
 
The elegantly elaborated cryptophanes constitute a family of the earliest molecular containers 
with a hydrophobic cavity, Figure 3. Reported by André Collet in 1981, cryptophanes are initially 
A B DC
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made up of two C3-symmetric cyclotribenzylene CTB units connected by three modifiable 
bridges. The first cryptophane synthesized was the cryptophane-A, which is still very useful 
nowadays to prepare new cryptophane derivatives. This cryptophane was initially constructed to 
bind lipophilic molecules like halogenomethanes and isobutanes constituting by this, the first 
family of molecular containers to isolate lipophilic guests from the bulk.18 Remarkably, 
enantioenriched cryptophanes were the first molecular hosts to isolate and discriminate between 
the two enantiomers of CHFClBr, one of the smallest chiral molecules. For a long period of time, 
cryptophanes have been mainly framed in fundamental research, where the study of their 
complexes has served to understand molecular recognition. Since 2001, these molecules have 
gained a lot of attention in xenon based sensing applications. The remarkable structural features 
of cryptophanes, from chirality, tunable cavity size and solubility have been heavily exploited to 
finely tune properties to applications. In this chapter a detailed description of cryptophanes’ 
structure, symmetry, conformations, synthesis, complexes and applications will be discussed. 
 
 
Figure 3: structure of cryptophane-[222] (OMe)6 or the so-called cryptophane-A, under the IUPAC name: 3,22-
(Epoxyethanoxy)-6,9:25,28-dietheno-7,36:17,26-dimethano 14,18:33,37 dimetheno18H,37 Hdibenzo[j,na1]. 
Cryptophane-A
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1. Cryptophanes: General Features 
1.1. Structure and Nomenclature:  
Cryptophanes are constructed from two C3-symmetric CTB units, connected by three bridges 
whose length and nature can be varied. Numerous cryptophane derivatives have been prepared so 
far and the readers can refer to different reviews made by Collet, Brotin, Dutasta and Holman to 
appreciate the large diversity of cryptophane derivatives, which have been prepared to date.25, 26, 
27 To talk about the CTB units, they have been synthesized since 1915 but correctly described in 
1965.28 These units are synthesized from three consecutive Friedel-Crafts alkylations of electron 
rich 3-4-disubstituted benzyl alcohols, which adopt a crown-shaped conformation. Depending on 
its substituents, CTB units can have an achiral C3v-symmetry if the substituents on the CTB rims, 
Rx and Ry are identical or a chiral C3 or C1-symmetry if they are different, Figure 4.
29 The two 
enantiomers of the chiral CTB units possess helical chirality, hence they can adopt an M or P 
helicity, which can interconvert at high temperature as will be seen later. CTB, by themselves, 
have been utilized for many applications, including binding of neutral molecules like fullerene, 
cations and anions and form liquid crystals.30,31,32 To talk about the cryptophanes’ bridges, they 
can vary in nature and length from alkyl, alkenyl, aryl or alkynyl chains.33,34,35 The CTB and the 
bridges, combined, can determine the properties of the resulting cage like cavity size, solubility, 
chirality and their affinities to the guests. 
 
Figure 4: CTB unit symmetry and helical chirality. 
C3v if RX = Ry
C3 if RX ≠ Ry
M P
RY > Rx
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The IUPAC nomenclature of cryptophanes is not adopted due to its complexity and length, 
Figure 3. Since the first reported cage, simpler names were given by A. Collet to different cages 
like A, B, C, E, etc... For example, cryptophane-A was the first cage prepared by Collet and co-
workers. This cage possesses three ethylenedioxy linkers and six methoxy groups on the two 
CTB units. Cryptophane-B, however is the syn-isomer of cryptophane-A, which is recently 
reported by Brotin et al.36 These simplified names reflect neither the structure nor the time at 
which the cages were synthesized. Henceforth, a more generalized naming system is adopted. 
This system is based on indicating the length of the linkers and the nature of substituents on the 
CTB caps whenever possible. For example cryptophane-A becomes [222] (OMe)6. For the 
moment no concrete naming system is adopted and each research group tends to name 
cryptophanes on their own way. 
1.2. Cryptophane Symmetry: 
Molecular symmetry of cryptophanes is one of the key features to be studied to better 
understand their mode of complexation and interactions with the guest. Inherited from the 
chirality of CTB caps and the arrangement of the substituents around the linkers, cryptophanes 
exist in two different diastereomers, the syn and the anti. This modification can have a huge 
impact on the binding properties of these derivatives, Figure 5. 
 
Figure 5: possible cryptophanes' configurations. 
Syn Anti
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Compared to syn-isomer, anti-cryptophane is more flexible and has better binding properties. The 
anti-diastereomer forms when two CTB with the same absolute configuration are connected (MM 
or PP). This derivative is always chiral whatever the nature of the substituents or the linkers are, 
like cryptophane-A with D3 symmetry. The syn isomer is formed when the two CTB connected 
have opposite handedness (MP). This isomer is achiral, provided that the substituents and the 
linkers are identical (R1=R2 and X=Z), like cryptophane-B with C3h symmetry, else it will be 
chiral like cryptophane-D (syn-Cryptophane-[222] (OMe)3) with C3 symmetry. Table 1 provides 
the details of the point group and the chirality of the two diastereomers depending on the nature 
of the substituents and the linkers.26  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: summary of cryptophanes’ symmetry and chirality. 
   
Configuration 
 
Substituents and 
linkers 
 
Symmetry 
 
Chirality 
 
 
Syn 
 
R1=R2, X=Z 36,37 
 
R1=R2, X≠Z 
 
R1≠R2,  X=Z29 
 
R1≠R2, X≠Z 
 
C3h 
 
Cs 
 
C3 
 
C1 
 
Achiral 
 
Achiral 
 
Chiral 
 
Chiral 
 
 
Anti 
 
 
 
 
R1=R2, X=Z37 
 
R1=R2, X≠Z38 
 
R1≠R2, X=Z39,40 
 
R1≠R2, X≠Z41 
 
D3 
 
C2 
 
C3 
 
C1 
 
Chiral 
 
Chiral 
 
Chiral 
 
Chiral 
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1.3. Conformation: 
The CTB bowls of cryptophanes can adopt two different conformations, a stable “crown” as 
proved by X-ray structure and a less stable “saddle” shaped conformation (disfavored by 13-16 
kJ/mol). The formation of the “crown” conformer is usually evidenced by 1H NMR spectroscopy, 
which shows distinct signals for the two diastereotopic protons of the methylene bridge (axial and 
equatorial protons). The latter pseudo-rotating “saddle” conformer is an intermediate in the inter-
conversion of the two “crown” conformational isomers (M and P) obtained at higher temperature 
(at 100 °C, the interconversion takes place in few minutes), Figure 6. It is specifically formed by 
an inward flipping of the CTB methylene bridge. The lack of stability of the latter compared to 
“crown” conformation is due to the repulsion of the two hydrogens on the methylene bridge.42,43 
The two conformations show distinct NMR signals and they can be easily identified. 
 
Figure 6: inter-conversion between CTB crown conformers passing by a relatively non-stable saddle conformer. 
 
Similar to CTB, tribenzotriquinacenes (TBTQ) are a family of three mutually fused indanes, 
developed by D. Kuck and coworkers.44,45 These molecules are similar to CTB in symmetry and 
shape but differ in conformational rigidity. TBTQ are usually more rigid than CTB thanks to the 
bridge fusing the three methylene groups. With their original structure and rigidity, these 
molecules are usually hard to obtain in C3-symmetry. Racemic mixture of TBTQ trialdehydes has 
Crown (C) Saddle (S) Inverted Crown (Ci) 
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been also used to construct cryptophanes by dynamic covalent assembly with enantiopure 
(1S,2S)-diamino-cyclohexane. This strategy led to the formation of three diastereomeric mixtures 
of multiple Schiff’s bases and their corresponding hydrolysis gave rise to the enantiopure M and 
P-TBTQ, Figure 7.46  
 
Figure 7: structure of a TBTQ derivative and the cryptophane derived by dynamic covalent assembly. 
 
Cryptophanes derived from CTB, however show some flexibility and undergo a similar type of 
conformational conversion to that of the CTB caps. These forms are the following, out-out (CC), 
in-out (CCi), saddle-out (CS) and in-in (CiCi) conformers, Figure 8. It is noteworthy that the 
presence of several conformers can complicate the characterization of the cryptophane 
derivatives. 
Figure 8: possible conformers of cryptophanes. 
 
Racemic mixture TBTQ
CC CS CiCiCCi
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The (CS) conformer or the so-called imploded form possesses a unique 1H NMR signature 
compared to the (CC) conformer.47,48,49 This form was initially observed in cryptophanes with 
long flexible linkers or in the presence of a solvent that does not fill the cavity. 50 Surprisingly, 
smaller cryptophane cages (i.e. cryptophane-[222] derivatives) are also capable to implode like 
cryptophane-[222] (OCH2CO2H)6. The imploded form can readily be formed upon heating or 
storing the compounds for a long time in the solid state. For example, the imploded form of m-
xylyl-bridged cryptophane was obtained at high temperature (210 °C). Purification of this form 
offered a clean detailed 1H NMR and single crystals were also analyzed assuring the (CS) 
conformation, Figure 9.47 
 
Figure 9: m-xylyl bridged cryptophane capable of forming imploded form on the left. Imploded form of the 
cryptophane as determined by the single-crystal structure on the right. 
 
Recently, we have discovered a new type of conformational isomer with cryptophane-[223] 
bearing a substituent on the central propylenedioxy linker. This conformation corresponds to the 
position of the central substituent that can be inside or outside the cavity, which is referred to as 
“self-encapsulation”. This new conformational change represents an easy way for cryptophanes 
to fill their cavity with low energetic cost. The process is solvent dependent and will be 
thoroughly discussed in the second part of this thesis.  
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1.4. Cryptophane Complexes: 
As mentioned previously, cryptophanes possess a lipophilic cavity suitable to accommodate 
different guest molecules. Being a container molecule, cryptophanes’ binding process is governed 
by constrictive binding property for the in-out exchange of the guest, Figure 10. Cryptophanes 
binding portals are the linkers and its cavity is defined by the three dimensional arranged six 
aromatic rings. Cryptophanes’ constrictive binding is based on “sliding door” mechanism, that is 
the optimization of the cryptophanes’ portals by squeezing or expansion to accommodate the 
corresponding guest.16 This mechanism involves conformational changes of its flexible linkers. In 
cryptophanes, the stability of the guest@cryptophane complex is governed by several factors, 
mainly the volume compatibility (very large or very small guests do not fit properly based on 
ratio of coefficient packing V guest/ V cryptophane = 0.55)
51, size and shape of the guest (globularly 
shaped guests) and electronic effect (highly polarizable atoms like xenon) and of course the 
symmetry of the cage itself, which greatly affects the binding properties.27  
 
Figure 10: constrictive binding of guests by sliding the portals (linkers), followed by the adjustment of the cavity 
size.  
 
Complexation studies are investigated in both organic and aqueous media depending on the cage 
solubility and the guest of interest. 1H NMR spectroscopy serves as a leading tool to study such 
interactions, showing a high shielding of the encapsulated guest by the effect of the cage’s ring 
Flexible portals Adjustment of the cage upon complexation
Guest
Guest
Guest
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current. Isothermal calorimetric titration (ITC) appears as another useful method to measure 
accurately the association constant in water or in organic solvents. In addition, this method gives 
access to thermodynamic parameters of complexation (ΔH°, ΔS° and ΔG°). Thus ITC is a very 
important analytical tool to understand how the binding process between a cryptophane and a 
guest molecule takes place. Brotin and co-workers have used intensively this method to 
determine the association constant between water-soluble cryptophanes and cationic species. 
Below is a representative ITC plot for the titration of cryptophane-[222] (OH)5 dissolved in LiOH 
(0.1M) and Tl(OAc) performed at 298K. This titration reveals the strong association constant (Ka 
= 2.39 109 M-1) of Tl+ by this cryptophane derivative, Figure 11.52 
 
Figure 11: representative plot of the raw ITC data for the titration of cryptophane-[222] (OH)5 (29.9 µM) with Tl+ 
(401 µM) in competition with Rb+ (299 µM). 
  
In the coming sections, we will describe the different types of guests encapsulated by 
cryptophanes in solution. 
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1.4.1. Encapsulation of Neutral Species: 
Cryptophanes are well known for their interesting ability to encapsulate neutral molecules like 
CHCl3, CH2Cl2, isobutane, CHFClBr, CHFClI, epoxides, and gases like methane and 
xenon.53,54,55,29,56,57 These complexation studies are done in solution. 1,1,2,2-tetrachloroethane 
appears as the solvent of choice because it is too big to enter the cavity of the smallest 
cryptophanes (cryptophane-[111], cryptophane-A, cryptophane-C). Thus it does not act as a 
competitor with the guest studied. Other non-competing solvents might also be employed like 
bis(trichlromethyl)ketone that was used by Crams and coworkers.58 Recent studies show that 
1,1,2,2-tetrachloroethane can partially enter the cavity of cryptophane-E and larger 
cryptophanes.48 What is quite interesting in these complexes is the ability of cryptophanes to 
scavenge lipophilic guests in organic solvents, without having a hydrophobic effect. Another 
remarkable feature is that cryptophanes differentiate guests based on little volume changes. For 
example, cryptophane-E has a higher affinity to CHCl3 compared to CHCl2Br.
59 
1.4.2. Enantioselective Binding of Guests: 
Enantioselective binding of chiral guests is also possible with cryptophanes. Unfortunately, 
the number of examples reported in the literature is rare because enantiopure cryptophanes are 
hard to obtain and the number of small chiral guests that can enter their cavity is limited and 
difficult to obtain in their enantiopure form. This enantioselective binding was first demonstrated 
by distinguishing the two enantiomers of CHFClBr by 1H NMR spectroscopy using cryptophane-
C ([222] (OMe)6). The difference in binding constants between the two diastereomeric complexes 
affects the orientation adopted by the guest inside the cavity and its magnetic properties, which 
will be readily detected by 1H NMR spectroscopy. Enantioselective complexation of R-methyl 
oxirane was also realized in water by enantiopure PP-cryptophane-[222] (OH)5 with a free 
Chapter 1: Bibliography 
Page | 30  
 
energy difference 1.7 kJ/mol compared to the less stable S-methyl oxirane@PP-cryptophane, 
Figure 12. Recently, the complexation of additional oxiranes by the same cryptophane derivative 
was also tested and studied by 1H NMR and electronic circular dichroism spectroscopy, ECD. 
Most interestingly, 2,2′-bioxirane, which has two chiral centers shows three diastereomers in the 
presence of enantiopure cryptophane. These diastereoisomers are readily distinguished by 1H 
NMR spectroscopy.60,61   
 
Figure 12: enantioselective encapsulation of (R)-epichlohydrin cryptophane by MM-cryptophane-[222] (OH)5. 
  
1.4.3. Encapsulation of Cationic Species: 
Cryptophane cages are also suitable for cation complexation. The encapsulation of organic 
(ammonium) cations has been thoroughly studied in the past. However, complexation of metallic 
cation is more recent. Remarkably, the binding of alkali cations (rubidium, cesium) occurs in 
water, a strong competing solvent, and under basic conditions in order to solubilize the 
cryptophane derivative. As revealed by titration experiments, this work has shown that thallium 
(Tl+) (caution: very toxic) is very well recognized under these conditions. More recently, some 
measurements have also been obtained at pH close to 7, with new cryptophane derivatives. In 
cation complexation, the presence of phenol groups seems mandatory to observe an efficient 
binding and the replacement of these groups by carboxylic acid moieties results in a lack of 
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complexation. For instance, cryptophane hexa-carboxylate does not bind cationic species such as 
cesium or thallium cations under the same conditions.62,63,64,65,66,67 
1.4.4. Encapsulation of Anionic species: 
The electron rich cavity of cryptophanes renders anion complexation impossible. Coordination 
of the aromatic rings with electron withdrawing transition metals from their outer rims makes 
cryptophane’s cavity poor in electrons, thus suitable for anion complexation. This has been 
smartly demonstrated by Holman and co-workers that reported a water soluble cryptophane-[333] 
(OMe)6 cage with six [Cp*Ru]
+ moieties. Encapsulation of [CF3SO3]
-, [SbF6]
- and [PF6]
- was 
then achieved using this cage and they were stabilized by π-anion interactions, Figure 13.68  
 
Figure 13: structure of water soluble cryptophane [333] (OMe)6 [Cp*Ru]Cl6. 68 
 
2. Synthesis of Cryptophanes 
The construction of cryptophane cages has been achieved in three different ways, the simplest 
direct method, the template method and the coupling method, all starting from the vanillic alcohol 
building block. These methods mainly differ in the way of creating and/or connecting the two 
CTB units.27 Each method has its own advantages and inconveniences and we will give one or 
two examples per each. 
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2.1. Direct Method or Two-Step Cryptophane Synthesis:                   
The direct method consists of the trimerization of properly bridged and substituted vanillic 
alcohol dimers. With six consecutive Friedel-Crafts alkylations under acidic conditions (usually 
formic acid works very well), the direct method provides cryptophanes in low yields and it gives 
a lot of side-product (mainly polymerized byproducts). The reaction is controlled by the 
diffusion, so it is not possible to use diluted conditions to decrease the formation of the 
byproducts. This strategy allows the access of exclusively D3 and C3h symmetrical cages, and it is 
more suitable for the construction of intermediate size cages (bridge size < 6) as the increase in 
the bridge length drops the yield to the favor of the intramolecular condensation.37,69 The 
approach has been used by chemists to obtain cryptophanes rapidly for complexation studies but 
it is less used to obtain sophisticated functionalized cages. An example is given with the synthesis 
of cryptophane-E, which has been obtained with a relatively high yield of 20%, Figure 14. In the 
case of cryptophane-A, the same approach gives rise to this derivative with an extremely low 
yield (1-2%).  
  
Figure 14: synthesis of cryptophane-E starting from vanillic alcohol by the direct method where it is obtained in 20% 
yield. 
 
 
Cryptophane-E
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2.2. Template Method: 
The template method is the earliest and by far the most employed approach to prepare 
cryptophane derivatives, because it allows the access to a wide range of cages of different 
symmetry and functionalization.18 It is also the most appropriate method to obtain fair quantities 
of cryptophanes. In this method a CTB unit is first constructed, then elaborated by the attachment 
of three bridges with peripheral benzyl alcohols to form the so-called “template”. The cyclization 
of the second CTB is usually carried under diluted acidic conditions usually 10-3 M in pure formic 
acid or in equal mixture of formic acid/CHCl3. Other conditions have been used to conduct the 
second intramolecular cyclization like perchloric acid/methanol mixture, and scandium triflate/ 
acetonitrile mixture. The latter provides a milder condition and makes purification easier.70 The 
main advantage of this method compared to the direct method is that it is not diffusion controlled, 
this indicates that more diluted conditions can be used, thus decreasing the polymeric side-
products. With this strategy, accessible synthesis of C1-symmetric cages with different bridges 
and substituents is achieved. A wide range of syn and anti-configurations are constructed. The 
diastereoselectivity of the cyclization is dependent on many conditions like substituents and 
linker’s length, which are usually hard to control and predict. For example, it was believed that 
cryptophanes with an odd number of carbons on the linker tend to give syn-configurations, 
whereas, even ones give anti-configurations. Opposite to this claim, nona- and dodecamethoxy-
[222] cryptophanes, give rise to anti and syn configurations, although they have even number of 
carbons on the linkers.71 As an illustration of the higher yields obtained with template method 
compared to the direct method, we can talk about cryptophane-A, which is obtained in a higher 
yields (80%) compared to 1-2% yield, Figure 15. 
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Figure 15: synthesis of cryptophane-A by the template method with 80% yield.  
 
2.3. Coupling Method: 
As its name implies, the method relies on the coupling of two properly functionalized CTB 
units. Unlike the first two methods, in the coupling approach no need to use acidic conditions. 
Coupling method was first utilized by Cram and coworkers in 1991 to couple a bis-alkyne-
bridged CTB by cupric oxidative coupling.58 This method was later employed to synthesize other 
cryptophanes like the cryptophane-[111] by Brotin, Dutasta and co-workers, Figure 16,55 and 
cryptophane-[000] by Hardie and co-workers.54 Asymmetric cryptophanes-[221] and [112] by 
Rousseau and co-workers72 and aryl-bridged cryptophane by Holman and co-workers73 have also 
been prepared in low yields by using a similar approach. 
 
Figure 16: synthesis of cryptophane-[111] by coupling method. 
 
Cryptophane-A 80 %
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2.4. Functionalization and Solubilization of Cryptophanes: 
As many other symmetrical lipophilic supermolecules, the main synthetic challenge relies on 
the selective functionalization and solubilization of the core. These two different aspects are very 
important for the design of xenon-biosensor, as it will be seen later. Added functionalities can 
eventually be used to introduce a sensing unit, water solubilizing groups, a chiral moiety to 
optically resolve cryptophanes enantiomers or an anchoring arm to attach them to nanoparticles. 
These functionalities can be introduced either before or after the cage cyclization. Herein, a 
detailed description of the functionalization strategies is addressed.  
Readily formed cryptophanes can be modified by substituting the existing functionalities, mostly 
methoxy groups, with other ones via alkylation, acetylation or dehydroxylation. Since 1987, 
André Collet reported an efficient selective procedure to remove the six methoxy groups on 
cryptophane-A core, using lithium diphenylphosphide producing a water soluble cage with six 
phenols. Since then, Brotin and co-workers have reported an improved approach. The six phenol 
moieties are then replaced by other functionalities like acetates or methyl esters, Figure 17. The 
latter are then hydrolyzed to give six carboxylic acid groups providing a water soluble cage up to 
pH = 5.74,34 Other cages of different linker size were also functionalized by this way offering 
water soluble cryptophanes.67  
 
Figure 17: functionalization of cryptophanes after a demethylation step either by alkylation or acylation reactions. 
Water soluble hexa-phenol Water soluble hexa-acid Hexa-acetate derivativeHexa-methoxy derivative
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The template method is the method of choice to synthesize asymmetric cages with different 
linkers’ length and substituents. This method is widely employed to construct different 
cryptophanes families like mono, tri and dually functionalized cages. In this strategy, a suitably 
decorated linker or linkers are grafted on the CTB followed by the formation of the second CTB 
cap. 
To talk about the mono functionalized cryptophanes, Brotin and co-workers were able to 
successfully synthesize mono-allyl protected cryptophane-A derivative, Figure 18. Exploiting the 
template method, a single ethylenedioxy arm possessing an allyl protected benzyl alcohol was 
introduced to a doubly alkylated CTB, cyclization under acidic conditions yielded the 
corresponding product, which was further utilized to construct a wide range of symmetric, 
asymmetric and dimeric cages.75,76,77,78  
 
Figure 18: synthesis of mono-allyl protected cryptophane-A from its corresponding template.  
 
Using the same strategy, Dmochowski and co-workers reported the synthesis of mono-
propargylic cryptophane-A derivative, which was then functionalized by copper catalyzed 
cycloaddition.79 By the same group, successful allyl, benzyl or propargyl tri-functionalized-[222] 
cages were described using scandium triflate or perchloric acid/methanol for the cyclization 
step.70,80 Equally, Rousseau and co-workers described a water soluble tri-functionalizable cage 
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with three polyethylene glycol groups (PEG) and three propargyl groups on the second CTB, 
which proved their reactivity for Huisgen cycloaddition.81 Schröder and co-workers also reported 
a dually dendronized cage with enhanced water solubility, Figure 19.82,83 In the latter case, it is 
worth mentioning that the corresponding di-acidic derivative has never been described. 
According to our knowledge in cryptophane synthesis, we believe that the two acidic moieties are 
grafted on the same CTB units, and that the structure of the dendrimer substituted cage is not 
correct. 
 
Figure 19: access of multiply functionalized cryptophane by template method. 
  
Apart from cryptophane-A platform, Brotin and co-workers reported a dually functionalized 
cryptophane-[223] core using the template method, bearing a central hydroxy group on the 
propylenedioxy arm and six methoxy groups on the CTB rims. Demethylation of this cage with 
lithium diphenylphosphide (1 M) provided the cryptophane hexa-phenol with central secondary 
alcohol, which is soluble in water under basic conditions and has a high affinity to metal cations 
One propargyl group Three propargyl groups Three propargyl and three peg chains
Two dendrimers Two carboxylic acids
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like cesium and thallium. The obtained phenol groups were either acetylated or alkylated by 
methyl bromoacetates. Hydrolysis of methyl esters provided a water-soluble cage with six 
carboxylic acid moieties and a central hydroxyl group, Figure 20. Further functionalizations were 
made on the central secondary alcohol like mesylation and alkylation as will be detailed in the 
second chapter.41  
 
Figure 20: family of dually-functionalized cryptophane cages bearing a central hydroxyl group and six modifiable 
groups on the CTB rims. 
 
Introducing water-solubilizing substituent is even more complicated with other cryptophanes 
such as cryptophane-[111] skeleton since this compound is devoid of substituents. Indeed, in 
absence of any existing functionality on cryptophane-[111] core,55 new methods have been 
developed to render it water soluble and functionalizable. Cryptophane-[111] core was first 
solubilized in water by the metalation of the arene rings with six [Cp*Ru]+ moieties.84 
Introduction of a single substituent was also possible by introducing iodine or bromine followed 
by palladium catalyzed coupling reactions.85,86,87  Metal-free water soluble cryptophane-[111] was 
also synthesized by Rousseau and co-workers, by an amide coupling of the mono-carboxylic acid 
derivative with a single tri-sulfonated linker, Figure 21. 
Dually functionalized cage Water soluble hexa-phenol Water soluble hexa-carboxylic acid 
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Figure 21: example on mono-functionalization of cryptophane-[111] by water-solubilizing group. 
3. Xenon-cryptophane Properties and Applications 
Xenon is an inert noble gas discovered by Ramsay and Morris Travers in 1898 and obtained 
by fractional distillation of the liquid air.88 The biocompatibility of the gas has been demonstrated 
in 1951, by Stewart C. Cullen who showed its anesthetic effect.89 Xenon is a doping agent that 
enhances athletic performance and it has been forbidden since 2015 by the World Anti-Doping 
Agency (WADA).90,91,92 Among the eight naturally occurring isotopes, only 129Xe and 131Xe are 
stable with natural abundance of 26.5% and 21.1% and nuclear spins of 1/2 and 3/2, respectively, 
making them NMR active. 129Xe is the most used isotope thanks to its higher abundance, simple 
NMR signature and the possibility to be hyperpolarized, which will be seen later. Bearing 54 
electrons and a volume of 42 Å3, xenon electronic cloud is highly polarizable, and it interacts 
strongly with the surrounding environment via London dispersion forces and hydrophobic 
interactions. This high polarizability is reflected by the large chemical shift range (about 300 ppm 
in water for non-covalently bound xenon) indicating also the large sensitivity of the gas to its 
surrounding environment.93 Apart from sensitivity, high polarizability renders the gas lipophilic 
and this may explain its anesthetic behavior.89 Ostwald solubility or the ratio of the volume of gas 
absorbed to the volume of the absorbing liquid at the same pressure and temperature is given in 
table 2, which shows a moderate and high solubility of the gas in aqueous and organic media, 
respectively. For example the solubility of the gas in fat tissues (1.3) is almost 10 times higher 
than that in blood (0.14).94 
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Liquid Ostwald Solubility 
Hexane 4.8 
Oil 1.9 
Fat Tissue 1.3 
DMSO 0.66 
Water 0.11 
Blood 0.14 
Plasma 0.1 
Saline 0.09 
 
Table 2: solubility of xenon in different media. 
 
In addition to the high sensitivity, wide range solubility and chemical inertness, long relaxation 
time is another important property to be added to the list. Unlike proton relaxation mechanisms, 
xenon relaxation times are affected by intrinsic and extrinsic parameters (transient and persistent 
Xe-Xe van der Waals dimer relaxations as the intrinsic factors (spin-rotation); atomic diffusion 
through gradients of the magnetic field and interaction with the cell wall relaxations as the 
extrinsic factors (dipole relaxation)). These relaxation processes contribute differently if xenon is 
in the solid, liquid or gas phase. For liquid state, relaxations are mostly decreased by wall and 
solvent interactions and the presence of oxygen or any paramagnetic species drastically decrease 
the relaxation times T1 and T2 of xenon.
95 
The simplest way to introduce xenon into the body is by inhalation.96 Thanks to this, real-time 
high-resolution lung imaging was achieved, which is usually hard to attain by the conventional 
MRI, due to low proton density. This is currently a hot research topic that may offer new imaging 
utilities for medical applications.97,98 Some 129Xe MRI brain experiments have been also realized 
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in rodents. Intravenous and arterial introduction of the gas allows a specified organs imaging.99,100 
All these experiments are promising and suggest that xenon can be used as an exogenous tracer 
for biomedical studies. 
As mentioned previously, the characteristic volume of xenon (42 Å3) allows its encapsulation in 
different hosts of matching cavity volume. In 1998, Bartik et al. reported the first 
129Xenon@Cryptophane-A inclusion complex in 1,1,2,2-tetrachloroethane-d2. The binding 
constant is impressively high, of about 4000 M-1 even higher than that of chloroform and 
dichloromethane in 1,1,2,2-tetrachloroethane-d2. The 
129Xe@Cryptophane complex is stabilized 
by London dispersion forces between the polarizable atom and electron rich aromatic rings. Over 
the past two decades, a wide variety of cages has been synthesized for this purpose, most 
interestingly,  the cryptophane-[111] cage synthesized by Brotin and Dutasta, showing the 
highest binding constant of xenon of about 10000 M-1 in 1,1,2,2-tetrachloroethane-d2 due to the 
perfect volume compatibility. Since then, cryptophane cages have been intensively used for 
xenon encapsulation in organic and aqueous media. Moreover, cryptophanes are not the only 
hosts for xenon encapsulation in solution, where several other molecular hosts capable of xenon 
complexing have been reported in the literature. 
3.1. Different Hosts for 129Xe Inclusion: 
α-cyclodextrins are cyclic oligosaccharides that possess a relatively apolar internal cavity of 
volume in the order of 140 Å3. This large cavity size makes the 129Xe association constant very 
weak (Ka = 22.9 M
-1) in water and the in-out exchange is relatively fast. The formation of 
xenon@cyclodextrin complex in that case was proved by proton–xenon heteronuclear NOE 
experiments.101 Recent study investigated a cyclodextrin based pseudo-rotaxane, where the large 
cavity was threaded with a disubstituted alkyl chain, to decrease its volume, hence slowed the in-
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out exchange rates.102 Thiacalix[4]arene also showed weak binding constants (Ka = 13.6 M
-1) to 
xenon, with a concentration dependent chemical shift variations.103 Ternary complexes of 
pillar[5]arene derivative, an organic guest and xenon were also studied, showing a variation in 
the xenon chemical shift upon adding the organic guest like hexane.104 Better association 
properties were recorded with cucurbit[n]urils CB, which are composed of n glycoluril units and 
have a hydrophobic cavity accessible through two identical portals surrounded by polar carbonyl 
groups. Specifically, water-soluble CB* [6] derivative has a high xenon binding constant in water 
of 3000 M-1 obtained by ITC. The appearance of two signals for the free (190 ppm) and 
encapsulated xenon (97 ppm) indicates a slow exchange between the bound and unbound species 
at the NMR time scale. It is worth mentioning that in CB xenon’s in-out exchange rate can be 
modulated by adding cations that interact with the polar carbonyl groups, hindering by this the 
kinetics of exchange, Figure 22.105,106,107,108 The first in-vivo imaging for the detection 129Xe@CB 
[6] in water was also performed, where it was possible to localize the cage in brain, heart, 
kidneys, liver and aorta. 109  
 
Figure 22: 129Xenon NMR spectra of xenon in the presence of CB* [6] in pure water (above) and aqueous Na2SO4 
solution at 298 K. 
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3.2.129Xenon@Cryptophane Complexes: 
Compared to the previously discussed molecules, cryptophane appears as the host of choice 
for xenon encapsulation due to many different reasons.110 Along with the high binding constants, 
slow exchange at the NMR time-scale and relatively optimized in-out kinetics, the possibility to 
functionalize cryptophanes is a significant property to be added on the list. With this property, 
successful grafting of water solubilizing or sensing units is made possible. In addition, the latter 
allows a perfect tuning of xenon complexation properties like chemical shifts, binding constant, 
and kinetics. For the moment, cryptophanes are the most investigated hosts in this domain, where 
a notable number of cages have been developed with various cavity size, substituents and 
applications. Each of these cages has different binding affinity and chemical shift depending on 
their structures and this will be detailed in the next paragraphs.  
3.2.1. 129Xenon@Cryptophane Binding Constants: 
One factor affecting xenon binding affinity is the cavity volume. In organic media, usually 
1,1,2,2-tetrachloethane, smaller cryptophanes like cryptophane-[111] and [222] (OMe)6 (A), with 
a cavity volumes of about 81 and 95 Å3  respectively, tend to have high binding constants, of 
10000 M-1 and 3900 M-1, respectively.55,110 Larger cages showed a lower binding constant as 
expected, like cryptophanes [223] (OMe)6, [233] (OMe)6 and [333] (OMe)6 (E), with binding 
constants of about 2800, 800 and 10 M-1 respectively.111 This trend confines with the packing 
coefficient of the guest to host volumes described earlier that must be 0.55. For example in 
cryptophane-[111] and cryptophane-A, these coefficients are equal to 0.49 and 0.6, respectively, 
which are more or less optimal for these complexations. In aqueous media, however, higher 
binding constants are usually observed due to the hydrophobic effect of the lipophilic cavity. The 
interaction in aqueous media is entropically favored, where water molecules filling possibly the 
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hydrophobic cavity tend to leave to be replaced by the lipophilic gas. For example, cryptophane-
[111] (RuCp*)6Cl6 exhibits a binding constant of about 29000 M
-1.84 Cryptophanes 
functionalized with hexa-carboxylic groups like cryptophane-A hexa-acid (Ka~6800 M
-1), [223] 
(OCH2CO2H)6 (Ka~2200 M
-1), [233] (OCH2CO2H)6 (Ka~2200 M
-1) and finally cryptophane-E 
(OCH2CO2H)6 (Ka~1000 M
-1) show higher binding constants compared to their congeners in 
1,1,2,2-tetrachloroethane, but still following the same decreasing trend in terms of increasing 
cavity volume.50 Tri-functionalized water-soluble cages, based on cryptophane-A derivative, 
were also described to effectively bind xenon showing incomparable high binding constants up to 
Ka~ 42000 M
-1, Figure 23. It is worth mentioning that these values are obtained by ITC and not 
by xenon NMR spectroscopy, making the comparison between the previously mentioned values 
difficult.80,112,113  
 
Figure 23: structure of water-soluble tri-functionalized cryptophanes cages bearing different functionalities 
displaying different xenon binding constants. 
  
Substituents on the cryptophanes rims, also affect the values of binding constants as illustrated in 
the previous example. A clearer effect can be seen with the tri-functionalized cryptophanes [111] 
shown in Figure 24, where adding three methoxy or three bromine atoms drops the binding 
constants to Ka~10 M
-1, this can be directly explained by the packing coefficient, which is 
approximately equal to 0.79 larger than the one described for the non-functionalized 
Ka= 420000 M-1 Ka= 33000 M-1 Ka= 17000 M-1
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cryptophane-[111] cages. It seems that these substituents hinder xenon binding by preventing the 
cage to adopt a syn periplanar expanded conformation.114 Up to now, rim functionalization is only 
limited to oxygen derived substituents. However, adding new original functions or different 
heteroatoms like sulfur or nitrogen is quite complicated. Thus the trend predicted of binding 
constants is restricted to what have been synthesized. 
 
Figure 24: structure of tri-functionalized cryptophane-[111] derivatives. 
 
3.2.2. 129Xe@Cryptophane Chemical shift: 
Xenon polarizability is clearly reflected by the ultimate sensitivity of its surrounding 
environment, which has been illustrated in different examples. For instance, in an original 
example, a series of deuterated cryptophanes were prepared and their 129Xe complexes were 
studied. The 129Xe NMR spectroscopy revealed that the encapsulation of xenon in completely 
deuterated cryptophane-A derivative leads to an upfield shielding of its signal by 1.19 ppm 
compared to the one non-deuterated cage. This example manifests the extraordinary sensitivity of 
this element to discriminate between the non-deuterated and deuterated cryptophane cages.115 In 
addition, a mixture of diastereomers may split a xenon signal into two, each corresponds to a 
different isomer.116,117 Variations in solvent, temperature, pressure, pH or structure of the host 
induce a detectable change in  129Xe chemical shift. Pines and co-workers have demonstrated the 
use of 129Xe@cryptophane-[222] derivative for MRI thermometry. Upon temperature change, the 
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chemical shift of the encapsulated 129Xe increases linearly with a rate of 0.1 to 0.3 ppm/K. This 
change is a result of increase in both, the cryptophane’s conformational flexibility and the 
accessibility of xenon to new cryptophane’s regions. The temperature variations were 
successfully mapped by MRI, facilitating the detection of temperature changes up to 0.1 °C.  
To talk about the effect of cavity volume on xenon’s chemical shift, a series of cryptophanes 
[222], [223], [233], [333] bearing identical substituents ((OMe)6 or (CH2CO2H)6), have been 
studied in 1,1,2,2-tetrachloethane-d2 or water. The study showed a subsequent decrease in the 
chemical shifts by almost 10 ppm from smallest to largest cages. Although this trend seems to be 
directly linked to cavity volume, in reality it is likely to be a consequence of many different 
parameters like cage’s shielding effect and most importantly the conformation adopted by the 
linkers upon xenon encapsulation.111  
In general, for cryptophanes-[222] type molecules, the chemical shift varies from 62-78 ppm in 
both aqueous and organic media. Contrary to the formerly mentioned trend, the smallest 
cryptophane-[111] has a chemical shift of 31 ppm in 1,1,2,2-tetrachloroethane-d2. In this cage, 
possible modulation of the chemical shifts in cryptophane-[111] is achieved by grafting electron 
donating or withdrawing groups of different sizes and orientations on the cage rims. For instance, 
Xe@tri-methoxy or Xe@tri-bromo functionalized cages show chemical shifts of 39 and 80 ppm, 
respectively. 114 Additionally, going from electron-poor hexa-boronic acid cryptophane to the 
electron-rich hexa-hydroxy cage by oxidation triggers a shielding in chemical shifts by almost 62 
ppm.118 This fact is also impressively illustrated in water soluble cryptophane-[111] (RuCp*)6 
Cl6. In this innovative example, the chemical shift of the water soluble cage is completely 
reversed and it appears at 301 ppm, downfield shifted by about 277 ppm compared to the organic 
version appearing at 31 ppm.84 These examples show that even a small structural change of the 
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cryptophane skeleton induces large chemical shift variations of the 129Xe signal. This effect is 
mainly a consequence of the ring current modification that takes place upon these changes. In 
turn the modification in ring current modifies the magnetic properties of the xenon nucleus, 
Figure 25.  
 
Figure 25: schematic presentation of 129Xe@cryptophanes chemical shifts in water and in organic media. 
 
4. Xe@Cryptophane Biosensors for NMR and MRI Applications 
Combining the exceptional properties of cryptophanes (encapsulation and modulation of 
chemical structure) and xenon (magnetic properties and hyperpolarization) paves the way to 
develop a new class of ultrasensitive non-invasive molecular MRI tracers. The principle of these 
NMR biosensors relies on varying the resonance frequency of the encapsulated xenon, compared 
to the bulk, which can be exploited to monitor changes at the molecular level.  This concept has 
been first demonstrated in 2001 by Pines and co-workers, where they described the first 
129Xe@Cryptophane biosensor for avidin in-vitro detection. A cryptophane-[222] monoacid, 
functionalized with a water solubilizing linker consisting of amino-acid chain, and a biotinylated 
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tail was specifically prepared for this purpose. Upon biotin-avidin complexation, a change in the 
cage environment i.e. rotational and vibrational motions is excellently translated by a 
hyperpolarized 129Xe chemical shift variation. In this example, an unambiguous assignment of 
free, caged and caged xenon recognizing the protein was done, showing a downfield shift by 
about 2.3 ppm upon avidin complexation, Figure 26.119 Later on, a detailed description of the 
obtained signals was performed, showing the sensitivity of the caged xenon to different 
diastereomers present in solution.116 Several versions of this biosensor bearing linkers of variable 
flexibility and length were synthesized, in an attempt to optimize its design to get better 
responsiveness (structure a in figure 37).120  
 
Figure 26: structure of the first Xenon@Cryptophane based sensor and the corresponding HP xenon spectrum, 
showing at around 70 ppm the signals of cryptophane-encapsulated species. Upon avidin addition, a shift of about 
2.3 ppm is observed with a decrease in the intensity of xenon encapsulated in functionalized cage.  
  
The important sensitivity gain delivered in this example is due to the use of hyperpolarized (HP) 
129Xe compared to the much less sensitive thermally polarized gas. Hyperpolarization is defined 
as a transient imbalance in the nuclear spin repartition between energy levels, which initially 
120 % 
Avidin
60 % 
Avidin
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follows the Boltzmann distribution.77 Perturbing Boltzmann populations of nuclear spins will 
increase the polarization consequently increasing the global magnetization. Typically, this will 
enhance the signal by four to five times orders in magnitude depending on strength of the 
magnetic field B0. Hyperpolarization is achievable by different methods like Brute force, 
dynamic nuclear polarization (DNP) but Spin Exchange Optical Pumping (SEOP) remains the 
most convenient and rapid method to produce small amount of hyperpolarized 129Xe, Figure 
27.121 Nevertheless this technique is not common in laboratories and it requires specific skills to 
design and operate this kind of apparatus. For this reason our team established an old 
collaboration with Dr. Patrick Berthault and his co-workers in CEA, (Paris, Saclay), who are 
specialized in the production of (HP) 129Xe by SEOP using the apparatus shown in Figure 27. In 
addition this group has succeeded to use (HP) 129Xe as an MRI tracer and developed new NMR 
sequences and protocols for efficient sensors detection. 
 
Figure 27: equipment for production of hyperpolarizing xenon gas of Berthault group at CEA Paris.  
 
Technically speaking, SEOP is a two-step process polarization. The first step involves the 
polarization of electronic spins of the gaseous alkali metal (Rubidium), followed by a transfer of 
this polarization to the nuclear spins of the noble gas by Fermi-contact interactions. Usually, 
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another gas (nitrogen) is added to the cell to favor this process and to quench the fluorescence of 
the rubidium atoms. In the first step, the presence of a magnetic field renders the magnetic 
moments (mg= +/- 1/2) of both the ground (
2S1/2) and excited states (
2P1/2) non-degenerate 
(different in energy). Circularly polarized laser tuned at the D1 transition of Rb, i.e. at 794.7 nm, 
is applied leading to the excitation of spin population from ground state (mg = - 1/2) to the 
excited state (mg = + 1/2). In other words, the angular momentum of the photon is transferred to 
the electron of the rubidium atom. The relaxation however takes place by the accumulation of 
spin population in the (mg = + 1/2) state rather than (mg = - 1/2) of the ground state thus leading 
to electronic spins hyperpolarization of the rubidium atoms. In the second step, the electronically 
polarized Rb steam collides with the noble gas (129Xe) leading to a spin exchange consequently 
forming a nuclear spin polarized 129Xe, Figure 28. Hyperpolarized, 129Xe can be stored at low 
temperature (77 K) in the solid state in a magnetic field of 0.1 T, where it is possible to maintain 
its polarization for a long time depending on the storage conditions.122,123 Great care has to be 
taken to avoid the gas depolarization by using for example special cells coated with silane- or 
siloxane coatings. 
 
Figure 28: SEOP cell is irradiated by circularly polarized laser light that can be absorbed by the Rb atoms. The first 
step involves a photon absorption resulting in selective population depletion from one Rb ground electronic state 
leading to its hyperpolarization. In the second step, gas-phase collisions allow spin order to be transferred from the 
Rb atom electrons to the noble gas nuclei by Fermi contact hyperfine interactions, thus hyperpolarizing the noble 
gas. 
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Over the last ten years, many efforts have been made to detect very low concentrations of xenon-
complexes. For example, Pines and co-workers have shown that hyper-CEST (Chemical 
Exchange Saturation Transfer) experiments can be used to gain more sensitivity.124 This 
technique relies on the indirect detection of the biosensor, which are usually present in 
micromolar concentrations via observing the variations at the bulk level, which is present in 
millimolar concentrations.125 In this experiment, caged xenon is first irradiated by a saturation 
pulse to depolarize it. The depolarized caged nucleus is then exchanged with the bulk by another 
(HP) one. Upon its encapsulation, (HP) 129Xe will be depolarized and exchanged again. The 
process is repeated many times leading to the accumulation of depolarized 129Xe in the bulk, 
which in turn decreases the intensity of free 129Xe, (on-resonance spectrum in Figure 29). 
Observing the difference between on/off resonance spectra allows the signal enhancement by 
three times order in magnitude consequently decreasing the detection threshold to picomolar 
range, Figure 29.  
 
Figure 29: hyper-CEST detection scheme for encapsulated 129Xe a) the initial spectrum obtained after a second of 
acquisition without selective irradiation b) selective radio frequency depolarization of the encapsulated 129Xe 
resulting in its depolarization and the accumulation of depolarized gas in the bulk c) the resulting spectrum from 
selective “on resonance” saturation of the encapsulated 129Xe showing a drop in its intensity. 
Free Xe
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This technique is currently used to record magnetic resonance images of some (HP) 129Xe tracers. 
Some of these tracers will be discussed in the next section. 
4.1.129Xe@Cryptophane Sensors:  
With the increasing number of Xenon@Cryptophane sensors, one can distinguish between two 
types, smart or density based sensors.77 In the former, an interaction with the biological target 
either generates or shifts the existing 129Xe signal, in the latter, a variation in signal intensity as a 
function of local environment is observed. In the next paragraphs, we will present briefly an 
overview of some xenon-based sensors. The biosensors will be arranged based on the 
contribution of different groups working in the field and the sensors derived from cryptophane-A 
will be referred to as cryptophane-[222] derivatives. 
4.1.1. Pines and Co-workers: 
The first milestone example described by Pines and coworkers established the basics of this 
field, and opened the gate for further developments at structural and technical levels. In parallel 
to the synthesis of biosensors, Pines and co-workers have developed new NMR techniques to 
enhance the (HP) 129Xe NMR sensitivity or to spatially map it. For example, spectrally resolved 
magnetic resonance images of a biotinylated sensor, Figure 30, were achieved. Cages were first 
immobilized on an avidin bearing surface thanks to the strong affinity between avidin and biotin 
(Ka = 10
15 M-1). Then, a current flow of (HP) 129Xe saturated water was passed through the 
sample. Thanks to the high chemical shift difference among the xenon pool and the cryptophane-
biotin complex, a successful detection of the bound xenon with almost zero background noise 
was performed, Figure 30.126   
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Figure 30: structure of the water soluble biotinylated biosensor immobilized on avidin bearing agarose beads. On the 
right are the spectrally resolved xenon-based MR images of the agarose bead. 126   
 
As previously illustrated, (HP) 129Xe is sufficiently sensitive to distinguish between 
diastereomeric mixtures of cryptophanes. To avoid this problem, the group proposed a new 
approach based on simply constructing supramolecular assemblies of cryptophane-[222] 
monoacid and amine-bearing dendrimers. These assemblies are stabilized by acid-base and 
hydrophobic interactions. A single assembly bears more than one cryptophane cage, which in 
turn leads to an amplification of the (HP) 129Xe signal intensity.127 In another example, the group 
utilized a mono-acid cryptophane-[222] derivative (structure b in figure 37) and attached it to a 
viral capsid. With almost hundred twenty-five cages grafted on the capsid surface, enhancement 
of sensitivity to picomolar (0.7 pM) level has been realized.128 In another example, the grafting of 
several cryptophane-[222] derivatives (structure c in figure 37) to EGPR-targeted bacteriophages 
for cancerous cell detection was also done. The detection of these cancerous cells was performed 
with high specificity. This was successfully demonstrated by using in-cellulo 129Xe NMR 
spectroscopy assisted with hyper-CEST experiments. Fluorescence imaging also assured the 
Splitting of the image between the
xenon in the bead and xenon in water.
Agarose bead sample with
immobilized biosensor
Liquid flow
Spectrally resolved MR
image of the sample
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specific cell-surface binding with minimal cell internalization of the targeted bacteriophage with 
cancerous cells.129  
4.1.2. Berthault and Co-workers: 
Among the different contributions of this group in the field, we chose here to discuss only 
some major examples. Similar to Pines, Berthault group selected to work with cryptophane-[222] 
monoacid cage and functionalized it with short DNA strand (structure d in figure 37). It is 
noteworthy that in this example an enantiopure cryptophane derivative was used for the design of 
the final molecule. Detection of the hybridization of this strand with its complementary sequence 
was made possible via simple (HP) 129Xe signal and a moderate downfield shift by 0.5 ppm was 
observed at low concentration (10 µM). At higher concentration, the authors observed micelle 
formation, which in turn resulted in the appearance of multiple signals. Interestingly, introducing 
a non-complementary sequence did not change the initial chemical shift. This type of 
experiments is rather complicated by 1H NMR especially at low concentrations.130  
In 2011, the same group reported the first internalization (endocytosis) of a cryptophane sensor to 
a cell, by grafting cryptophane cages to the transferrin protein (a cell penetrating peptide). A dual 
detection by 129Xe NMR and fluorescence imaging assured the internalization. Unfortunately, the 
hydrophobic nature of the cage led to non-specific interactions with cell membranes, which were 
also revealed by 129Xe NMR, Figure 31.131 These results highlighted the hydrophobicity of 
cryptophanes and suggested that a modification of the cage’s solubility has to be considered. The 
problem can be solved for instance by introducing water-solubilizing substituents on the 
cryptophane skeleton, which is crucial to ensure a good solubility in physiological media for in-
vivo 129Xe MRI experiments. 
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Figure 31: a) structure of the cryptophane derivative, b) hyperpolarized xenon spectrum of xenon trapped in 
transferrin linked cages obtained in one scan, and the sub-spectrum was obtained by accumulation of 256 selective 
excitations with a repetition time of 122 ms after c) microscopic image of the cells incubated with the biosensor d) 
fluorescence imaging assuring the presence of the biosensor in the studied cells.131 
  
To avoid the solubility problems, the consortium formed by groups of P. Berthault, T. Brotin and 
B. Rousseau turned their attention towards new cryptophane derivatives showing higher 
solubility in water at neutral pH. Thus, they replaced the initial cryptophane-[222] derivative by 
the more soluble cryptophane-[222] hexacarboxylate. From this molecule several biosensors have 
been prepared. 
A bimodal biosensor incorporating a cryptophane-[222] hexacarboxylate and a biarsenical 
compound CrAsH for fluorescent detection of peptides was also prepared (structure e in figure 
37) by this group. Upon binding with an optimized tailored peptide sequence, the CrAsH probe 
enhanced significantly its fluorescence properties. The tracer also displayed a modified 129Xe 
NMR chemical shift that can reach 9.2 ppm.132,133  
The same group showed that the couple xenon-cryptophane complex could be used as a pH 
sensor. Two examples have been reported with a modified cryptophane-[222] derivatives bearing 
respectively three and six carboxylic acid moieties. In these examples, a change of the pH of the 
a
c d
b
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bulk resulted in a change of the encapsulated xenon chemical shift. For instance, with the 
cryptophane-[222] hexacarboxylate, a modification of the pH from 3.5 to 10.8 resulted in an 
upfield shift of 129Xe NMR signal by about 4 ppm.134 In a second novel approach for pH sensing, 
the group employed two pH-sensitive cryptophane-[222] derivatives bearing respectively three 
and six carboxylic acid moieties. In this example, the pH is accessed by measuring the difference 
in chemical shifts between the two cages (ΔδAB) upon pH variation. This approach is rather more 
convenient and accurate than observing the difference in chemical shifts between the free (HP) 
129Xe and encapsulated one, because the latter can be affected by several parameters like the 
nature of a buffer, temperature or the presence of ions in solution, Figure 32.40 
 
Figure 32: structure of pH-sensitive cryptophanes A and B and the corresponding plot of chemical shift difference of 
A and B as a function of pH. 40 
  
This strategy can be used to map the pH in tissues but it requires chemical modification of the 
cage’s structure by replacing carboxylic acid by other groups, which are responsive at 
physiological pH.  
A smart biosensor made of NTA group grafted on an enantiopure cryptophane-[222] hexa-
carboxylate derivative for zinc detection has been specifically prepared. The use of enantiopure 
ΔδAB/ ppm
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cage avoids the multiplication of the bound (HP) 129Xe signal since the NTA group contains a 
stereogenic center, leading to the formation of two diastereomers in solution. Upon binding with 
zinc, the 129Xe signal downfield shifts by 1.2 ppm. The depolarization of this signal by specific 
irradiation allowed to obtain an MR image and to detect low concentration of zinc in the 
nanomolar range (30 nM). Interestingly, the concept of multiplexing experiments has been nicely 
exemplified by introducing different cations (Cd2+, Zn2+, Pb2+) into the solution. The (HP) 129Xe 
spectrum, revealed for each cation, a specific signature. This example shows that it is possible to 
detect several analytes at very low concentrations in a very short time (within seconds) with only 
one xenon-carrier, Figure 33.135,136  
 
Figure 33: structure of NTA-substituted cryptophane-A hexa-acid, and the corresponding HP 129-xenon NMR 
spectrum upon different metal cations chelation.
135,136
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4.1.3. Dmochowski and Co-workers: 
In a first attempt to study cryptophane internalization and cytotoxicity, Dmochowski and 
coworkers bioconjugated modified cryptophane-[222] derivative (structure f in figure 37) with 
three cationic peptides, (D-Arg)9, TAT and (RGD)4 by [3+2] cycloaddition. The first two 
versions are not specific, whereas the third biosensor targets cancer cells overexpressing αvβ3 
integrin receptor. The three cryptophanes showed a little cytotoxicity on a concentration suitable 
for (HP) 129Xe NMR. Cell internalization was monitored by fluorescence imaging, but no (HP) 
129Xe NMR was performed at that time.137 Starting from the same cryptophane derivative and 
using the same strategy, a folate-targeted biosensor (structure g in figure 37) was also prepared. 
The sensor bears water solubilizing peptide chain, Cy3 fluorophore and a folate interacting unit. 
Confocal microscopy and (HP) 129Xe NMR spectroscopy proved the endocytosis of the sensor 
selectively by folate membrane receptors.138 
Protein targeted cryptophanes were also developed. Using the same strategy ([3+2] 
cycloaddition), the tri-propargyl cryptophane-[222] derivative (structure h in figure 37) was 
functionalized with three p-benzenesulfonamide, varying in linker’s length. These biosensors 
target human carbonic anhydrase protein and they distinguished between the two isozymes of 
carbonic anhydrase with a chemical shift difference of about 4.3 ppm.139,140  
Calcium-activated calmodulin-targeted cryptophane off-on biosensor was also developed using a 
similar strategy. In the absence of activated calmodulin, an intramolecular interaction between 
the cryptophane-[222] derivative and its corresponding peptide chain prevents xenon binding, 
which is revealed by the absence of the characteristic 129Xe@Cryptophane signal. In contrast, 
adding the activated protein restores the ability of the cage to bind xenon, hence displaying a 
characteristic signal by (HP) 129Xe NMR.141  
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Concerning 129Xe@Cryptophane complexes sensitivity to their physical environment, 
Dmochowski and coworkers developed another smart pH sensor for cell labeling. This cage bears 
a pH sensitive peptide chain that undergoes conformational change upon going from pH = 5.5 to 
pH = 7.5. The peptide adopts a functional conformation at acidic pH, capable of acid cell 
labeling, whereas it loses its penetration activity upon neutralization. These conformational 
variations were successfully studied by tryptophan fluorescence, electronic circular dichroism 
and xenon NMR spectroscopies. In this example, hyper-CEST proved a high sensitivity of the 
sensor up to picomolar concentrations. Most importantly, the interaction of acidic cell with this 
biosensor showed a record breaking chemical shift of about 13.4 ppm relative to the non-bound 
form at neutral pH, Figure 34.142  
 
Figure 34: a) structure of the biosensor, hyper-CEST 129Xe NMR spectra at pH 7.5 b) Xe@cells, red trace (196.3 
ppm); Xe@aq, blue trace (192.3 ppm); (c) Xe@sensor (65.0 ppm) and at pH 5.5; (d) Xe@cells, red trace (198.0 
ppm); Xe@aq, blue trace (192.0 ppm); (e) Xe@sensor-cells, red trace (78.4 ppm) and Xe@sensor, blue trace (68.0 
ppm). Sums are shown as solid black lines. Figure adapted from reference 142. 
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4.1.4. Schröder and Co-workers: 
Schröder and his team have significantly contributed in this field. We will present below some 
interesting examples dealing with the design and synthesis of new biosensors dedicated for 
instance for membrane interactions studies and bimodal sensors for in-cellulo MRI. 
Taking the advantage of cryptophane’s lipophilic nature, a detailed study on bimodal 
cryptophane-[222] derivative partitioning between different liposomal vesicles has been 
conducted. In this study, two new cryptophane-[222] derivatives functionalized with fluorescent 
probes (for example structure j in figure 37) were prepared. The partition and interactions of 
these conjugates between different lipid bilayers were assessed both by fluorescence imaging and 
129Xe NMR assisted hyper-CEST experiments. The two complementary techniques served to give 
a clear image about the interaction modes, indicating a different response of the cages in different 
lipid layers.143 Two other cages, of bimodal cryptophane-[222] derivatives bearing fluorescent 
probes and anchoring units were also developed.144 Using these new constructs, they were able to 
perform a simultaneous detection of these sensors by (HP) 129Xe NMR and fluorescence in cells. 
Thanks to 129Xe hyper-CEST experiments, the detection of this biosensor at concentrations as 
low as 15 µM was made possible, Figure 35.145 
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Figure 35: structure of the biosensor bearing a fluorophore, b) 1H MRI of the two compartment phantom housing 
cells encapsulated within alginate beads. Blue compartment is filled with CrA-FAM labeled cells and the red one is 
incubated with unlabeled cells. c) Localization of the two compartments by a single CEST-acquisition (2 min) 
compared to the more sensitive accumulations of 20 CEST-acquisitions.145 
 
 Using the same technique, this group was able to nicely target metabolically labeled glycans 
(glycopolymers species) located at the cell membranes and cannot be easily reached with 
conventional 1H MRI. The strategy is based on an immediate attachment of the biosensor on the 
labeled glycan surface via a covalent bond (structure k in figure 37). Particularly, the glycans 
were labeled by an azide-bearing synthetic sugar, which is then incorporated as an azide-
functionalized sialic acid at the terminal of the glycans.  Taking the advantage of this terminal 
azide function, the group engineered an alkyne bearing cryptophane-[222] cage. This cage was 
allowed to react with the azide function by a copper catalyzed “click” reaction. By this, a 
successful multimodal (fluorescent probe and (HP) 129Xe sensor) labeling of the cell was 
achieved. Fluorescence imaging was employed to assess the efficiency of the binding. Then, (HP) 
129Xe NMR experiments were also conducted to image these labeled cells.146  
 
 
a b c
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4.1.5. Xin Zhou and Co-workers: 
Development of cryptophane-[222] derivatives for biothiol detection was achieved in organic 
media. A mono-functionalized cryptophane-[222] bearing an acrylate moiety aimed to react with 
biothiols derivatives such as cysteine, homocysteine, or glutathione has been prepared. 
Interestingly, the reaction between the two molecules by 1-4 addition resulted in a change of the 
129Xe NMR chemical shift approximatively by 1.5 ppm (structures m and n in figure 37).147,148 In 
another example, Zhou and co-workers described the synthesis of a cryptophane for detection of 
H2S (structure o in figure 37) in organic solution. In this example, the cage was also decorated 
with azido-bearing weakly fluorescent molecule. Upon H2S addition, immediate reduction of the 
azido group to an aniline takes place leading to fluorescence enhancement combined with a 
change in (HP) 129Xe NMR chemical shift.149 
In a third example, this group also reported the synthesis of cryptophane dimer for mercury 
detection.  As exemplified in Figure 36, the two cryptophane-[222] derivatives are connected by 
a dipyrrolylquinoxaline linker. Upon addition of mercuric cations into the solution, a 
conformational change of the whole structure occurs from an open clamp to a closed one.  This 
change brings the two cages closer to each other, which in turn affects the 129Xe chemical shift, 
Figure 36.150 
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Figure 36: a) structure of the cryptophane dimer and the conformational change observed upon mercury cation 
addition, b) HP 129-xenon NMR spectrum with and without the metal ion c) chemical shift image (CSI MRI) of 
sensor c1) with, and c2) without the addition of cation. 
 
It is worth mentioning that the above mentioned summary does not fully cover all examples 
described in literature. We tried only to select the most relevant examples of each group without 
going into exhaustive details. Some other groups also contributed in this field like Freund and co-
worker who described the interaction between cryptophane-[222] derivative bearing a specific 
peptide ligand with the major histocompatibility complexes protein (structure i in figure 37).151 
Meersmann and co-workers also described a new sensing strategy based on the modulation of 
(HP) 129Xe relaxation times by grafting a gadolinium (III)-DOTA unit on the cryptophane-[222] 
monoacid core. This sensor could be turned off by performing a selective reaction to remove the 
gadolinium (III) from DOTA unit thus increasing the (HP) 129Xe relaxation times.152  
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Figure 37: structures of some biosensors developed by different groups. 
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4.2. Physical and Structural Requirements to Construct Efficient Sensors: 
After discussing the advances reached in xenon-based MRI applications, especially at the 
technical level, we can resume the different requirements needed to obtain a suitable (HP) 129Xe 
based biosensors. One of these requirements is the selective binding of xenon compared to other 
guests in physiological media. Fast in-out exchange of xenon is another important feature to be 
considered since it allows a continuous replacement of the caged xenon with a hyperpolarized 
one from the bulk. The latter is crucial for the detection of xenon-sensor at low concentration by 
using the hyper-CEST technique. This sequence will enhance the sensitivity by several orders of 
magnitude. A slow exchange at the NMR-scale is also required to clearly distinguish among the 
different species in solution (free xenon, caged xenon and caged xenon recognizing a biological 
target). Long T1 relaxation is also crucial to be able to manipulate xenon without losing 
polarization (i.e. transfer of the hyperpolarized gas, mixing and measurement). The xenon carrier 
itself has to be water soluble to avoid self-aggregation or interaction with cells membrane. In 
addition it must be prepared in fair quantities and easily modified in order to introduce a sensing 
unit. Finally, the carrier has to be non-toxic and its bio-distribution has to be assessed prior in-
vivo MRI experiments. These two requirements can only be evaluated at the end of the 
synthesis.77 
5. Objectives 
Cryptophane derivatives have been heavily used to build xenon biosensors because they meet 
most of the requirements listed above. As seen previously, the overwhelming majority of 
designed biosensors use a cryptophane-222 core, where the tethering unit or units are usually 
grafted on the aromatic core of the cage. Two main types of these cores are used, the 
cryptophanol-[222] and the cryptophane-[222] hexacarboxylate derived from cryptophane-A. The 
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former cage is mono-functionalizable via the only available hydroxyl group and thus no 
symmetry problem is encountered and the platform can be prepared in gram scale. However, with 
five methoxy groups, the cage suffers from limited water solubility and it tends either to 
aggregate or to interact with the cell membranes. Cryptophane-[222] hexacarboxylate shows a 
higher water solubility, but the cage is D3-symmetric thus its mono-functionalization and 
purification is tough because statistical mixture of byproducts are inevitably obtained. Other 
cryptophane-[222] cages are sometimes used but they also suffer from similar problems.  
In this regard, development of a new platform bearing two orthogonal reactive functions could be 
seen as a solution of the formerly mentioned problems. Hence, in addition to the six identical 
functions on the aromatic core, a chemical function can be introduced on the cryptophane 
backbone. This allows the grafting of a tethering unit and hydrophilic groups selectively and 
separately.  
Cryptophane-[223] core appears to be the optimal cage of choice for such a design. Structurally 
speaking, the cage possesses two ethylenedioxy and a propylenedioxy arms, where the latter can 
be selectively functionalized, and six identical functionalities at the aromatic rims, Figure 38. 
Xenon complexation by cryptophane-[223] has already been assessed in water and this carrier 
offers convenient characteristics (in-out exchange, binding constants…) suitable for xenon-based 
sensing applications.  
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Figure 38: possible dual functionalization of cryptophane-[223] cages. 
In 2015, our group has successfully reported a first generation of cryptophane-[223]-type 
molecules, which proved satisfying water solubility at neutral pH and suitable xenon 
complexation properties. Our results have revealed, however, that these molecules showed little 
reactivity towards introducing a sensing unit as it will be detailed in the next chapter.  
In this thesis, a developed version of mono-functionalized cryptophane-[223] with enhanced 
reactivity has been prepared and their xenon complexation properties have been also assessed. To 
demonstrate the originality of our approach, we have grafted on this skeleton several sensing 
units. The detailed synthetic pathways leading to these platforms, along with their successful 
functionalization will be described in the following chapter. (HP) 129Xenon NMR studies of the 
obtained sensors will be also investigated in chapter 3. The advantages and disadvantages of our 
strategy will be then discussed in details.  
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1. 1st Generation of Dually Functionalized Cryptophane-[223] Derivative 
In this chapter, before describing in details our synthetic work, we wish to present an 
overview of the first generation of cryptophane-[223] cages bearing two orthogonal 
functionalities synthesized by Dr. Laure-Lise Chapellet et al. We will also discuss the main 
advantages and disadvantages of this strategy.41 
Anti-cryptophane-[223] derivative (C2-symmetry) possesses a unique propylenedioxy arm, where 
a central anchoring unit can be added. This allows us to keep the six hydroxyl groups untouched 
to introduce other substituents. The addition of functionality at the center of the propylenedioxy 
arm decreases the molecular symmetry (C1-symmetry). However, it is important to note that no 
additional stereocenter is created upon this structural change since the two CTB units possess the 
same absolute configuration (MM or PP). This won’t be the case for syn-cryptophane-[223] type 
molecules, where the two CTB units possess different descriptors (MP/PM). Consequently, 
introduction of a new functionality at this position does not complicate the synthesis of such 
constructs since no diastereomeric mixtures are obtained.  
Chapellet et al. described the first generation of bi-functionalized [223] cages. These cages were 
decorated with a secondary alcohol grafted on the central carbon of the propylenedioxy arm and 
six carboxylic acid moieties on the CTB rims, Figure 39. This platform was successfully obtained 
in eight steps starting from the commercially available vanillic alcohol 1.  
Chapter 2: A new Generation of Dually Functionalized Cryptophane-[223] 
Page | 70  
 
 
Figure 39: structure of a dually functionalized cryptophane-[223] derivative bearing a central secondary alcohol on 
the propylenedioxy linker. 
  
A CTB unit, 5 functionalized with two ethylenedioxy substituted vanillic alcohols  was allowed 
to react via an SN2 type reaction with 3-methoxy-4-(oxiran-2-ylmethoxy)phenylmethanol 6 
prepared in two steps from vanillic alcohol 1. The second ring closing reaction was then 
performed under two different conditions. The first cyclization condition of compound 7 employs 
a Lewis acid, scandium triflate, Sc(OTf)3, without protection of the central hydroxyl group and 
the benzyl alcohol, hence decreasing the number of required steps. Applying these conditions led 
to the formation of the desired anti-cryptophane 8 in a moderate yield (23%). The second strategy 
required the protection of both the benzyl alcohols as THP, compound 9, and the central alcohol 
by an allyl function, compound 10, followed by the cyclization in formic acid/ chloroform 
mixture (50 /50) to offer the protected cage 11 in a higher yield (44%). Although this strategy 
requires more steps, it facilitates the purification of cryptophane precursors by increasing their 
lipophilicity. The protection as an OTHP acetal gives rise to multiple diastereomers thus 
complicating the precursors 9 and 10 characterization, Figure 40. It is noteworthy that the 
separation of these stereoisomers is not necessary as the second cyclisation offers only one cage 
as two enantiomers.  
1st generation of dually functionalized cages 
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Figure 40: a) scandium triflate catalyzed cyclization versus b) formic acid catalyzed cyclization to obtain the dually 
functionalized cage.  
  
With this platform in hands, the gate was opened to produce a complete generation of dually 
functionalized cages. For example, demethylation of the six methoxy groups of compound 8 
provided the hexa-phenol cage with central secondary alcohol 12. This cage is soluble in LiOH 
(0.1 M), and it showed high affinity towards thallium and cesium cations with respective binding 
constants of 109 and 108 M-1 at 298 K, respectively, Figure 41.64 
 
Figure 41: structure of water soluble hexa-phenol for Tl cation complexation. 
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Introduction of six water-solubilizing substituents (carboxylic acid precursors or six PEG groups) 
was done under smooth conditions by selective alkylation of the six phenols on the CTB rims of 
compound 12 offering compounds 13 and 14. The hydrolysis of the 13 to the corresponding 
hexa-carboxylic acid cage was also performed. These conditions leave the secondary alcohol 
function unreacted, Figure 42. These cages show acceptable solubility at neutral pH at moderate 
concentrations. 
 
Figure 42: structure of water-soluble or pre-water soluble dually functionalized cages, bearing either six methyl ester 
groups 13 or six PEG groups on the aromatic rims, 14. 
  
To test the reactivity of the central hydroxyl group on compound 13, it was first converted into an 
electrophile via mesylation reaction to give compound 15 and then allowed to react with different 
nucleophiles like sodium azide and ethanethiolate. These experiments have shown that there was 
no possibility to perform any nucleophilic substitution at this position due to steric hindrance. 
Under different reaction conditions (thermal or microwave assisted reactions), we observed that 
the mesylated derivative was either recovered as an imploded form or it was hydrolyzed to the 
initial alcohol, compound 13. In addition, attempts to exploit the nucleophilicity of the hydroxyl 
group, in the presence of six ester functionalities also failed due to selectivity issues. Strong bases 
were always needed to deprotonate the hydroxyl group. This in turn led to the deprotonation of 
the -protons of the ester groups leading to the formation of side-products, Figure 43.  
13 14
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Figure 43: illustration of failed trials to alkylate cryptophane 13. 
 
Oxidation of the secondary alcohol in compound 13 to the corresponding ketone was also 
achieved by using Dess martin periodinane reagent in dichloromethane to give cryptophane 16. 
The yield obtained is modest (34%) and an optimization is required to get the cage in decent 
amounts. This functionality can be exploited in performing imine condensation or Wittig type 
reactions to graft a spacer and a sensing unit, Figure 44.   
 
Figure 44: oxidation of the secondary alcohol of cryptophane 13 into a ketone. 
 
The 129Xe NMR spectra of the water-soluble cages displayed two peaks for free and encapsulated 
xenon indicating a slow exchange at NMR time scale. A fast in-out exchange dynamics of xenon 
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was also observed suitable for hyper-CEST technique to detect the cages at low concentrations. 
This interesting work established the bases of a new design for dually functionalized cages, 
solving by this the symmetry and water solubility problems. The main disadvantage, however, is 
the little reactivity of the central secondary alcohol. The limited reactivity prevents the possibility 
to easily elaborate biosensors and an optimization of the cryptophane skeleton is required. 
In this manuscript, we present a second developed generation of dually functionalized 
cryptophane-[223] derivatives. In this work, a simple replacement of the secondary alcohol by a 
primary one enlarged the scope of reactivity of this cage towards nucleophilic substitution, 
electrophilic activation and oxidation, Figure 45. Successful grafting of different sensing units as 
well as water solubilizing groups was also possible proving by this that our cages possess all the 
specificities needed to build-up xenon biosensors. In the next sections, we describe the synthetic 
strategy leading to these derivatives. It is worth mentioning that a part of this work has been 
recently published in the Journal of Organic Chemistry. Baydoun et al, JOC, 2019, DOI: 
10.1021/acs.joc.9b01093. 
 
Figure 45: structure of the second generation of bi-functionalized cages.  
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2. Retrosynthetic Analysis of Modified Cryptophane-[223] Derivatives 
The targeted cryptophane-[223] derivatives presented in this manuscript are asymmetric with 
two types of linkers: two ethylenedioxy and one functionalized propylenedioxy arms. Template 
method is employed, because it allows a selective introduction of different linkers having various 
length and substituents.  
Basically, compound 27 shown in Figure 46 can be obtained after either performing a chemical 
transformation to an existing properly functionalized cryptophane or directly by cyclizing a 
precursor molecule containing a primary alcohol. 
Three routes can be envisioned to obtain compound 27, routes I, II and III. The retrosynthetic 
analyses of these strategies are shown in Figure 46 and Figure 47. We decided to detail only the 
successful strategy (synthetic route I) in this manuscript. 
In route I, compound 27 can be obtained by performing a hydroboration-oxidation step on the 
terminal alkene of cryptophane 26. This crucial step assures a regioselective insertion of the 
hydroxyl group on the terminal position. Cryptophane 26 itself is a result of classical cyclization 
of the tri-substituted template 25 by three consecutive Friedel-Crafts alkylations. In turn, the 
latter can be obtained after a double alkylation of a mono-substituted derivative 23 by compound 
24 whose synthesis has already been reported.153 The mono-alkylated synthon 23 is a result of an 
alkylation between 4154 and an alkenyl substituted vanillic alcohol 22. Compound 22 can be 
easily prepared by reacting vanillic alcohol 1 with 3-chloro-2-chloromethyl-1-propene 19.  
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Figure 46: retrosynthetic analysis strategy I leading to anti-cryptophane 27. 
 
The two other envisioned synthetic routes (strategies II and III) employ more or less the same 
steps discussed in route I, namely cyclization and alkylation, but differ in the origin of the 
primary alcohol. In route II for example, the hydroxyl group on the cryptophane 27 is a result of 
a reduction of the methyl ester group. Route III, however, represents the simplest way since it 
requires less synthetic steps. In this route the primary alcohol function is introduced at the very 
beginning of the synthesis. It is worth mentioning that all the chiral synthons shown in Figure 46 
have been isolated as racemic mixtures. In addition, most of these synthetic steps involve 
different protection at a certain stage of the synthesis. 
 
Figure 47: retrosynthetic routes II and III. 
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3. Synthesis of Cryptophane 27 
A modified template method has been used to prepare cryptophane 27. First, a CTB cap is 
synthesized, followed by its elaboration with properly functionalized benzyl alcohols and finally 
their cyclization to offer the cage of interest.  
The CTB cap, 4 was synthesized in three linear steps, based on a known procedure starting from 
the commercially available 4-(hydroxymethyl)-2-methoxyphenol 1.25 Vanillic alcohol 1 was first 
protected by a reaction with allyl bromide under basic conditions (potassium carbonate) to give 
the allyl protected 2 in 75%. This protection step is necessary because the cyclisation of 
unprotected vanillic alcohol produces side-products in large quantities.153 Compound 2 was then 
cyclized under acidic conditions using perchloric acid/methanol by performing simultaneously 
three Friedel-Crafts alkylations to offer the tri-allyl CTB 3 in a moderate yield (57%). The latter 
was then de-protected by using palladium acetate, triphenylphosphine and trimethylamine in 
THF/water mixture to offer CTB 4 in 79% yield, Figure 48.  
 
Figure 48: synthesis of the first CTB 4 cap. 
 
The second important step involves the synthesis of the substituted vanillic alcohol arm bearing 
either the primary alcohol or its precursors. The simplest thing to be tried was to introduce a 
primary alcohol unit, 3-bromo-2-bromomethyl-1-propanol, 17, on the vanillic alcohol 1 by an 
alkylation step under basic conditions (potassium carbonate). Attempts to make compound 20 
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failed, producing a lot of side-products that could not be easily identified by NMR spectroscopy 
or mass spectrometry. The second possibility was to alkylate the vanillic alcohol 1 by an ester 
substituted group (3-bromo-2-bromomethyl-1-methyl propanoate) 18. This can be eventually 
reduced to the corresponding alcohol derivative 20. Based on this, the same reaction conditions 
were used and they gave rise to the desired alkylated compound followed by an elimination 
reaction to offer the byproduct 21. Finally, the use 3-chloro-2-chloromethyl-1-propene, 19, in 
excess provided the desired product, 22 in a decent yield (65%), Figure 49.  
 
Figure 49: tried strategies for adding the primary alcohol moiety or its precursors. 
 
Having synthesized these two parts, it is time now to assemble them by an alkylation step in 
DMF under smooth basic conditions. In this step, a statistical mixture of three products is 
unavoidable thus leading to the formation of the desired compound in a moderate yield. Herein, 
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protection of the benzyl alcohol is not necessary to assure a good separation of the three main 
products. The desired product 23 was isolated as a racemic mixture in 40% yield, Figure 50. 
 
Figure 50: scheme showing the synthesis of 23 in racemic form and the corresponding byproducts. 
 
Double alkylation of the mono-alkylated compound 23 by the two ethylenedioxy arms 24 was 
also performed under basic condition using cesium carbonate in DMF to offer the desired product 
25 in 84% yield. The two arms have to be protected in the form of OTHP acetal to decrease the 
polarity of the cryptophane precursor and facilitate its separation on silica gel, Figure 51. 
Unfortunately, addition of THP groups produces several diastereomeric compounds that cannot 
be separated by column chromatography and it complicates the interpretation of the 1H NMR 
spectra. Nevertheless, some characteristic protons signals can be clearly identified. For instance, 
the 1H NMR spectrum of compound 25 shows fifteen protons in the aromatic regions ranging 
between 6.65 and 7.00 ppm and two protons characteristic of the alkene group at 5.3 ppm. In 
40%
29%
224 23
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addition, six axial and equatorial protons of the CTB are displayed between 3.4 and 4.6 ppm 
respectively.  
 
Figure 51: synthesis of cryptophane 26 by cyclization using formic acid and the hydroboration-oxidation step to 
introduce the primary alcohol derivative 27. 
 
The formed tri-alkylated template 25 was successfully cyclized under diluted concentrations (10-3 
M) in a mixture of formic acid and chloroform (50/50: v/v) at 60 °C for about 6 hours. This 
reaction involves rapid deprotection of the OTHP groups and it allows three Friedel-Crafts 
alkylations affording the desired anti-cryptophane 26 in 34% yield. At this stage, the anti-
configuration has been adopted based on previous results obtained with cryptophane-[223] 
derivatives.64 As usual, this cryptophane is obtained as a racemic mixture and it has a C2-
symmetry. This symmetry is clearly revealed by 1H NMR spectrum that displays only six singlets 
in the aromatic region between 6.6 and 6.7 ppm corresponding to twelve protons. In addition, the 
two alkenyl protons are shown at 5.58 ppm and appear as a singlet. Finally, the six methoxy 
groups grafted on the cryptophane skeleton are revealed as three sets of singlet, Figure 52. At this 
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stage, we can take advantage of the presence of the double bond to perform subsequent reactions 
like metathesis or addition reactions for instance. 
It is noteworthy that employing an alkene function during the synthetic pathway saves a lot of 
protection steps, which would be required if we used a more reactive primary alcohol function 
instead. For instance, we can assume that the latter function will be surely dehydrated under the 
acidic conditions used for the cyclization step. 
 
Figure 52: 1H NMR spectrum of cryptophane 26 illustrating the C2-symmetry. 
 
To introduce a primary alcohol on the alkene arm of cryptophane 26 several reactions can be 
imagined but a hydroboration-oxidation step seems to us the best way to afford the desired 
product 27. To do so, we have used 9-BBN (0.5 M in THF), NaOH (3 M) and H2O2 in a mixture 
of THF and CH2Cl2 (80/20). Based on the analysis of the crude product, the reaction gave rise to 
exclusively cryptophane 27 and the second regioisomer was not detected. Purification of the 
CDCl3
H2O
26
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compound afforded cryptophane 27 in an excellent yield (94%). The low solubility of starting 
material led us to change the usual conditions. Thus, such type of boron-based oxidation is 
carried only in THF, where it acts as both a solvent and a boron stabilizing ligand. In our case, 
using these conditions resulted in a decrease of the reaction yield (56%). Addition of CH2Cl2 was 
thus mandatory to completely dissolve the starting material and to drive the reaction to 
completion. Other peroxide-based conditions (Oxone) were also tried to perform the oxidation of 
the double bond. Unfortunately, these conditions led to a complete decomposition of the starting 
material. It is noteworthy that oxidation of the double bond led to a decrease of the molecular 
symmetry. Thus, anti-compound 27 has a C1-symmetry and it was isolated as a racemic 
compound. The proton NMR spectrum of the cage also reflects the lowering of the symmetry 
since the aromatic protons now appear as twelve singlets.  The proton signal corresponding to the 
alkene group is no longer present and it is replaced by a new downfield shifted signal at 2.4 ppm 
that corresponds to the β hydroxyl proton (shown in red in Figure 54). Fortunately, we succeeded 
to obtain X-ray quality crystal of compound 27 from a chloroform/ethanol mixture and to get its 
X-ray structure. An ORTEP representation allowed us to assure the anti-configuration as 
assumed before. The cavity volume of the host was estimated to be 108 Å3 with an electron count 
of 30, which is compatible with the presence of an ethanol molecule, Figure 53.  
 
Figure 53: ORTEP representation of compound 27. Two different views are shown. Hydrogen atoms have been 
removed for clarity. The cavity is filled with an ethanol molecule (not shown). The displacement ellipsoids were 
plotted at 30% probability level. 
Chapter 2: A new Generation of Dually Functionalized Cryptophane-[223] 
Page | 83  
 
 
Figure 54: 1H NMR spectrum of compound 27 reflecting the C1-symmetry and zoomed is the central proton on the 
propylenedioxy arm (shown in red for illustration). 
 
4. Reactivity of the Primary Alcohol on Cryptophane 27 
Attachment of a primary alcohol on the middle of the propylenedioxy arm offers new routes 
for further functionalizations. For example, we can imagine converting the hydroxyl group into a 
nucleophile under basic conditions. It might be also transformed into an electrophile by 
performing a mesylation reaction for instance. Finally, we can perform an oxidation reaction to 
convert the alcohol group into an aldehyde or a carboxylic acid. These different 
functionalizations are needed to introduce a spacer that will carry the sensing arm. 
4.1. Electrophilic Activation and Nucleophilic Substitution of the Primary Alcohol: 
To invert the reactivity of the primary alcohol to an electrophile, it is necessary to convert it 
into a good leaving group. This can be achieved by the reaction of the alcohol function of 
compound 27 with mesyl-chloride or tosyl-chloride for instance. Surprisingly, the transformation 
27
CDCl3
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of the primary alcohol to the corresponding tosylate group via a reaction with p-toluenesulfonyl 
chloride in pyridine failed and the starting material was recovered. This lack of reactivity is 
probably due to the bulkiness of the tosylate group. Using excess of the less bulky 
methanesulfonyl chloride in a pyridine/dichloromethane at 60 °C afforded the expected 
mesylated compound 28 in a good yield (82%), Figure 55. For this compound, the 1H NMR 
spectrum shows a deshielding of the β hydroxyl proton by about 0.4 ppm with respect to the 
starting material. In addition, a singlet integrating for three protons at 3.07 ppm corresponding to 
the methyl group of the mesylate is also clearly visible on the spectrum. 
 
Figure 55: mesylation of cryptophane 27 followed by nucleophilic substitution by potassium thio-acetate to form 
cryptophane 29. 
 
With the mesylated cryptophane 28 in hands, many different reactions can be envisaged. For 
instance, a reaction with sodium thio-acetate in DMF/CH2Cl2 mixture afforded the protected thiol 
derivative 29 in a moderate yield (43%). This example offers the first nucleophilic substitution 
reaction performed on an electrophilic cryptophane-[223] derivative. The formation of the cage 
was evidenced by 1H NMR spectrum that shows the disappearance of the methyl group 
corresponding to the mesylate group (3.07 ppm). Instead, this signal was replaced by another 
singlet appearing at 2.37 ppm and that stands for the methyl group of the thio-acetate moiety. The 
potential hydrolysis of this cage gives rise to the thiol-substituted derivative. This might have 
27 28 29
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many promising applications as a peroxide sensor or as a precursor to build-up new cryptophane 
derivatives. 
Interestingly, this reaction did not afford only new cryptophane derivatives, but also it 
demonstrated the higher accessibility and electrophilic reactivity of the cage compared to its 
secondary alcohol congener. The thorough investigations performed on this derivative revealed 
some interesting features (self-encapsulation phenomena) that will be discussed in more details in 
the second part.  
4.2. Oxidation of Cryptophane 27: 
Beside the successful electrophilic activation of the cage, oxidation of the primary alcohol to 
the corresponding aldehyde and carboxylic acid appears a promising approach to attach new 
functionalities by a wide range of reactions like Wittig type reactions, reductive imination, aldolic 
condensation or amide coupling reactions.  
The partial oxidation of the primary alcohol 27 to the aldehyde 30 was performed using Dess-
Martin periodinane in freshly distilled CH2Cl2 at room temperature. It is worth mentioning that 
the use of freshly distilled CH2Cl2 is mandatory to render the reaction complete, Figure 56. Other 
conditions were also tried like BAIB/ TEMPO reagents in CH2Cl2 at room temperature offered 
exactly the same results.155 The 1H NMR spectrum of the crude aldehyde 30 shows a complete 
conversion of the alcohol, which is revealed by the appearance of the characteristic aldehyde 
peak at 9.92 ppm. A deshielding of the β hydroxyl proton by about 1 ppm (3.22 ppm) is also 
observed. Other impurities corresponding to Dess Martin monoiodinane byproduct are detected 
on this spectrum. Unfortunately, attempts to purify the obtained product by column 
chromatography on silica gel led to transformation of this derivative. 1H NMR spectrum showing 
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two additional signals between 4.0 to 5.0 ppm confirms the transformation of this derivative. This 
might be explained by the formation of the enol tautomer but the integration does not assure this 
assumption. A partial decomposition of the compound can be also envisaged to explain these 
results. 
 
Figure 56: oxidation of cryptophane 27 into an aldehyde 30 and then to the carboxylic acid derivative 31. 
 
Thus to avoid this problem, the aldehyde derivative was immediately used in the next oxidation 
step without further purification. The second oxidation to carboxylic acid 31 was carried using 
sodium chlorite in acetonitrile/water mixture at room temperature to offer the desired product 31 
in a good yield (70%).156 This cage was stable enough and it was purified by two different 
methods, either by precipitation from chloroform/diethyl ether mixture or by column 
chromatography on silica gel. In the latter case, the acid derivative was converted into the 
corresponding benzyl ester 32 that is more easily purified by chromatography. This step was 
followed by a hydrogenolysis reaction with a palladium catalyst in a dichloromethane/methanol 
mixture to give rise to the acid derivative 31 in an excellent yield (95%). However, the first 
purification method was preferred and it offers the compound in a higher yield (70%), Figure 56. 
27 30
31 32
Chapter 2: A new Generation of Dually Functionalized Cryptophane-[223] 
Page | 87  
 
Direct oxidation of the primary alcohol 27 to the carboxylic acid 31 using trichloro-cyanuric acid 
failed showing a complete decomposition of the starting materials.157 
The above described derivatives constitute new family of functionalizable cryptophane-[223] 
type cages, which will be further elaborated by other chemical transformations. 
5. Synthesis of Water-Soluble Platforms for Xenon-Based Sensors 
The introduction of water-solubilizing substituent is another key transformation that has to be 
considered. Interestingly, our cryptophane skeleton possesses several functionalities that can be 
selectively modified to introduce these substituents. The following paragraph is dedicated to the 
different strategies used to introduce the water solubilizing groups. 
5.1. Demethylation Reaction: 
Prior to the introduction of water-solubilizing groups on the cryptophane rims, a 
demethylation step of the six available methoxy groups is required. Demethylation of these 
groups using lithium diphenylphosphide (1 M) is well established on this type of molecular host. 
The synthesis of lithium diphenylphosphide was described by E. Vejeds158 and used by A. Collet 
to produce cryptophane-[222] (OH)6 and optimized by Brotin and co-workers. This method is 
selective for methyl ether deprotection, due to the steric hindrance of diphenylphosphide, and it 
leaves unreacted the three bridges. Even though this reagent can be kept for weeks in a fridge, we 
recommend using freshly prepared solution of lithium diphenylphosphide to obtain reliable 
results.  
Introducing water solubilizing precursors at the very beginning of the synthesis can be done by 
demethylation of the methoxy groups of compound 26, Figure 57. Attempts to perform this 
reaction with freshly prepared LiPPh2, at 60 °C in THF produced the expected demethylated 
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product but it showed also the disappearance of the NMR signal corresponding to the double 
bond. The appearance of several byproducts indicates the decomposition of the starting material 
under these conditions. 
 
Figure 57: attempts to demethylate cryptophane 26 to form cryptophane 33. 
 
We switched to another strategy, which is the demethylation of cryptophane 27 bearing a primary 
alcohol function followed by a selective alkylation step. Our previous experience with 
cryptophane 12 revealed that secondary alcohol was reactive towards the phenol alkylation 
reaction when methyl bromoacetate is used as an electrophile. As our alcohol 27 is less hindered 
and even less basic than that in cryptophane 12, a protection step is hence necessary to selectively 
functionalize the six phenols. As mentioned previously, the demethylation step is performed 
under basic conditions and an acidic workup is usually needed to recover the demethylated 
product. Keeping this information in mind, we must choose an acid and base tolerant protecting 
group. Based on our knowledge, we believe that a tetrahydropyranyl group would be a good 
candidate to resist both basic and mild acidic conditions. So we first protected the cage 27 as an 
acetal under mild acidic conditions using PPTS/DHP reagents. Compound 34 was thus obtained 
in a good yield (75%), Figure 58. Adding a new stereocenter on the cage led to the formation of a 
mixture of diastereomers, which are not separable by column chromatography but they can be 
easily distinguished by 13C NMR spectroscopy.  
3326
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Figure 58: protection of cryptophane 27 by a THP group followed by a demethylation step to form cryptophane 35. 
 
Compound 34 was then subjected to a demethylation step in a freshly prepared LiPPh2 (1 M) 
solution in THF at 60 °C for 48 hours. A long reaction time was used to insure that all the 
methoxy groups are removed. The reaction was then treated at 0°C using mild acidic (ammonium 
chloride; pH ~ 5.0) conditions to keep the THP group intact. Although highly polar, we were able 
to purify the cage 35 on silica gel using a mixture of DMF/acetone as an eluent. This offered the 
pure compound 35 in a good yield (84%), Figure 58. The 1H NMR of this dual functionalized 
cage in DMSO-d6, displays several signals corresponding to the hydroxyl groups of the two 
diastereomers and twelve overlapped protons in the aromatic regions. The axial and equatorial 
protons give a more complicated pattern and they cannot be resolved. Again, the 1H NMR 
spectrum shows a splitting of certain signals because of the presence of the two couple of 
diastereomers, Figure 59.  
This dually functionalized compound 35 is a leading chemical platform to construct xenon-based 
biosensors. The six available phenols can be functionalized selectively with different water 
solubilizing groups keeping the primary alcohol intact. Then the latter can be selectively 
deprotected and transformed at a later stage in the synthesis. 
27 34 35
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Figure 59: 1H NMR spectrum of cryptophane 35 in 400 MHz spectrometer. 
 
5.2. Introducing Water-Soluble Groups:  
Cryptophane rims can be decorated with different solubilizing functions like carboxylic acid 
derivatives, polyethylene glycol (PEG) or sulfonyl groups. In our case, we focused on grafting 
selectively six ester groups on the cryptophane 35 rims as precursors to six carboxylic acid 
functions. 
 
Figure 60: alkylation of compound 35 followed by a deprotection step to form compounds 38 and 39. 
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We chose to introduce two types of ester group, methyl or benzyl esters to access the carboxylic 
acid derivative by hydrolysis under basic condition or hydrogenolysis with a palladium catalyst. 
These cryptophanes can be obtained by performing an SN2-type reaction on an appropriate 
alkylating reagent. To do so, the cage was dissolved in DMF in presence of cesium carbonate. 
Then alkylation with methyl or benzyl bromoacetate afforded the expected derivatives 36 and 37 
in 54% and 70% yields, respectively. These two precursors were also isolated as diastereomeric 
mixtures but their purification was tedious owing to their high lipophilicity. It is worth 
mentioning that unlike cryptophane 37, benzyl protected cryptophane 36 tends to implode easily 
as ascertained by its 1H NMR spectrum. This imploded form seems to be reversed back to its 
initial (CC) conformer after the OTHP deprotection. Consequently, the unprotected cage 38 was 
obtained in an excellent yield (93%). The inversion to the initial (CC) conformer is mostly due to 
the used reaction conditions (CH2Cl2 at 40 °C). Under these conditions, the cage will be surely 
filled back with dichloromethane thus restoring the initial conformation. Same conditions were 
used to obtain the unprotected derivative 39 and it was also obtained in almost quantitative yield 
(93%), Figure 60.  
Successful selective grafting of water-solubilizing precursors on the compound 35 afforded us 
two new platforms, 38 and 39 for 129Xe-based biosensing applications. These two derivatives can 
be either used immediately to graft a sensing unit or can be subjected to subsequent reactions. 
5.3. Chemical Transformations of Cryptophanes 38 and 39: 
One of the strategies used to functionalize the primary alcohol of methyl protected cage 39, 
was to simply alkylate it under basic conditions. In this reaction two main requirements have to 
be considered, the reaction temperature and the used base. In order to avoid implosion of the 
cryptophane skeleton, a relatively low reaction temperature has to be employed (between 25 and 
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40 °C). Additionally, mild bases have to be used because strong ones will deprotonate the α-ester 
protons leading to the formation of many side-products.  
We chose to introduce a protected carboxylic acid arm via the alkylation of the hydroxyl group 
by benzyl bromoacetate to form derivative 40, Figure 61. Taken the above considerations into 
account, we chose either potassium tert-butoxide or DBU as bases due to their bulky structure 
and matching pKa. In both cases, the cage was dissolved in DMF in the presence of the base, and 
then the alkylating agent was added at room temperature. None of these conditions worked, and 
these reactions resulted in the formation of many side-products. 
 
Figure 61: structure of compound 40. 
 
These conditions triggered us to use another strategy, which is the oxidation of the primary 
alcohol. The readily established oxidation conditions used to oxidize cryptophane 26, were also 
employed here. So the benzyl or methyl esters derivatives, 38 and 39 were first oxidized to 
aldehydes by Dess Martin periodinane in dry CH2Cl2 to offer cryptophanes 41 and 42. The 
1H 
NMR spectra of these cages show a complete conversion of the starting material, which were 
used in the next step without prior purification. The obtained aldehydes were subjected to a 
second oxidation step to form the corresponding acid using sodium chlorite, in an 
acetonitrile/water mixture at room temperature. The lipophilicity of the cages allowed us to 
40
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purify them by column chromatography to offer the corresponding pure benzyl and methyl ester 
derivatives 43 and 44 in 70 and 78% over two steps, respectively, Figure 62.  
 
Figure 62: oxidation of compounds 38 and 39 to the aldehyde and the corresponding acids 43 and 44. 
 
Figure 63: 1H NMR spectrum of compound 43 in CDCl3 in 400 MHz spectrometer. 
 
The proton spectrum of the benzyl ester protected cage 43 is displayed above, showing 
overlapped signals of thirty protons corresponding to the benzyl protecting groups, twelve signals 
ranging between 6.2 to 6.36 ppm corresponding to the aromatic protons of two CTB and 
interestingly a deshielded signal of the β carboxylic acid proton located at 3.15 ppm, Figure 63.  
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These two formerly presented cryptophane-[223] derivatives set up a new family of dually 
functionalizable platforms. These platforms can be immediately used for building different 
xenon-carriers for MRI applications. The synthesis of these compounds constitutes a very 
important result as it considerably simplifies the introduction of the sensing unit. It is noteworthy 
that this could not be achieved with the water-soluble cryptophane hexa-carboxylate. In addition, 
the presence of a carboxylic acid function at the cage’s propylenedioxy linker is of special 
interest because it is widely used in biochemistry to elaborate sensors via amide coupling 
reactions. The cleavage of the six other ester groups can also afford very easily the corresponding 
water-soluble sensors. 
6.  Functionalization of Cryptophane-[223] Derivatives by Sensing Units 
In the first chapter we presented a wide range of 129Xe-based biosensors, which are mostly 
derived from cryptophane-[222] monoacid. The attachment of the sensing unit to this 
cryptophane core is usually achieved by an amide coupling. In our case, we used the same 
approach to link different amine or aniline-bearing sensing units to cryptophane derivatives 43 
and 44. This step is followed by the cleavage of the protecting groups to offer the water soluble 
cryptophane-[223] molecular sensors. In the next paragraphs, we will present the different 
sensing units grafted to the cryptophane-[223] cores and the problems encountered during the 
synthesis, Figure 64.  
 
Figure 64: schematic presentation showing the possible functionalization of compound 43 and 44 by an amide 
coupling reaction. 
1.
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6.1.Hydroxamic Acid Functionalized Water-Soluble Cryptophane-[223]: 
Hydroxamic acids are a family of organic compounds of molecular structure 
RCC(O)N(RN)OH (RC = alkyl/aryl; RN = alkyl/aryl or H), Figure 65. These compounds were first 
described by H. Lossen in 1869, where he reported the synthesis of oxalohydroxamic acid from 
diethyl oxalate and hydroxylamine.159 Hydroxamic acids are weak acids that undergo two 
consecutive deprotonations of the first (N-OH) proton to give the hydroxamato group and a 
second deprotonation (NH-O) to offer the hydroximato function. The pKa of the first 
deprotonation ranges between 8.5 and 9.4 in aqueous media.160 Hydroxamic acids are 
characterized by their ability to chelate a wide range of transition metals. The chelating ability is 
readily exploited by nature, in which they exist in many bacteria as the so-called siderophore for 
coordinating dissolved iron-(III). These iron-(III)-siderophore complexes are recognized by cell-
surface proteins, which transport them to the cytoplasm where they release their iron-(III) 
content. Additionally, they act as inhibitors for Ni (II) urease and Zn (II)-containing 
metalloproteins like matrix metalloprotease (MMP), which are involved in cancerous cell 
proliferation.161,162 
Hydroxamic acids coordinate transition metals via the two oxygen atoms as proved by X-ray 
crystal structures. In contrast, coordination of transition metals via an oxygen-nitrogen 
coordination mode has never been reported so far, at least for the primary hydroxamic acid 
derivatives. 
 
Figure 65: structure of hydroxamic acid function and its corresponding (O, O) chelation modes. 
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As established in literature, hydroxamic acids chelates effectively the late transition metals like 
copper, nickel and zinc with comparable binding constants in the order of 105 M-1. This triggered 
us to connect this simple chemical function to our dually functionalized cage and study its 
interaction with different cations.160 
The link between hydroxamic acid and cryptophane 43 was achieved via an amide coupling 
reaction. Herein, the source of our hydroxamic acid function is the commercially available O-
benzyl hydroxylamine. 
 
Figure 66: synthesis of compound 46 bearing a hydroxamic acid function. 
 
In order to assess the feasibility of the reaction we first tried the amide coupling on cryptophane 
31. The coupling reaction between this cage and the O-benzyl hydroxyl amine was performed in 
pyridine using phosphorous oxychloride as a coupling reagent, Figure 66.163 Under these 
conditions the carboxylic acid is first converted to the acyl chloride and then reacted with the 
amine function. This reaction offered the coupled compound 45 in 62% yield. The 1H NMR 
spectrum of this compound shows a characteristic deshielded proton of the amide group at 9.7 
ppm. Interestingly the diastereotopic protons of the benzyl group appear as an AB system at 4.9 
ppm. Finally, the latter derivative was deprotected at room temperature using a hydrogenolysis 
reaction under classical conditions (H2, Pd/C (10%), CH2Cl2/MeOH mixture). These conditions 
afforded the compound 46 in a good yield (70%).   
31 45 46
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Figure 67: synthesis of water-soluble cryptophane-[223] 48 bearing a central hydroxamic acid function. 
 
These results prompted us to extend our work to compound 43. Compound 43 was preferred 
because the seven benzyl groups can be removed in a single hydrogenolysis step. The coupling 
reaction between O-benzyl hydroxylamine and compound 43 offered compound 47 in a low yield 
(26%). The low yield can be explained in part by the difficulties encountered during the 
purification of this derivative. The latter compound was then deprotected by hydrogenolysis. This 
deprotection step was monitored by TLC. Although the TLC shows a full conversion of the 
protected cage, compound 48 was only isolated in 40% yield, Figure 67. This might be due to the 
difficulties to extract this compound. Compared to the starting material, the 1H NMR spectrum of 
48 displays in DMSO-d6 a deshielded set aromatic protons ranging between 6.6 and 7.0 ppm. In 
addition, a characteristic signal of the proton of the hydroxamic acid function is observed at 9.6 
ppm. It is worth mentioning that this derivative is soluble in water at a pH ranging between 4 and 
14.  
Compound 48 clearly demonstrate the interest of our approach. Indeed, this compound represents 
the first dually functionalizable cryptophane-[223] sensor, showing acceptable solubility at 
neutral pH. Compound 48 has been prepared in twelve steps from CTB 4. Even though this 
synthesis looks tedious this platform can be designed in a relatively short period of time (1-2 
months) in fair quantities. Our approach allows us to bring solutions to the symmetry and 
solubility problems encountered with other cryptophanes. 
43 47 48
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6.2.Cryptophane-[223] Bearing an APTRA Derivative: 
APTRA or (o-aminophenol-N,N,O-triacetic acid) ligand has been first reported by London 
and coworkers in 1988. It was initially used to detect cytosolic magnesium and it was connected 
to an aromatic fluorinated reporter. Unexpectedly, this unit showed a higher affinity to calcium 
compared to magnesium, where its detection limit is in mM range whereas that of the calcium is 
in the µM range. Several MRI and fluorescent probes were developed based on a chelating 
APTRA ligand. Development of more sensitive reporters capable to detect calcium in pico-molar 
range can be achieved by designing a new (HP) 129Xe@cryptophane derivative functionalized 
with an APTRA function.164,165,166,167 
Our targeted APTRA derivative 52 is functionalized with an aniline moiety to anchor it to the 
cryptophane-[223] derivative via an amide bond, Figure 68. This unit was synthesized in three 
linear steps starting from a commercially available 2-amino phenol 49 based on a slightly 
modified known experimental procedures.168,169 It starts with the alkylation of the 49 with methyl 
bromoacetate using DIPEA as a base to afford compound 50 in a moderate yield (60%). Nitration 
of compound 50 in a mixture of nitric and acetic acid afforded compound 51 in 80% yield. The 
last step involved a hydrogenation step using catalytic amount of palladium on charcoal. This 
reaction gave rise to APTRA derivative 52 in a good yield (90%). 
 
Figure 68: synthesis of the APTRA unit 52. 
49 50 5251
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Here again, the reaction was performed on the organic version 31 to ensure its viability. Coupling 
of the APTRA derivative 52 with the compound 31 was performed in pyridine and phosphorous 
oxychloride. This reaction offered compound 53 in low yield (22%) due to partial decomposition 
of the APTRA moiety, Figure 69.  
 
Figure 69: synthesis of organic version of cryptophane-[223] 53 bearing an APTRA derivative. 
 
We then extended this reaction to the pre-water soluble version 44. We chose this compound 
because it has the same protecting groups as derivative 52. The linkage between the two units 
was also performed by an amide coupling reaction using phosphorous oxychloride and pyridine 
to give the product 54 as a white solid in 30% yield, Figure 70. The 1H NMR spectrum of this 
pre-water soluble precursor 54 displays a characteristic signal at 9.07 ppm corresponding to the 
amide proton and three additional signals in the aromatic region that belong to the APTRA core. 
For the hydrolysis step, several conditions were tried to simultaneously remove the nine methyl 
groups and all use different hydroxide salts like LiOH, NaOH and KOH as summarized in Table 
3. The solvent used for this step was either a mixture of THF/water or with methanol. The 
starting material was first dissolved in THF then the metal hydroxide solution was added at zero 
°C then to 25 °C and monitored by TLC. All the tried reactions revealed the disappearance of 
starting material within only 10 minutes, except for the first entry, where it was left over night at 
52
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40 °C. After that, the crude was extracted with CH2Cl2 and then acidified using HCl in ice to 
offer a white powder. This was then checked by 1H NMR to reveal either partially hydrolyzed 
(LiOH) or decomposed byproducts (NaOH) and this was confirmed by HRMS. A last trial with 
18 equiv. of KOH (0.3 M) provided the targeted product 55 in about 70% yield. The formation of 
this product was confirmed by HRMS.  
 
Figure 70: synthesis of water soluble cryptophane 55 functionalized by an APTRA derivative. 
 
It seems that there is a very narrow window between the hydrolysis and decomposition of this 
compound, where a careful tuning of the chosen base and its equivalence must be done to avoid 
these problems. Unfortunately, the hydrolyzed compound 55 shows also some light sensitivity 
issues where it turns brownish when exposed to light. This prevented us from studying its (HP) 
129Xe encapsulation properties because they may give misleading results. 
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Hydroxide salt 
 
Equivalence 
 
 
Concentration M 
 
Temperature °C 
 
Solvent 
 
Results 
 
LiOH 
 
10 
 
0.01 
 
0 to 40 
 
THF/Water 
 
Partial hydrolysis 
 
LiOH 
 
 
27 
 
 
0.01  
 
0 to 25 
 
THF/Water/MeOH 
 
Partial hydrolysis 
 
NaOH 
 
 
50 
 
2.5 
 
0 to 25 
 
THF/Water 
 
Decomposed 
 
NaOH 
 
 
27 
 
0.01 
 
0 to 25 
 
THF/Water 
 
Decomposed 
 
KOH 
 
 
18 
 
0.3 
 
0 to 25 
 
THF/Water 
 
Product 74% 
 
Table 3: different trials to hydrolyze compound 54 to the water soluble cryptophane 55.  
 
6.3. Biotin Functionalized Cryptophane-[223] Cage: 
To further illustrate the feasibility of our approach, we turned our attention towards the bio-
conjugation of cryptophane-[223] by a biotin arm for avidin detection. This was chosen because 
of the high binding constant, which is estimated to be in the range of K = 1015 M-1. Our biotin 
source is the commercially available biotin-PEG2-amine, which will be linked to the 
cryptophane-[223] core by amide coupling reaction, Figure 71.119 
 
Figure 71: synthesis of compound 56 by an amide coupling reaction of cryptophane 43 and biotin-PEG 2- amine. 
43 56
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To link these two parts, we simply used the well-established amide coupling conditions i.e. 
phosphorous oxychloride/ pyridine. Unfortunately the reaction did not work and the cryptophane 
was recovered at the end of the synthesis. The usual coupling conditions using EDCI/HOBt in the 
presence of DIPEA in DMF for 16 hours gave better results and provided compound 56 as a 
white powder in 71% yield. The purification of this compound is quite tedious due to its high 
polarity. The 1H NMR spectrum of 56 shows a clear signature of the biotin arm in the up field 
region as also demonstrated by the 13C NMR and the HRMS, Figure 72. 
 
Figure 72: 1H NMR of compound 56 in CDCl3 in 400 MHz spectrometer. 
 
The production of the water-soluble sensor 57 necessitates an additional hydrogenolysis step. 
Hydrogenolysis using the classical conditions (H2, Pd/C in a CH2Cl2/MeOH mixture) revealed 
the appearance of a benzyl protected new byproduct. The lack of benzyl deprotection might be 
due to the sulfur atom, which poisons the catalyst. We switched then to the hydrolysis condition 
using 18 equiv. of KOH (0.3 M) in THF/water mixture for 30 minutes, and this time the product 
56
H2O
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57 was successfully obtained after an extraction and acidification step. The 1H NMR spectrum of 
this derivative shows the full disappearance of the six benzyl groups but the compound is still not 
pure. The formation of compound 57 was also confirmed by HRMS and xenon NMR 
experiments. Further work has to be done to optimize this step, Figure 73.  
 
Figure 73: synthesis of water soluble cryptophane 57. 
 
The success of this reaction clearly shows that it is possible to enlarge the scope of reactivity with 
our platforms. Further experiments will be necessary in the future to improve the grafting of the 
sensing arm. 
 
 
56
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From a structural point of view, we have been able to construct water-soluble selectively 
functionalizable cryptophanes, solving by this the solubility and symmetry problems encountered 
when using other cages. To test if our platforms attain the requirements for the targeted sensing 
applications, we have studied the (HP) 129Xe NMR spectroscopy of these cages in collaboration 
with Dr. Patrick Berthault at the Laboratoire de Structure et Dynamique par Résonance 
Magnétique (LSDRM) at CEA in Saclay, France. The production of the (HP) 129Xe is achieved 
by a batch mode SEOP, with a polarization ranging between 15 to 20%. The hyperpolarized 
129Xe NMR experiments were performed at 11.7 T. In addition to this, isothermal titration 
calorimetry (ITC) experiments were also conducted to assure the interactions of our sensors with 
the targeted analytes. 
1. Characterization of Cryptophane 48 Bearing a Hydroxamic Acid Group 
Cryptophane derivative 48 is water-soluble over a large range of pH. Two experimental 
campaigns were launched to see the effect of metals chelation and pH variation by (HP) 129Xe 
spectroscopy and ITC. 
1.1.  Effect of pH: 
To ascertain the ability of cryptophane 48 to bind xenon, a simple (HP) 129Xe NMR was done 
in D2O at 298 K. This spectrum shows two peaks corresponding to the free xenon in solution at 
196 ppm and the caged xenon at 55 ppm, Figure 74. Indeed the latter signal is upfield shifted 
compared the free xenon due to cryptophane’s shielding effect of the six aromatic rings 
surrounding the encapsulated xenon. The appearance of two signals indicates a slow in-out 
exchange dynamics of xenon. This behavior has already been observed with cryptophane-[223] 
type derivatives that show also specific signal for the 129Xe@Cryptophane-[223] between 50 and 
60 ppm.  
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Figure 74: one-scan (HP) 129Xe NMR spectrum of compound 48 in D2O recorded at 25 °C. 
 
In the first chapter, we presented the remarkable ability of (HP) 129Xe@cryptophane complexes 
to sense the slight variations in the pH.38,134 We specifically discussed two cages, the cryptophane 
hexacarboxylate and the cryptophane tri-carboxylate, each bearing different ionizable groups. 
Having seven ionizable groups on cryptophane 48 derivative triggered us to investigate the effect 
of pH change and eventually compare it to the previously reported results.  
For this purpose the (HP) 129Xe NMR spectra of compound 48 (0.2 mM) was studied at three 
different pH values (pH= 3.3, 8.2 and 9.9) in D2O at 298 K. The spectra at each pH show two 
NMR signals. One signal corresponding to xenon dissolved in the bulk at 196 ppm and the 
upfield shifted signal of the caged one, Figure 75. At pH 9.9, 8.2 and 3.3 the encapsulated xenon 
peaks are located at 58.4 (green), 59.4 (red) and 61.3 ppm (blue), respectively, Figure 75. 
Between pH values of 9.9 and 8.2 not much variation in the encapsulated xenon signal is 
observed (1 ppm) although the pKa value of the hydroxamic acid group is reported to be in this 
range.160 This result indicates that the ionization of the hydroxamic acid function grafted on the 
Free xenon
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propylenedioxy arm is not “felt” by the encapsulated xenon. This result seems to be very 
surprising and disappointing because the hydroxamic function is very close to center of the cage. 
Consequently, we assumed that the close proximity between this function and the encapsulated 
xenon would result in a greater effect. The lack of sensitivity can be, in part, explained by the 
localization of the sensing unit. In contrast to the other examples reported in the literature, this 
sensing unit is located on the linker. Consequently it won’t affect the ring current of the CTB 
units as in the case of other biosensors developed so far.  
The drop of the pH to acidic conditions (pH = 3.3) resulted a greater chemical shift variation by 
about 3 ppm. This variation is due to the change of ionization state of the carboxylic acid groups 
grafted on the CTB rims, which in turn modifies the ring current of the benzene rings. Similar 
effect was previously observed with cryptophane-[222] hexacarboxylate, where the change in the 
pH values from 3.5 to 10.8 resulted in a downfield shift by nearly 4 ppm.134 The greater variation 
observed in case of cryptophane-[222] hexacarboxylate compared to our cryptophane-[223] 
derivative can be explained by the smaller cavity size of this compound. 
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Figure 75: one-scan 129Xe NMR spectra recorded at 298 K of compound 48 (0.2 mM) in D2O at pH = 9.9 (green), pH 
= 8.9 (red) and pH = 3.3 (blue). 
 
1.2.  Zinc and Nickel Complexation by ITC and (HP) 129Xe Spectroscopy: 
Grafting a hydroxamic acid function on the cage’s 48 arm allowed us to study the chelation of 
different metal cations like zinc and nickel. To assure that our probe chelates these cations we 
used ITC experiments. This technique allows us to access not only the binding constants but also 
the thermodynamic parameters of the complexation (G°, H°, S°). To avoid misleading results 
it was necessary to conduct these experiments in presence of a buffer. Indeed, in absence of 
buffer, the addition of a small amount of cationic species changes the pH of the solution and in 
turn it affects the parameter of complexation. It took a while for us to optimize the experimental 
conditions due to solubility issues of the metal salt. For instance, ZnCl2 was not soluble neither in 
HEPES, phosphate buffer nor MOPS. It is noteworthy that a cloudy solution was obtained in all 
cases even though some articles reported these conditions.170 Fortunately, we found that 2-amino-
2-hydroxymethyl-1,3-propanediol (TRIS) (20 mM, pH = 7.5) could be used to dissolve zinc 
chloride.  
Free xenon
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Figure 76: chelation of zinc cation by compound 48. 
 
The titration of cryptophane 48 (0.08 mM) with ZnCl2 (1mM) in 20 mM of TRIS buffer at pH = 
7.5 has shown an effective complexation of the zinc cation by the hydroxamic acid function, 
Figure 76. Our measurements are compatible to 1:1 complex. This binding process is exothermic 
and the following thermodynamic parameters have been measured ΔH°= - 4.3 ± 0.08 kcalmol-1 
and Ka = 4.4 ± 0.22×10
4 M-1 obtained at 298 K. This leads to a calculated positive TΔS° ~ 0.63 
kcal mol-1K-1 and ΔG° = - 6.3 kcal mol-1, Figure 77. Similar results are obtained upon titration of 
our cage with NiCl2. Assuming a 1:1 complex, the obtained thermodynamic parameters are the 
following Ka = 3.64 ± 0.14×10
4 M-1; ΔH° = - 5.75 ± 0.10 kcal mol-1 leading to a free enthalpy of 
complexation ΔG° and entropy of complexation TΔS° of - 5.6 kcal mol-1 and 0.15 kcal mol-1 K-1, 
respectively. It is worth mentioning that these thermodynamic parameters are a resultant of 
different processes taking place in addition to the metal chelation, like the dehydration of the 
metal ion, the metal-induced deprotonation of the hydroxamic acid function, and finally their 
interactions with the buffer.  
48
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Figure 77: representative plot of the raw ITC data for the titration of 48 with Zn2+. Titrations were carried out at 298 
K in TRIS buffer (20 mM, pH = 7.6) with 48 (0.08 mM) in the sample cell and 1mM of Zn2+ in the syringe. 
 
Additional titration experiment in TRIS (20 mM pH = 7.5) was conducted with cryptophane-
[222] hexacarboxylate (0.08 mM) and ZnCl2 (1 Mm) to study the effect of the six carboxylate 
groups on such a complexation, Figure 78. The obtained enthalpogram shows very little 
endothermic interaction between the zinc cation and the carboxylated cage. Thus, it can be 
concluded that the effect observed in Figure 77 results only from the interaction of the 
hydroxamic acid arm with the zinc cation. 
48
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Figure 78: representative plot of the raw ITC data for the titration of cryptophane-[222] hexa-acid with Zn2+. 
Titrations were carried out at 298 K in TRIS buffer (20 mM, pH = 7.6) with cryptophane (0.08 mM) in the sample 
cell and 1mM of Zn2+ in the syringe. 
 
Metals-hydroxamic acid complexation has been exhaustively studied in literature and our results 
are in accordance with what has been reported. For example, the binding constant (Ka = 3.64 ± 
0.14× 104 M-1) of Ni2+ cation with cryptophane 48 is of the same order as the one obtained with 
benzohydroxamic acid chelator reported by Harty and co-workers.171 In the latter example, the 
authors reported a two-site sequential binding of consecutive binding constants (K1 = 1.5×10
4 M-1 
and K2 = 850 M
-1) corresponding to formation of 1:2 complex. Similarly, zinc binding by our 
cryptophane chelator reveals a moderate binding constant (Ka = 4.4 ± 0.22×10
4 M-1) lower than 
that reported with acetohydroxamic acid (Ka = 2.8×10
5 M-1). In another study, the Zn2+-
acetohydroxamic acid complexation reveals the formation of a 1:2 complex of respective binding 
constants K = 4.3×109 M-1 and K = 1.5×104 M-1. These results indicate that the binding 
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mechanism and strength is strongly dependent on the experimental conditions and the structure of 
hydroxamic acids.172,173 The fact that we obtain a 1:1 complex rather than a 1:2 one can be 
explained by the molecular size of the cages used. Thus, the steric hindrance prevents two cages 
to be in close proximity.  
After confirming the chelating ability of our cage, we have investigated the complexation process 
by (HP) 129Xe NMR spectroscopy. These studies were performed in the same experimental 
conditions as the one used for the titration experiments: TRIS buffer (20 mM, pH = 7.5). Here 
again, the successive addition of zinc cation solution from 1 to 5 equiv. did not induce significant 
change of the (HP) 129Xe@cryptophaneZn2+ complex. Although the zinc cation is very close to 
portals of the cryptophane’s skeleton, only little spectral modifications are observed. This result 
is a bit disappointing compared to the previously reported biosensor with cryptophane-[222] 
derivative bearing an NTA arm, Figure 33. The localization of this sensing unit makes a great 
difference since as previously mentioned; it affects more significantly the ring current of the 
benzene ring. In turn, it induces larger magnetic modifications on the encapsulated xenon. This 
result approves also the little change in xenon signal at pH between 8.2 and 9.9.  
The little sensitivity of xenon NMR at this position can also be exemplified by studying the 
cryptophane 34 bearing a THP group. Cage 34 exists as a mixture of two diastereomers but xenon 
NMR spectroscopy was unable to distinguish two signals corresponding to each of them. This 
result also contrasts with the reported examples of cryptophane derivatives bearing a mixture of 
diastereomers. However, it assures our hypothesis concerning the position of the sensing 
units.116,117 
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2. Complexation Studies of Cryptophane 57 Bearing a Biotin Derivative 
After proving that our platforms cannot serve as smart xenon biosensors due to the position of 
the sensing unit, we wanted to test its ability as density based sensor instead. This requires the 
grafting of a sensing unit that has a high affinity to the targeted moiety. For this reason, we chose 
the classical biotin-avidin complex due to the high binding constant reported (Ka = 10
15 M-1). The 
hyperpolarized 129Xe NMR experiments of compound 57 revealed two peaks, one corresponds to 
the free xenon in solution, resonating at 196 ppm and another sharp signal at 52 ppm 
corresponding to the encapsulated xenon in the cavity of 57. The sharp signal obtained for 
Xe@57 gives an indication about the purity of our compound because assessing this parameter by 
conventional spectroscopic techniques was hard. We used only HRMS to assure the formation of 
our compound. Upon avidin addition, broadening of the initial signal is observed with a shift by 
about 5 ppm (57.5 ppm). It is worth mentioning that the complex precipitates partially under the 
used experimental conditions, so an optimization of these conditions is required. Nevertheless, 
this chemical shift change and broadening have already been observed with the first example of 
xenon cryptophane biosensor reported by Pines and co-workers. Interestingly, unlike Pines 
example which shows four signals corresponding to the two cryptophanes diastereomers, only 
one sharp signal is obtained in our case, thus facilitating the analysis, Figure 79. 
These promising results assure that our platforms can still be used as MRI tracers, if conjugated 
with biological probes that have a very high affinity to the targeted units. 
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Figure 79: one-scan 129Xe NMR spectra recorded at 298 K of compound 57 (0.9 mM) in PBS buffer with 10% D2O 
at pH  = 6.4, and upon of one equiv. of avidin (0.2 mM) at pH  = 7.4.  
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In this part of the manuscript, we have successfully described the leading strategy towards 
new cryptophane-[223] derivatives functionalized by a primary alcohol. This function exhibits a 
greater reactivity towards electrophilic activation and nucleophilic substitution compared to the 
secondary alcohol in the first generation of cryptophane-[223] derivatives. Thanks to the various 
chemical transformations, we were able to elaborate two real platforms (cryptophanes 43 and 44) 
bearing six ester groups and a unique carboxylic acid arm. The presence of a carboxylic acid 
moiety at the propylenedioxy bridge allows the selective grafting of a spacer and a sensing arm. 
To prove the versatility of our cages, we grafted different sensing units like hydroxamic acid for 
metal chelation, APTRA derivative for calcium detection and finally a biotin arm for avidin 
binding. This was followed by a hydrolysis or hydrogenolysis step to produce the water soluble 
sensors. With these platforms, we were able to solve the two main problems encountered with 
cryptophanes namely the symmetry and water solubility. To study the responsiveness of our 
platforms, we investigated cryptophane 48 bearing a hydroxamic acid unit for metal chelation. 
The ability of this cage to bind metals has been confirmed by ITC experiments. The (HP) 129Xe 
NMR spectroscopy of this cage showed a little sensitivity upon metal chelation. These 
discouraging results can be explained mainly by the position of the sensing arm. Being at the 
center of the propylenedioxy arm, the sensing unit has less probability to change the benzene ring 
currents. This in turn induces fewer changes in the magnetic field around the encapsulated cage. 
The fact that compound 48 is poorly responsive by 129Xe NMR, does not prevent its employment 
as an MRI tracer but this novel strategy does not seem appropriate to design “smart” biosensors 
as previously defined. However, this study allowed us to assure the importance of the sensing 
arm position to get “smart” biosensors and we were able to find discrete solutions for this 
synthetic challenge. 
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EXPERIMENTAL DETAILS: 
Organic Synthesis: 
Mass spectra (HRMS) were performed by the Centre de Spectrométrie de Masse, University of 
Lyon. Analyses were performed with a hybrid quadrupole-time of flight mass spectrometer, 
microToF QII equipped with an Electrospray ion source. Data Analysis® 4.0 was used for 
instrument control, data collection, and data treatment. HRMS analyses were performed in full 
scan MS with a mass range from 50 to 2000 Da at an acquisition rate of 1 Hz. Transfer 
parameters were: RF Funnel 1, 200 V; RF Funnel 2, 200 V; hexapole, 50 V; transfer time, 70 μs 
and PrePulse storage time, 1 μs before each acquisition batch, external calibration of the 
instrument was performed with a sodium formate clusters solution. 1H and 13C NMR spectra were 
recorded at 400 and 100.6 MHz, respectively. Chemical shifts are referenced to Me4Si (
1H, 13C). 
Column chromatographic separations were carried out over Merck silica gel 60 (0.040-0.063 
mm). Analytical thin layer chromatography (TLC) was performed on MERCK silica gel TLC 
plates F-254. The solvents were distilled prior to use: DMF and CH2Cl2 from CaH2, THF from 
Na/benzophenone and pyridine from KOH. 
ITC Experiments: 
Isothermal titration calorimetry (ITC) experiments were performed at 298 K. In a standard 
experiment, the host solution (0.08 mM) in TRIS (20 mM, pH = 7.5) was placed into the 
calorimeter cell (1,4 mL) and 28 successive aliquots (10 μL) of guest solution (10 times more 
concentrated, 1mM) were added via a computer-automated injector at 3 min intervals. Heat 
changes were recorded after each addition. Heats of dilution were measured by a blank 
experiment (in absence of host) under the same conditions and they were subtracted from the 
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titration data prior to curve fitting. The first injection was discarded from each data set to remove 
the effect of guest diffusion across the syringe tip during the equilibration process. Titrations 
curves were fitted with the one binding site model using origin software. 
Production of hyperpolarized xenon: 
Hyperpolarized xenon was produced in the batch mode via SEOP (Spin Exchange Optical 
Pumping) using a home-built setup. Rubidium is used as the alkali metal, and five minutes suffice 
to produce five milliliters of xenon at a polarization ranging from 15 to 20%. Frozen 
hyperpolarized xenon immersed in a bath of liquid nitrogen and subjected to a magnetic field of 
0.3 T provided by a solenoid is transported near the NMR magnet.  There it is sublimated in the 
fringe field of the magnet and transferred thanks to a vacuum line to the NMR tube. A hollow 
spinner enabled us to condense it in the upper part of the NMR tube (screw capped Wilmad PP-
528) without cooling the solution. The hyperpolarized 129Xe NMR experiments were performed 
at 11.7 T (129Xe resonance frequency 138.35 MHz) using a 5mm-broadband inverse probe head. 
Crystallography:  
A suitable crystal of Cryptophane 27 was selected and mounted on a Gemini kappa-geometry 
diffractometer (Agilent Technologies UK Ltd) equipped with an Atlas CCD detector and using 
Cu radiation (λ= 1.5418 Å). Intensities were collected at 150 K by means of the CrysAlisPro 
software. Reflection indexing, unit-cell parameters refinement, Lorentz-polarization correction, 
peak integration and background determination were carried out with the CrysAlisPro software. 
An analytical absorption correction was applied using the modeled faces of the crystals. The 
resulting set of hkl was used for structure solution and refinement. The structures were solved by 
direct methods with SIR97 and the least-square refinement on F2 was achieved with the 
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CRYSTALS software. All non-hydrogen atoms were refined anisotropically. The hydrogen 
atoms were all located in a difference map, but those attached to carbon atoms were repositioned 
geometrically. The H atoms were initially refined with soft restraints on the bond lengths and 
angles to regularize their geometry (C---H in the range 0.93--0.98 Å, O--H = 0.82 Å) and 
Uiso(H) (in the range 1.2-1.5 times Ueq of the parent atom), after which the positions were 
refined with riding constraints. Residual electronic density inside and in between the cryptophane 
cages was located but could not be modelled. The contribution of the disordered solvent 
molecules was removed using the SQUEEZE algorithm. The volume of the cryptophane cage 
was calculated to be 108 Å3 using the VOID algorithm within the PLATON software. CCDC 
1900550 contains the supplementary crystallographic data for cryptophane 27. These data can be 
obtained free of charge from the Cambridge Crystallographic data Centre via 
www.ccdc.cam.ac.uk/data request/cif. 
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Synthesized compounds: 
Compound 22: 3-chloro-2-chloromethyl-1-propene or 19 (4.49 ml, 64.8 mmol, 2 
equiv.) was added under argon to a mixture of K2CO3 (4.48 g, 32.4 mmol, 1 
equiv.) and vanillic alcohol 1 (5 g, 32.4 mmol, 1 equiv.) in acetone (60 mL). The 
reaction mixture was heated for 16 hours at 80 °C under an argon atmosphere. 
Then, the solvent was evaporated under reduced pressure. The solid residue was 
then dissolved in ethyl acetate (200 mL). The organic layer was washed three times with 0.1 M 
NaOH solution and finally washed with water. The organic layer was dried over Na2SO4 and the 
solvent was evaporated under reduced pressure. The crude was then subjected to column 
chromatography on silica gel (CH2Cl2/AcOEt: 80/20). After evaporating the solvents, compound 
22 was collected as a white solid (5.1g, 65%). Mp: 60 °C.  
 
1H NMR (400 MHz, CDCl3, 25 °C): δ (ppm) 6.91-6.83 (m, 3H), 5.34 (m, 2H), 4.65 (s, 2H), 4.58 
(d, J = 5.8 Hz, 2H), 4.18 (s, 2H), 3.84 (s, 3H), 1.65 (t, J = 5.8 Hz, 1H). 
13C {1H} NMR (100.6 MHz, CDCl3, 25 °C): δ (ppm) 149.8, 147.4, 140.7, 134.5, 119.3, 117.5, 
114.2, 111.06, 69.4, 65.2, 55.9, 45.08  
HRMS (ESI): m/z [M+Na]+ calcd. for C12H15NaClO3 265.0607 found 265.0602. 
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Compound 23: Derivative 22 (2.0 g, 8.2 mmol, 1 equiv.) was 
added under an argon atmosphere to a stirred mixture of 
Cs2CO3 (5.4 g, 16.4 mmol, 2 equiv.) and cyclotriguiacylene 4 
(3.5 g, 8.6 mmol, 1 equiv.) in DMF (120 mL). The mixture was 
heated up to 80°C for 16 hours under an argon atmosphere. 
Then, the dark-brown mixture was poured in water (200 mL) and extracted 5 times with ethyl 
acetate (800 mL). The combined organic layer was then washed 5 times with water (500 mL) and 
dried over Na2SO4. Evaporation of the solvent under reduced pressure left an oily residue, which 
was purified on silica gel (AcOEt/petroleum ether: 90/10). Evaporation of the fractions gave rise 
to compound 23 (2 g, 40%) as a glassy product. 
 
1H NMR (400 MHz, CDCl3, 25 °C): δ  (ppm) 6.92 (s, 1H), 6.87 (s, 1H), 6.84 (s, 1H), 6.79 (s, 
1H), 6.77 (s, 1H), 6.73 (s, 1H), 6.69 (s, 1H), 6.67 (s, 1H), 6.58 (m, 1H), 5.40 (s, 1H), 5.37 (s, 1H), 
5.29 (m, 2H), 4.71 (s, 3H), 4.67-4.62 (m, 4H), 4.52 (m, 2H), 3.84 (s, 3H), 3.79 (s, 3H), 3.71 (s, 
3H), 3.65 (s, 3H), 3.52-3.46 (m, 3H), 1.54 (m, 1H). 
13C {1H} NMR (100.6 MHz, CDCl3, 25 °C): δ (ppm)  (100.6 MHz, CDCl3) 149.3, 147.8, 147.1, 
146.1, 144.9, 144.8, 143.7, 143.6, 140.2, 133.8, 132.1 (2C), 131.9, 131.5, 130.9, 118.96, 115.6, 
115.2, 115.0, 114.8, 113.3, 113.2, 112.0, 111.8, 110.5, 69.6, 69.4, 64.9, 55.75, 55.7, 55.5, 55.3, 
36-35.9 (3C). 
 HRMS (ESI): m/z [M+Na]+ calcd. for C36H38NaO9 637.2413 found 637.2408. 
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Compound 25: 2-((4-(2-bromoethoxy)-3-methoxybenzyl)-
oxy)tetrahydro-2H-pyran 24 (4.106 g, 11 mmol, 2 equiv.) was 
added under an argon atmosphere to a stirring mixture of 
Cs2CO3 (7.69 g, 23 mmol, 2 equiv.) and CTB 23 (3.65 g, 5.94 
mmol, 1 equiv.) in DMF (140 mL). The reaction mixture was 
heated to 80°C for 16 hours under an argon atmosphere. Then, 
the yellowish mixture was poured in water (200 mL) and ethyl acetate (200 mL). The aqueous 
layer was extracted 5 times with ethyl acetate (500 mL). The combined organic layer was then 
washed 5 times with water (500 mL) and dried over Na2SO4. The solvent was removed under 
reduced pressure to leave a glassy solid, which was purified on silica gel (AcOEt/petroleum 
ether: 90/10) to give rise to compound 25 (5.63 g, 84%) as a white glassy solid. 
 1H NMR (400 MHz, CDCl3, 25 °C): δ (ppm) 7.01-6.65 (15s, 15H), 5.30 (s, 1H), 5.29 (s, 1H), 
4.73-4.63 (m, 10H), 4.53 (m, 2H), 4.43-4.32 (m, 8H), 3.90 (m, 2H), 3.86 (2s, 6H), 3.74-3.71 (3s, 
9H), 3.61 (s, 3H), 3.48-3.53 (m, 5H), 1.85-1.59 (m, 12H). 
 13C {1H} NMR (100.6 MHz, CDCl3, 25 °C): δ (ppm) 149.8, 149.7 (2C), 148.6, 148.5, 148.3, 
147.6 (2C), 147.5, 146.9 (2C), 146.8, 147.5, 140.6, 134.5, 133.1 (2C), 132.5, 131.9 (2C), 131.8 
(3C), 120.5 (3C), 119.2, 117.0, 116.9, 116.1, 115.1, 113.8-114.3 (8C), 112.1 (2C), 111.0, 97.7 
(3C), 70.1, 69.9, 68.6 (2C), 68.4, 67.93, 65.1, 62.2 (2C), 55.7-56.2 (6C), 36.3 (2C), 30.5 (2C), 
25.4 (2C), 19.4 (2C).  
HRMS (ESI): m/z [M+Na]+ calcd. for C66H78NaO17 1165.5136 found 1165.5131. 
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Cryptophane 26: CTB 25 (0.70 g, 0.62 mmol) was dissolved in a 
mixture of chloroform (300 ml) and formic acid (300 ml). The 
solution was then stirred for 6 hours at 55 - 60 °C. The solvent was 
then evaporated under reduced pressure to leave a yellow residue. It 
was then purified by column chromatography on silica gel 
(CH2Cl2/Acetone: gradient 97/3 up to 95/5). The white solid was 
then crystallized in a mixture of CH2Cl2 and ethanol. The crystals were collected on a fritted glass 
and washed with diethyl ether. Compound 26 (0.19 g, 34%) was obtained as a white solid.  
 
1H NMR (400 MHz, CDCl3, 25 °C): δ (ppm) 6.77 (s, 2H), 6.72 (s, 2H), 6.65 (s, 2H), 6.655 (s, 
2H), 6.64 (s, 2H), 6.62 (s, 2H), 5.58 (s, 2H), 4.63-4.56 (m, 6H), 4.46 (d, J=10.7 Hz, 2H), 4.35 (d, 
J=10.7 Hz, 2H), 4.29-4.09 (m, 8H), 3.80 (s, 6 H), 3.79 (s, 6H), 3.75 (s, 6H), 3.43-3.36 (m, 6H). 
13C {1H} NMR (100.6 MHz, CDCl3, 25 °C): δ (ppm)  149.5 (2C), 149.4 (2C), 147.7 (2C), 
147.3(2C), 146.6 (2C), 146.4 (2C), 140.0 (1C), 133.8 (4C), 132.2 (2C), 131.9 (2C), 131.3 (2C), 
130.6 (2C), 120.7, 120.4 (2C), 120.3 (2C), 113.9 (2C), 113.3 (2C), 113.2 (2C), 112.2 (2C), 69.6 
(2C), 68.9 (2C), 68.8 (2C), 56.1 (2C), 55.5 (2C), 55.4 (2C), 36.4 (2C), 36.08 (2C), 36.04 (2C). 
 HRMS (ESI): m/z [M+Na]+ calcd. for C56H56NaO12 943.3669 found 943.3664. 
 
 
 
 
26
Experimental Part  
Page | 125  
 
Cryptophane 27: Derivative 26 (0.28 g, 0.304 mmol) was 
dissolved in a mixture of THF (20 mL) and CH2Cl2 (5 mL) 
under an argon atmosphere. Then, 9-BBN (1.81 mL, 0.5M, 
0.9 mmol, 3 equiv.) was added dropwise at 0 °C. The 
solution was stirred at 50 °C for 5 hours. The mixture was 
then quenched at 0 °C by a dropwise addition of a NaOH 
solution (0.56 mL, 3M) and then by addition of H2O2 (1.7 mL, 15%). The reaction was stirred 
overnight at room temperature for 16 hours. Then, the reaction was quenched by a dropwise 
addition of 20 ml of Na2S2O3 solution at 0 °C. The reaction mixture was poured in CH2Cl2 (50 
ml) and the aqueous layer was washed 5 times with CH2Cl2 (each time 50 ml). The combined 
organic layers were dried over Na2SO4 and the solvent was evaporated under reduced pressure. 
The residue was subjected to column chromatography using silica gel (CH2Cl2/acetone: gradient 
90/10 up to 80/20). Compound 27 (0.27 g, 94%) was then isolated as a white solid and washed on 
a frit with diethyl ether. 
 1H NMR (400 MHz, CDCl3, 25 °C): δ 6.79-6.61 (m, 10 H), 6.51 (s, 2H), 4.62-4.53 (m, 6H), 
4.25-3.93 (m, 14 H), 3.87-3.77 (4s, 12 H), 3.74 (s, 3H), 3.71 (s, 3H), 3.43-3.34 (m, 6H), 2.40 (m, 
1H). 
13C {1H} NMR (100.6 MHz, CDCl3, 25 °C): δ (ppm) 149.6, 149.5 (2C), 149.4, 147.5, 147.4, 
147.3, 146.7, 146.6 (2C), 146.63, 146.3, 134 (2C), 133.8 (2C), 132.5, 132.3, 132.1, 131.5, 131.3, 
131.1, 130.8, 130.6, 120.5, 120.4, 120.2, 120.0, 114.3, 114.2, 113.6, 113.2, 112.7, 112.3, 112.1, 
111.8, 69.8, 69.5, 68.9, 68.7, 68.5, 67.0, 64.3, 56.3 (2C), 55.5 (2C), 55.4, 55.3, 40.2, 36.4 (2C), 
36.1 (3C), 36.  
HRMS (ESI): m/z [M+Na]+ calcd. for C56H58NaO13 961.3775 found 961.3770. 
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Cryptophane 28: Excess of methanesulfonyl chloride (1.3 
mL, 16.8 mmol) was added at 0 °C to a mixture of 
cryptophane 27 (0.5 g, 0.53 mmol), CH2Cl2 (25 mL) and 
pyridine (2.3 mL, 28.5 mmol). The mixture was stirred for 16 
hours at 70 °C before the addition of methanol (25 mL) at 
room temperature. The solvents were evaporated and the 
resulting solid dissolved in CH2Cl2 (100 mL). The organic layer was washed twice with water (50 
mL) and brine (50 mL), dried over Na2SO4 and evaporated. Silica gel chromatography 
(CH2Cl2/acetone: gradient 95/5 up to 90/10) afforded pure cryptophane 28 (0.42 g, 82%) as a 
white solid.  
 
1H NMR (400 MHz, CDCl3, 25 °C): δ (ppm) 6.83-6.62 (m, 10H), 6.56 (s, 2H), 4.76-4.70 (m, 
6H), 4.56-4.48 (m, 2H), 4.34-4.21 (m, 2H), 3.92-3.22 (m, 10H), 3.88 –3.74 (6s, 18H), 3.49-3.33 
(m, 6H), 3.07 (s, 3H), 2.84-2.68 (m, 1H). 
13C {1H} NMR (100.6 MHz, CDCl3, 25 °C): δ (ppm)  149.6 (2C), 149.5, 148.0, 147.8, 146.9, 
146.8 (2C), 146.7 (2C), 146.5 (2C), 134.1, 134.0, 133.9 (2C), 132.4 (3C), 132.2, 131.6 (2C), 
130.9, 130.8, 120.5, 120.4 (2C), 120.3, 114.2 (2C), 113.8, 113.6, 113.3, 112.8, 112.6, 69.7, 69.1, 
69.0, 67.8, 64.9, 64.0, 56.4, 55.8 (2C), 55.7 (2C), 55.6 (2C), 53.6, 39.7, 37.1 (2C), 36.5 (2C), 
36.3, 36.2, 31.1. 
HRMS (ESI): m/z [M+Na]+ calcd. for C57H60 NaO15S 1039.3550 found 1039.3545 
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Cryptophane 29: A mixture of cryptophane 28 (0.15 g, 
0.150 mmol, 1 equiv.), potassium thioacetate (0.1 g, 0.85 
mmol, 5 equiv.), DMF (2 mL) and CH2Cl2 (0.5 mL) was 
stirred for 3 days at 100 °C before the addition of CH2Cl2 (20 
mL) and water (20 mL) at room temperature. The aqueous 
layer was extracted by CH2Cl2 (3 × 20 mL). The combined 
organic layers were washed by water (4 × 20 mL), NaCl (20 mL), dried over Na2SO4 and 
evaporated. Silica gel chromatography (CH2Cl2/acetone: 94/6) and washing over a fritted glass 
with diethyl ether afforded pure cryptophane 29 (0.065 g, 43%) as a white solid.  
 
 1H NMR (400 MHz, CDCl3, 25 °C): δ (ppm) 6.85–6.62 (m, 10H), 6.54 (s, 2H), 4.75 – 4.50  (m, 
6H), 4.37- 4.20 (m, 3H), 4.19- 3.91 (m, 8H), 3.88–3.73 (6s, 18H), 3.51–3.33 (m, 6H), 3.31–3.10 
(m, 1H), 3.21–3.10 (m, 1H), 2.59 –2.44 (m, 1H), 2.37 (s, 3H). 
13C {1H} NMR (100.6 MHz, CDCl3, 25 °C): δ (ppm) 195.7, 149.6 (2C), 149.5 (2C), 147.6, 
147.1, 146.9, 146.8, 146.7 (2C), 134.2, 134.1, 134.0, 133.9, 132.6, 132.5, 148.0, 131.7 (2C), 
131.6 (2C), 130.7 (2C), 120.5 (2C), 120.7, 120.4, 114.4 (2C), 113.8, 113.7, 112.6, 112.5, 112.4, 
69.8 (2C), 69.5, 69.1, 69.0, 66.4, 65.4, δ 64.8, 56.4 (2C), 56.0, 55.8, 55.7, 55.6, 40.3, 36.6 (2C), 
36.2 (2C), 36.1 (2C), 30.7, 27.9.  
HRMS (ESI): m/z [M+Na]+ calcd. for C58H60NaO13S 1019.3652 found 1019.3647 
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 Compound 30: Compound 27 (0.26 g, 0.20 mmol, 1 equiv.) was 
introduced and dissolved in freshly distilled CH2Cl2 (26 ml). 
Excess of Dess martin periodonane (15% wt solution in CH2Cl2 
2.6 ml) was then added. The reaction mixture was stirred under 
argon for 16 hours at room temperature. The next day crude was 
filtered on a fritted glass and the filtrate was collected and 
evaporated under reduced pressure. The resulting crude was crystalized from chloroform diethyl 
ether to give beige precipitate that were collected on a fritted glass and washed with ether. The 
produced product was used directly in the next step without further purification on silica 
because of its sensitivity. 
HRMS (ESI, [M+Na]+) calcd. for C56H56O13 959.37 found 959.35. 
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Compound 31: cryptophane 32 (0.1 g, 0.1 mmol, 1 equiv.) was 
introduced and dissolved in acetonitrile (3 ml) and water 
(0.3ml). Then sodium chlorite (0.019 g in 0.2 ml H2O, 0.212, 2 
equiv.) was added along with sodium phosphate monobasic 
(0.0031g in 0.01 ml H2O, 0.0212, 0.2 equiv.) and then hydrogen 
peroxide (0.102 ml). The mixture was kept for 16 hours and 
then quenched with sodium thiosulfate (0.2 ml) at 0 °C. The solvent was then evaporated under 
reduced pressure and the resulting crude was crystalized from CHCl3 and diethyl ether to give 
white precipitate. These precipitate were filtered on a fritted glass and washed with ether to give 
the compound 31 (0.07 g) as pure white product in 70% yield.  
Compound 31: compound 32 (0.07 g, 0.067 mmol) was dissolved in a mixture of CH2Cl2/MeOH 
(4ml/2ml) along with catalytic amounts Pd/C (10% by weight). The mixture was kept under 
hydrogen for 16 hours at room temperature. The obtained crude was then filtered on celite 
followed by the evaporation of solvent, to afford compound 31 as a white solid (0.059 g, 95%).  
1H NMR (400 MHz, CDCl3, 25 °C): δ (ppm) 6.77-6.57 (12s, 12 H), 4.63- 4.55 (m, 6 H), 4.38- 4 
(m, 12 H), 3.8-3.75 (6s, 18 H), 3.43-3.36 (m, 6 H), 3.3 (m, 1H). 
13C {1H} NMR (100.6 MHz, CDCl3, 25 °C): δ (ppm) 172.7, 149.59, 149.54, 149.47, 149.41, 
147.9, 147.7, 146.76, 146.73, 146.67, 146.64, 146.5, 146.3, 134.0, 133.8, 133.7 (2C), 132.6, 
132.4, 132.2, 132.1, 131.5, 131.4, 131.1, 131.0, 120.2 (3C), 120.1, 114.1 (3C, 113.6 (2C), 113.5 
(2C) 112.6, 69.6, 69.5, 68.8 (2C), 65.2, 64.8, 56.3 (2C), 55.8, 55.6, 55.5 (2C), 45.3, 36.4 (2C), 
36.15 (4C). 
HRMS (ESI, [M+Na]+) calcd. for C56H56NaO14 975.3567 found 975.3562. 
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Compound 32: Potassium carbonate (0.07g, 0.506 mmol, 
2.5 equiv.) was added along with compound 31 (0.19g, 
0.2 mmol, 1 equiv.) and dissolved in DMF (2.5 ml) for 10 
minutes. After that benzyl bromide (0.046 ml, 0.38 mmol, 
2 equiv.) was added and the mixture was heated for 16 
hours at 50 °C. After 16 hours the crude was washed five 
times with ethyl acetate and the produced organic layer was washed 5 times with water. The 
resulting organic layer was dried over Na2SO4 and then filtered. The solvent was evaporated 
under reduced pressure then the crude was subjected to column chromatography using SiO2 
(CH2Cl2/ acetone: 90/10) to give it as pure white product (0.1 g, 50%). 
 
1H NMR (400 MHz, CDCl3, 25 °C): δ (ppm) 7.36- 7.29 (m, 5 H), 6.67-6.53 (12 s, 12H), 5.32-
5.27 (d, J=12.5 Hz, 1H), 5.2-5.16 (d, J=12.5 Hz, 1H), 4.62-4.55 (m, 6H), 4.4-3.9 (m, 12 H), 3.79-
3.69 (6s, 18 H), 3.43 -3.35 (m, 6H), 3.31 ( m, 1H). 
13C {1H} NMR (100.6 MHz, CDCl3, 25 °C): δ (ppm) 170.6, 149.5, 149.49 (2C), 149.4, 148.0, 
147.6, 147.0, 146.8, 146.7 (2C), 146.6 (2C), 135.9, 134.0, 133.9 (2C), 133.4, 132.37, 132.3, 
132.0, 131.8, 131.4, 131.3, 130.87, 130.8, 128.5 (2C), 128.1, 127.8 (2C), 120.4 (3C), 120.2, 
114.1, 114.0, 113.94, 113.61, 113.16 (2C), 113.09, 112.49, 69.67, 69.61, 68.95 (2C), 66.61, 
64.79, 64.25, 56.28 (2C), 56.07, 55.56 (2C), 55.5, 46.02, 36.42 (2C), 36.12 (2C), 36.03 (2C). 
HRMS (ESI): m/z [M+Na]+ calcd. for C63H62NaO14 1065.4037 found 1065.4032. 
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Cryptophane 34: A solution of PPTS (0.12 g, 0.47 mmol) 
in CH2Cl2 (1 mL) was added to a solution of 27 (0.3 g, 0.31 
mmol) and 3,4-dihydropyran (0.1 mL, 1.09 mmol) in THF 
(8 mL). The solution was heated up to 60 °C for 48 hours. 
Then, the solvent was evaporated under reduced pressure. 
The oily residue was subjected to column chromatography 
on silica gel (CH2Cl2/acetone: 90/10) to give rise to compound 34 as a mixture of two 
diastereomers in the form of white solid (0.23 g, 75%) was collected on a fritted glass and 
washed with diethyl ether. 
 
1H NMR (400 MHz, CDCl3, 25 °C): δ (ppm)  6.76-6.55 (12s, 12H), 4.69 (m, 1H), 4.60-4.55 (m, 
6H), 4.20-3.97 (13H), 3.88 (m, 2H), 3.78 (3s, 9H), 3.76-3.74 (3s, 9H), 3.59 (m, 1H), 3.38-3.35 
(m, 6H), 2.60 (m, 1H), 1.82-1.50 (m, 6H). 
13C {1H} NMR (100.6 MHz, CDCl3, 25 °C): δ (ppm) 149.4 (3C), 147.9, 147.6, 147.4, 147.3, 
147.2, 146.8, 146.7, 146.5 (2C), 134.0, 133.95, 133.9, 133.8, 132.4 (2C), 131.4 (4C), 130.6 (2C), 
120.5 (4C), 114 (2C), 113.7, 113.5, 113.0, 112.8, 112.4 (2C), 112.3, 98.4, 69.7, 69.0, 65.5, 65.4, 
64.7, 62.6, 61.8, 56.2, 55.8, 55.6 (2C), 55.5, 55.4, 40.5, 36.4 (2C), 36.0 (4C), 30.7, 25.5, 19.71, 
19.2. 
HRMS (ESI): m/z [M+Na]+calcd. for C61H66NaO14 1045.4350 found 1045.4344. 
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Figure 80: 13C NMR of cryptophane 34 composed of a mixture of diastereomers in CDCl3. 
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Cryptophane 35: (4 mL, 4.1 mmol, 20 equiv.) of lithium 
diphenylphosphide (1 M) was added to a solution of 34 
(0.21 g, 0.21 mmol) in THF (3 mL) under an argon 
atmosphere. The red solution was heated up to 60 °C for 48 
hours. Then, the mixture was poured in 20 mL of water and 
then extracted 5 times with CH2Cl2. The aqueous solution 
was acidified at 0 °C with an ammonium chloride solution (10 mL, pH ~ 5). The resulting 
precipitate was collected on a fritted glass and washed with water. The dried solid was then 
washed several times with diethyl ether to give a beige solid. The solid was then purified on 
column chromatography (silica gel, acetone/DMF: 96/4) to give clean compound 35 as a mixture 
of two diastereomer (0.16 g, 84%). 
 
1H NMR (400 MHz, DMSO d6, 25 °C): δ (ppm)  8.42-8.22 (6s, 3 H), 7.95-7.74 (6s, 3H), 6.65-
6.48 (m, 12H), 4.66 (m, 1H), 4.47-4.39 (m, 6H), 4.13-3.87 (m, 13H), 3.72 (m, 1H), 3.34 (m, 2H), 
3.22-3.17 (m, 6H), 2.33 (m, 1H), 1.67-1.49 (m, 6H). 
13C {1H} NMR (100.6 MHz, CDCl3, 25 °C): δ (ppm)  146.8, 146.7, 146.3, 146.2, 146, 145.9, 
145.6, 145.4, 145.06, 145.0, 144.8, 144.7, 134.3, 134.1, 134.0, 133.9, 132.9, 132.8, 131.4, 131.2, 
130.9, 130.8, 129.7, 129.6, 120.5, 120.3, 119.3 (2C), 118.7, 118.5, 118.02 (2C), 117.4, 116.9, 
115.6, 115.5, 98.9, 69, 68.7 (2C), 67.6, 66.5, 65.9, 62.2, 35.6 (2C), 35.2 (4C), 30.8, 25.5, 19.8, 
19.7. 
HRMS (ESI): m/z [M+Na]+ calcd. for C55H54O14Na for 961.3411 found 961.3405. 
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Figure 81: 13C NMR spectrum of compound 35 in DMSO-d6 in 400 MHz spectrometer.  
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Compound 36: Benzyl bromoacetate (0.88 mL, 
5.5 mmol, 12 equiv.) was added under an argon 
atmosphere to a solution of compound 35 (0.44 
g, 0.46 mmol, 1 equiv.) and Cs2CO3 (1.83 g, 5.5 
mmol, 12 equiv.) in DMF (8 mL). The mixture 
was heated for 16 hours at 60 °C under argon. 
The mixture was poured in water and then extracted 5 times with AcOEt. The combined organic 
layers were then washed 5 times with water, dried over Na2SO4. Filtration and evaporation of the 
solvent under reduced pressure gave an oily residue, which was subjected to column 
chromatography on silica gel (CHCl3/acetone: 95/5). Compound 36 was collected as viscous oil 
(0.43 g, 54%) as a mixture of two diastereomers. This compound was used without further 
purification for the next step.  
 
1H NMR (300 MHz, CDCl3, 25 °C): δ (ppm) 7.15-7.01 (m, 30 H), 6.42-5.99 (12s, 12H), 5.00-
4.8 (m, 12 H), 4.36-4.07 (m, 18 H), 3.88- 3.49 (m, 13 H), 2.87- 2.82 (m, 6H), 1.98 (m, 1H), 1.45 
(m, 6H). 
HRMS (ESI, [M+Na]+) calcd. for C109H102NaO26 1849.6557 found 1849.6552. 
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Compound 37: Methyl bromoacetate (0.2 mL, 2.28 
mmol, 24 equiv.) was added under an argon atmosphere 
to a mixture of cryptophane 35 (0.09 g, 0.095 mmol, 1 
equiv.) and Cs2CO3 (0.37 g, 1.13 mmol, 12 equiv.) in 
DMF (3 mL) and CH2Cl2 (1 mL). The mixture was heated 
up to 50 °C for 16 hours under argon. Then, the mixture 
was poured in water and extracted 5 times with AcOEt. The combined organic layers were then 
washed 5 times with water and dried over Na2SO4. Evaporation of the solvent gave rise to an oily 
residue, which was subjected to column chromatography on silica gel (CHCl3/acetone: gradient 
90/10 to 85/15). Compound 37 was isolated as a white solid as a mixture of two diastereomers 
(0.090 g, 70%) and used without further purification for the next step. 
 
1H NMR (400 MHz, CDCl3, 25 °C): δ (ppm) 6.86-6.68 (10 H, 10s), 6.55-6.53 (2H, 2s), 4.68-
4.48 (18 H, m), 4.44-3.75 (35 H, m), 3.35-3.34 (6H, m), 2.51 (1H, m), 1.83 (m, 6 H). 
HRMS (ESI): m/z [M+Na]+ calcd. for C73H78NaO26 1393.4679 found 1393.4673. 
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Compound 38: PPTS (0.3 g, 1.3 mmol, 5 equiv.) in 
methanol (2 mL) was added in one portion to 
cryptophane 36 (0.47 g, 0.25 mmol) in CH2Cl2 (6 
mL). The solution was heated to 40 °C for 48 hours. 
Then, the solvents were evaporated under reduced 
pressure and the residue was purified on silica gel 
(CH2Cl2/acetone: 96/4). Compound 38 (0.4 g, 93%) was obtained as white glassy solid.  
 
1H NMR (400 MHz, CDCl3, 25 °C): δ (ppm) 7.42-7.30 (m, 30H), 6.58-6.39 (12s, 12H), 5.31-
5.00 (m, 12H), 4.60-4.36 (m, 18 H), 4.18-3.83 (m, 14H), 3.26-3.05 (m, 6 H), 3.02 (m, 1 H). 
13C {1H} NMR (100.6 MHz, CDCl3, 25 °C): δ (ppm) 169.5, 169.3, 169.2 (2C), 169, 168.8, 
148.4, 147.9, 147.6, 147.5 (2C), 147.4, 147.2 (4C), 146.0 (3C), 135.6 (2C), 135.5, 135.4 (3C), 
134.7, 134.3, 133.8, 133.5, 133.4, 133.37, 133.2 (2C), 132.9, 132.0, 131.6, 131.3, 128.5-128.8 
(30 C), 121.1, 120.7, 120.6, 119.7, 119.4, 119.2, 119.1, 118.8, 118.1, 115.5, 113.5, 113.1, 69.7, 
69.1, 68.8, 68.6, 68.1, 68.0, 67.9, 67.9, 67.8, 67.7, 67.2, 67 (2C), 66.9 (2C), 66.8, 66.7, 66.6, 66.3, 
63.4, 41.1, 36.2, 35.9, 35.7 (3C).  
HRMS (ESI): m/z [M+Na]+ calcd. for C104H94NaO25 1765.5981 found 1765.5976. 
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Compound 39: PPTS (0.050 g, 0.2 mmol) in methanol 
(3 mL) was added under an argon atmosphere to a 
solution of 37 (0.17 g, 0.12 mmol) in CH2Cl2 (5 mL). 
The solution was stirred under argon at 40 °C. The 
solvents were evaporated under reduced pressure and 
the oily residue was subjected to column 
chromatography on silica gel (CH2Cl2/acetone: 80/20). After evaporating the solvents, compound 
39 (0.14 g, 93%) was collected on a fritted glass as a white solid and was washed with a small 
volume of diethyl ether. 
 
1H NMR (400 MHz, CDCl3, 25 °C): δ (ppm) 6.82-6.55 (12s, 12 H), 4.66-4.46 (m, 18 H), 4.34-
3.78 (m, 32 H), 3.40-3.34 (m, 6H), 2.29 (m, 1H).  
13C {1H} NMR (100.6 MHz, CDCl3, 25 °C): δ (ppm) 170.0, 169.8, 169.7 (2C), 169.6, 169.2, 
148.3, 147.9, 147.6 (3C), 147.4, 147.2, 147.1 (2C), 147.0, 145.9 (2C), 134.9, 134.8, 134.4, 133.8, 
133.5, 133.48, 133.3, 133.2, 133.1, 132.9, 131.8, 131.7, 121.0, 120.8, 120.3, 119.7, 119.3, 119.2, 
118.9, 118.4, 118.1, 114.7, 113.5, 113.1, 69.6, 69.2, 68.8 (2C), 68.6, 68.3, 67.7 (2C), 67.5, 67.3, 
67.0, 66.5, 66.3, 51.8-52.1 (6C), 41.0, 35.7-36.2 (6C).  
HRMS (ESI): m/z [M+Na]+ calcd. for C68H70NaO25 1309.4103 found 1309.4098. 
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Compound 41: Excess of Dess martin periodinate 
reagent (15% wt solution in CH2Cl2, 0.9 mL; 0.37 mmol) 
was added at room temperature to a solution of 38 (0.1 g, 
0.057 mmol) in freshly distilled CH2Cl2 (13 mL). The 
solution was stirred at room temperature for 16 hours. 
Then, the solution was filtered on a fritted glass. The filtrate solution was collected and the 
solvent was removed under reduced pressure to leave a solid residue. Dissolution in a minimum 
of CH2Cl2 and precipitation with diethyl ether gave rise to compound 41 as white solid. This 
compound decomposes on silica gel. Thus, 41 was used without further purification for the 
next step. An HRMS spectrum allows us to ascertain the structure of 41.  
 
HRMS (ESI): m/z [M+Na]+ calcd. for C104H92NaO25 1763.5825 found 1763.5819.  
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Compound 42: Excess of Dess martin periodinate (15% wt 
solution in CH2Cl2) reagent (0.4 mL; 0.16 mmol) was added 
at room temperature to a solution of 39 (0.15 g, 0.11 mmol) 
in freshly distilled CH2Cl2 (4 mL). The solution was stirred 
at room temperature for 16 hours under an argon atmosphere. 
Then, the solution was filtered on a fritted glass. The filtrate solution was collected and the 
solvent was removed under reduced pressure to leave a solid residue. Dissolution in a minimum 
of CH2Cl2 and precipitation with diethyl ether gives rise to compound 42 as white solid. This 
compound also decomposes on silica gel. Thus, compound 42 was used without further 
purification for the next step. An HRMS spectrum allows us to ascertain the structure of 42.  
HRMS (ESI): m/z [M+Na]+ calcd. for C68H68NaO25 1307.3947 found 1307.3942. 
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Compound 43: Sodium chlorite (0.01 g in 0.1 ml 
water, 0.16 mmol, 3 equiv.) was added along with 
sodium monobasic phosphate (99.45 µg in 0.01 ml 
water, 0.0083 mmol) and H2O2 (1.59 µl) to a solution of 
compound 41 (0.1 g, 0.06 mmol, 1 equiv.), CH3CN (1.5 
mL), H2O (0.15 mL) under an argon atmosphere at 
room temperature. The, solution was stirred for 16 hours at room temperature and the solvent was 
removed under reduced pressure. The resulting residue was subjected to column chromatography 
on silica gel (CH2Cl2/acetone: 75/25). After evaporation of the solvents, compound 43 (0.07 g, 70 
%) was collected as white solid. 
 
1H NMR (400 MHz, CDCl3, 25 °C): δ (ppm) 7.44-7.30 (m, 30H), 6.62-6.36 (12s, 12H), 5.31-
5.09 (s, 12H), 4.55-4.37 (m, 18 H), 4.15-3.95 (m, 12H), 3.19-3.15 (m, 6H), 3.07 (m, 1H).  
13C {1H} NMR (100.6 MHz, CDCl3, 25 °C): δ (ppm) 172.5, 169.6, 169.4, 169.3, 169.2 (2C), 
169.1, 147.8, 147.7 (2C), 147.6 (2C), 147.4 (2C), 147.3, 147.2 (2C), 146.2, 145.9, 135.2,-135.5 
(6C), 134.4 (2C), 133.6 (2C), 133.3, 133.2 (2C), 133.1 (2C), 133.0, 132.4, 132.0, 128.6-128.8 
(30C), 120.9 (2C), 120.6, 120.27 (2C), 119.1 (2C), 118.8, 118.3, 117.5, 114.5, 114.2, 69.4, 69.3, 
68.8 (2C), 68.1, 68.0, 67.9 (2C), 67.2 (2C), 67.0-66.9 (6C), 64.8 (2C), 62.8, 45.6, 36.1 (2C), 35.7 
(4C).  
HRMS (ESI): m/z [M+Na]+ calcd. for C104H92NaO26 1779.5774 found 1779.5769. 
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Compound 44: Sodium chlorite (0.035 g in 0.35 mL water, 
0.38 mmol, 2 equiv.) was added along with sodium 
monobasic phosphate (0.01g in 0.017 mL water, 0.07 mmol) 
and H2O2 (0.53 mL) to a solution of compound 42 (0.25 g, 
0.19 mmol, 1 equiv.), CH3CN (5.3 mL), H2O (0.15 mL) 
under an argon atmosphere at room temperature. The, solution was stirred for 16 hours at room 
temperature and then quenched with sodium thiosulfate (2 mL) at 0°C. The solvent was then 
removed under reduced pressure. Then, the crude was recrystallized from CH2Cl2 and diethyl 
ether to give a white precipitate. Filtration on a frit allows us to collected compound 44 (0.19 g, 
78%) as a white solid. This solid was washed several times with diethyl ether and dried in air. 
 
1H NMR (400 MHz, CDCl3, 25 °C): δ (ppm) 6.81-6.60 (12s, 12 H), 4.66-4.42 (m, 18 H), 4.38-
4.13 (m, 12 H), 3.83-3.76 (6s, 18 H), 3.39-3.36 (m, 6 H), 3.24 (m, 1H). 
13C {1H} NMR (100.6 MHz, CDCl3, 25 °C): δ (ppm) 172.6, 170, 169.9 (4C), 169.8, 147.8, 
147.7, 147.7 (2C), 147.6, 147.5 (2C), 147.4, 147.3 (2C), 146.4, 146.2, 134.5 (2C), 133.7, 133.6, 
133.5, 133.4 (4C), 133.3, 133.2, 132.9, 132.3, 121.0 (2C), 120.1 (2C), 119.7, 119.3 (2C), 118.2 
(2C), 117.4, 115.4, 115.0, 69.5 (2C), 68.8 (2C), 67.7 (2C), 67.6 (2C), 67.2, 67.0, 65.6, 65.2, 52.0-
52.2 (6C), 45.9, 36.3 (3C), 35.9 (3C). 
HRMS (ESI): m/z [M+H]+ calcd. for C68H69O26 1301.4077 found 1301.4072. 
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Compound 45: Cryptophane 31 was introduced (0.13 
g, 0.13 mmol, 1 equiv.) and then dissolved in freshly 
distilled pyridine (2ml). Then O-benzyl hydroxylamine 
(excess, 0.04 ml) was added and the solution was 
brought to -15 °C. POCl3 (excess, 0.05 ml) was 
introduced drop wisely and the solution was stirred for 
30 minutes at -15 °C then for 5 hours at room temperature. The obtained yellowish solution was 
poured cautiously in ice/water/NaHCO3 at 0 °C in which a lot of precipitates were obtained. The 
solution was filtered then extracted 5 times with CH2Cl2 and the solvent was evaporated under 
reduced pressure. The obtained crude was purified on silica (CH2Cl2/Acetone: 90/10) to afford 
the product as white powder which was further washed with diethyl ether (0.09 g, 62%). 
1H NMR (400 MHz, CDCl3, 25 °C): δ (ppm) 9.70 (s, 1H), 7.42-7.3 (m, 5H), 6.74-6.55 (12s, 
12H), 4.96-4.91 (d, j=, 11.5 Hz, 1H), 4.91-4.94 (d, j=11.5, 1H), 4.62-4.55 (m, 6H), 4.26-3.82 (m, 
12H), 3.79-3.67 (6s, 18H), 3.4-3.36 (m, 6H), 3.09 (m, 1H).  
13C {1H} NMR (100.6 MHz, CDCl3, 25 °C): δ (ppm)  169.7, 149.6, 149.5, 149.4, 149.3, 148.1, 
147.86, 146.8, 146.7, 146.6 (2C), 145.4, 135.6, 134.0, 133.9, 133.7, 133.6, 133.2, 132.4, 132.0 
(2C), 131.5, 131.48, 131.4, 130.9, 129.2 (2C), 128.6, 128.4 (2C), 120.3 (2C), 120.1, 119.9, 114.7, 
114.4, 114.2 (2C), 113.7, 113.5, 112.9, 112.5, 77.2, 69.7, 69.4, 68.9, 68.7, 66.6, 64.5, 56.3, 56.3, 
55.69, 55.61, 55.5, 55.4, 46.1, 36.4, 36.1 (4 C).  
HRMS (ESI): m/z [M+H]+ calcd. for C63H63NaNO14 1080.4146 found 1080.4140. 
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Compound 46: The protected cryptophane 45 (0.07 g, 0.066 
mmol) was introduced along with catalytic amount of Pd/C 
(10% by weight) and then dissolved in CH2Cl2/ Methanol 
mixture. The solution was purged first with Argon then with 
hydrogen and placed under hydrogen atmosphere for 24 
hours. The produced solution was filtered on cellite and 
washed with CH2Cl2 for several times. It is important to mention that the product was slightly 
colored (reddish). Following this, the solvent was evaporated under reduced pressure and the 
obtained solid was washed with diethyl ether to offer pure product 46 (0.02 g 30%). 
1H NMR (400 MHz, CDCl3, 25 °C): δ (ppm) 10.21 (s, 1H), 6.76-6.6 (12s, 12H), 4.56-4.53 (m, 
6H), 4.24- 3.92 (m, 12H), 3.83-3.74 (6s, 18H), 3.41-3.37 (m, 6H), 3.2 (m, 1H). 
HRMS (ESI): m/z [M+H]+ calcd. for C56H57NNaO14 990.3676 found 990.3671. 
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Compound 47: Excess of POCl3 (0.013 mmol) 
was slowly added at -15 °C to a solution of 43 
(0.14 g, 0.08 mmol, 1 equiv.) and O-benzyl 
hydroxylamine (0.020 mL) in pyridine (3 mL).  
The solution was stirred for 30 minutes at this 
temperature hours and then stirred for further 5 
hours at room temperature. The solution was quenched by addition of a mixture of 
ice/water/NaHCO3 at 0 °C. The obtained mixture was washed 5 times with CH2Cl2. Then the 
combined organic layers were dried over Na2SO4. The solution was filtered and the solvent was 
removed under pressure to leave a residue. Purification on silica gel (CH2Cl2/acetone: 95/5) gave 
rise to compound 47 (0.04 g; 26%) as a white solid. This solid was collected on a fritted glass and 
washed several times with diethyl ether. 
1H NMR (400 MHz, CDCl3, 25 °C): δ (ppm) 9.63 (s, 1H), 7.43-7.26 (m, 35H), 6.59-6.26 (12s, 
12H), 5.35-4.94 (m, 14H), 4.65-4.34 (m, 18H), 4.05-3.68 (m, 12H), 3.27-3.19 (m, 6H), 2.89 (m, 
1H).  
13C {1H} NMR (100.6 MHz, CDCl3, 25 °C): δ (ppm)  169.5, 169.4, 169.3, 169.2, 169.1, 168.7, 
168.6, 147.9, 147.7, 147.6, 147.66, 147.5, 147.3 (2C), 147.2 (2C), 146.5, 146.4, 146.3, 135.3-
135.7 (6C), 134.6, 134.2, 133.7, 133.6, 133.4 (2C), 133.3, 133.2, 133.1 (2C), 132.6, 132.1, 129.5-
129.5 (35C), 121.0, 120.7, 120.0, 119.6, 119.5, 119.1, 118.8, 118 (2C), 115.5 (3C), 115.2, 78.1, 
69.7, 69.1, 68.7, 68.4, 68.1, 67.9, 67.8 (2C), 67.3, 66.8-66.9 (6C), 66.5, 66.0, 64.7, 47.3, 36.0, 
35.9, 35.7 (4C).  
HRMS (ESI): m/z [M+Na]+ calcd. for C111H99NNaO26 1884.6353 found 1884.6347. 
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Compound 48: Hydrogen gas was bubbled into a 
solution of cryptophane 47 (0.057 g, 0.03 mmol) 
and Pd/C (10%) (0.05 g) in a mixture of CH2Cl2 (2 
mL) and methanol (1 mL). The solution was kept 
under hydrogen atmosphere for two nights at room 
temperature. Then, the mixture was filtered on 
cellite and washed CH2Cl2 and methanol. The solvents were evaporated under reduced pressure 
to leave a residue. It was then dissolved in aqueous NaOH (0.3 M) and the aqueous layer was 
washed 3 times whit CH2Cl2. Acidification with few drops of conc. HCl at 0 °C gave rise to a 
precipitate which was collected on a fritted glass and washed several times with diethyl ether. 
Compound 48 (0.015 g, 40%) was obtained as a white solid.  
 
1H NMR (400 MHz, CDCl3, 25 °C): δ (ppm) 9.69 (s, 1H), 6.94-6.69 (12s, 12H), 4.79-4.29 (m, 
30 H), 3.98-3.84 (m, 7H).   
13C {1H} NMR (100.6 MHz, CDCl3, 25 °C): δ (ppm) 171.5, 170.4 (3C), 170.1, 170.0, 168.3, 
148.5, 148.2, 147.5, 147.4, 146.3 (2C), 146.2, 146.1, 146.0, 145.9, 145.4, 144.8, 134.9, 133.8, 
133.7, 132.9, 132.8 (3C), 132.7, 132.6, 132.3, 132.2, 132.0, 123.9, 120.2, 118.8 (2C), 118.6, 
118.4, 117.8, 117.4, 117.1, 115.7 (2C), 115.3, 68.9, 68.2, 67.9 (2C), 67.8, 67.2, 66.9, 66.8, 66.0, 
65.6, 65.4, 65.1, 43.3, 35.4-35.0 (6C).  
HRMS (ESI): m/z [M+Na]+ calcd. for C62H57NNaO26 1254.3066 found 1254.3061. 
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Figure 82: 1H NMR spectrum in DMSO-d6 of compound 48. 
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Figure 83: HSQC of compound 48 in DMSO-d6 in a 400 MHz spectrometer. Zoomed is the aromatic region 
corresponding to twelve proton and their corresponding carbons. 
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Compound 53: Cryptophane 31 (0.035 g, 0.036 
mmol, 1 equiv.) was first introduced and 
dissolved in freshly distilled pyridine (1ml). Then 
the aniline 52 (0.0148 g, 0.0435 mmol, 1.2 
equiv.) was added and the mixture was brought to 
-15 °C. After that POCl3 (1.1equiv., 4.03 µl, 
0.043 mmol) drop wisely and then stirred at -15 °C for 30 minutes then at room temperature for 5 
hours. The obtained solution was quenched by introducing it in H2O/NaHCO3/ Ice at 0 °C. After 
that the crude was extracted 5 times with CH2Cl2 and then dried (note a lot of precipitate are 
obtained) over Na2SO4. The solvent was evaporated under reduced pressure and the crude was 
subjected to column chromatography using SiO2 (CHCl3/Acetone: 70/30) to give 53 as the white 
product with (0.01 g, 22%).  
1H NMR (400 MHz, CDCl3, 25 °C): δ (ppm) 9.30 (s, 1H), 7.52 (d, 1H), 6.93 (m, 2H), 6.78-6.56 
(12s, 12H), 4.7-4.56 (m, 8H), 4.97-3.97 (m, 16 H), 3.84-3.69 (9s, 27 H), 3.46-3.37 (m, 6 H), 3.25 
(m, 1H). 
13C {1H} NMR (100.6 MHz, CDCl3, 25 °C): δ (ppm) 171.6 (2C), 169.2, 168.8, 150.0, 149.6, 
149.5 (2C), 149.3, 147.9, 147.8, 146.88, 146.8, 146.7 (2C), 146.6, 145.5, 135.7, 134.0, 133.9 
(2C), 133.8, 133.7, 133.1, 132.28, 132.24, 132.1, 131.6, 131.5, 131.0, 130.9, 120.6 (3C), 120.6, 
120.2, 114.21 (2C), 113.9, 113.8, 113.7, 113.6, 113.5, 112.8, 112.5, 107.6, 69.7, 69.4, 68.9, 68.8, 
66.0, 65.9, 65.8, 64.5, 56.3, 56.2, 52.8, 55.7, 55.6, 55.5, 53.6, 52.1, 51.7 (2C), 48.4, 36.4, 36.3, 
36.1 (4C). 
HRMS (ESI): m/z [M+H+]+ calcd. for C71H74N2O20 1274.4834 found 1275.4908 
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Compound 54: Compound 44 (0.13 g, 0.09 
mmol, 1 equiv.) was introduced and then 
dissolved in freshly distilled pyridine (1 
mL). Then compound 52 was added (0.033 
g, 0.09 mmol, 1equiv.). The mixture was 
stirred at -15 °C, then POCl3 (0.010 mL, 0.1 
mmol, 1.2 equiv.) was added drop wisely and the mixture turned red upon addition. The solution 
was stirred for 30 minutes at -15 °C then stirred for 5 hours at room temperature where it turned 
orange. The solution was then poured carefully on a mixture of ice/water/NaHCO3. The obtained 
solution was extracted 5 times with CH2Cl2, then dried over Na2SO4, filtered and the solvent was 
evaporated under reduced pressure. The brownish crude was subjected to column 
chromatography using silica gel (CHCl3/ Acetone: 65:35) the desired product as white powder 
(0.05 g, 30%).  
1H NMR (400 MHz, CDCl3, 25 °C): δ (ppm)  9.07 (s, 1H), 7.44 (m, 1H), 7.04 (m, 1H), 6.84 (m, 
1H), 6.82-6.52 (12s, 12H), 4.69-4.45 (m, 20 H), 4.26-4.15 (m, 18 H), 3.84-3.64 (9s, 27H), 3.46-
3.34 (m, 6H), 3.12 (m, 1H). 
13C {1H} NMR (100.6 MHz, CDCl3, 25 °C): δ (ppm)  171.6 (2C), 170, 169.9, 169.89, 169.8 
(2C), 169.5, 169.3, 169.2, 149.8, 147.9, 147.8, 147.7 (3C), 147.5, 147.44, 147.41, 147.2, 147.0, 
146.6 (2C), 135.6, 134.9, 134.4, 133.9, 133.6, 133.57, 133.5 (2C), 133.4 (3C), 133.1 (2C), 132.3, 
132.2, 121.1, 120.6, 120.4, 120.2, 119.7, 119.4, 118.9, 118.5, 118.0, 116.3, 115.7, 115.4, 1114.0, 
107.6, 69.9,69.21, 68.7, 68.5, 67.9, 67.6, 67.5, 67.4, 67.2, 67.8, 66.0 (2C), 53.6 (2C), 52.1, 52.09, 
52.05 (2C), 52.026 (2C), 51.9, 51.7 (2C), 49.1, 36.2 (3C), 35.9 (3C).  
HRMS (ESI): m/z [M+Na]+ calcd. for C83H86N2NaO32 1645.5061 found 1645.5056. 
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Figure 84: 1H NMR spectrum of compound 54 in CDCl3 in a 400 MHz spectrometer. 
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 Compound 55: Compound 54 (0.03 g, 
0.0184 mmol, 1 equiv.) was dissolved in THF 
(1.18 ml) and then (0.3 M) KOH solution (1.1 
ml, 18 equiv.) was added drop wisely at 0 °C. 
The reaction was stirred for 30 minutes at 
room temperature. The solvent was evaporated under reduced pressure and then the crude was 
dissolved in a minimum amount of water. The obtained aqueous layer was washed twice with 
CH2Cl2. The resulting aqueous layer was acidified at 0°C with concentrated HCl solution. The 
obtained precipitate was collected on a fritted glass and then washed with ether to give compound 
55 (0.02 g, ~74%) as a white compound. The compound showed high sensitivity to light and heat 
and it structure is confirmed by HRMS.  
HRMS (ESI): m/z [M+Na]+ calcd. for C74H68N2NaO32 1519.3652 found 1519.3647. 
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Compound 56: To a solution of 
43 (0.07 g, 0.039 mmol, 1equiv.) 
dissolved in DMF (1.5 ml) was 
added EDCI.HCl (0.01 g, 0.055 
mmol, 1.4 equiv.), HOBt (0.015 
g, 0.11 mmol, 0.28 equiv.) and DIPEA (0.11 mmol, 0.02 ml, 3 equiv.) and stirred for 10 minutes. 
Then Biotin peg 2-amine (0.014 g, 0.039 mmol, 1 equiv.) dissolved in DMF (0.5 ml) was added 
and the mixture is stirred for 16 hours. The reaction mixture was extracted 5 times with CH2Cl2 
and the resulting organic layer was washed 5 times with brine. The solvent was removed under 
reduced pressure and the resulting crude was subjected to column chromatography on silica gel 
(CH2Cl2/MeOH: 95/5). Compound 56 (0.06 g, 71%) was obtained as white solid.   
1H NMR (400 MHz, CDCl3, 25 °C): δ (ppm) 7.3-7.2 (m, 30H), 6.6-6.3 (12s, 12H), 5.8 (bd s, 
1H), 5.3-5 (m, 12 H), 4.5-4.3 (m, 19H), 4.2-3.7 (m, 13 H), 3.47-3.4 (m, 10H), 3.1-3.3 (m, 7H), 
3.01 (m, 1H), 2.9 (m, 1H), 2.8 (m, 1H), 2.6 (m, 1H), 2.1 (m, 2H), 1.6 (m, 4H), 1.44 (m, 2H).  
13C {1H} NMR (100.6 MHz, CDCl3, 25 °C): δ (ppm) 173.2, 171.1, 169.6, 169.7 (5C), 163.4, 
148, 147.6, 147.4 (3C), 147.2 (4C), 147, 146.4, 135.3 (6C), 134.4, 134.1, 133.5, 133.4 (21C), 
133.2 (2C), 133 (2C), 133.7, 132.6, 131.8, 128.6 (30C), 120.8, 120.5, 120.2, 119.7, 119.3, 118.9, 
118.6, 118.2, 117.9, 117.5, 115.5, 114.7, 70.1, 69.9, 69.7 (2C), 69.5, 69, 68.6, 68.4, 67.9, 67.8, 
67.7, 67.4, 67.2 (4C), 66.8 (3C), 667.7 (3C), 66.3, 65.56, 61.5, 60, 55.2, 47.6, 40.3, 39, 35.9 (2C), 
35.7(2C), 35.63 (2C), 30.2, 27.8 (2C), 25.3.  
HRMS (ESI): m/z [M+2Na]2+ calcd. for C120H120Na2N4O29S 1079.3777 found 1079.3772. 
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Compound 57: Compound 56 
(0.06 g, 0.028 mmol, 1 equiv.) 
was dissolved in THF (1.6 ml) 
and then (0.3M) KOH solution 
(1.6 ml, 18 equiv.) was added 
drop wisely at 0 °C. The reaction was stirred for 30 minutes at room temperature. The solvent 
was evaporated under reduced pressure and then the crude was dissolved in a minimum amount 
of water. The obtained aqueous layer was washed twice with CH2Cl2. The resulting aqueous layer 
was acidified at 0 °C with diluted HCl solution. The obtained precipitate was collected on a 
fritted glass and then washed with ether to give compound 57 as a white compound. Optimization 
of purification is necessary to be done. The formation of 57 is confirmed by mass spectrometry 
and the mass found for this derivative is 1572.4942. 
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Figure 85: hyperpolarized 129Xe NMR spectrum of compound 34 recorded at 298 K in C2D2Cl4-d2. 
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Figure 86: Calorimetric titration of compound 48 in H2O/TRIS (20 mM; pH = 7.6). The solution host (c = 0.08 mM) 
was placed into the calorimeter cell (1.4 mL) and 28 successive aliquots (10 L) of Ni2+ solution (c = 1.0 mM) were 
added at 3 min intervals. 
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Figure 87: Hyperpolarized 129-xenon spectra of compound 48 in TRIS buffer (20 mM, pH = 7.5) at 25 °C a) in 
absence of Zn2+ (green spectrum). b) in presence of 1.0 equiv. of Zn2+ (blue spectrum). c) in presence of 5.0 equiv. of 
Zn2+.
Xe@48
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In the introductory chapter of the first part, we presented the main features of cryptophane 
derivatives. Among these features, we are particularly interested in investigating the symmetry 
and the inherent chirality of cryptophanes. Cryptophanes symmetry has an obvious impact on 
their complexation properties. Depending on the adopted configuration, i.e. syn or anti, 
cryptophanes can be chiral or achiral (see chapter I). For example, the syn derivative is achiral 
provided that the two CTB units and the three linkers are identical. Otherwise these syn-
cryptophanes exhibit an inherently chiral structure. On the other hand, the anti-derivatives are 
always chiral regardless the nature of substituents and the linkers. Thus, many different chiral 
cryptophane derivatives can be prepared and each derivative is expected to exhibit characteristic 
chiroptical properties.  
The chiroptical properties of enantiopure cryptophanes can be exploited to study the cryptophane 
itself (determination of the absolute configuration, molecular conformation in solution or in the 
solid state). More importantly, these chiroptical properties can be also used to study their 
interactions with chiral or achiral guests. Nowadays, chemists possess in hands a lot of 
chiroptical techniques to investigate these molecules and their complexes. For instance, the 
determination of the specific optical rotation can be achieved via optical rotation dispersion 
(ORD) or polarimetric measurement. Electronic and vibrational circular dichroism spectroscopies 
(ECD, VCD) are additional tools to characterize these molecules. These two techniques are 
complementary and they possess their own advantages and disadvantages. Recently, Raman 
Optical Activity (ROA) has emerged as another useful technique to gain information about the 
absolute configuration of organic molecules such as cryptophanes and their complexes. X-ray 
crystallography is another tool that can be used to characterize compounds in the solid state 
providing information about the absolute configuration of these molecules. 
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In the following sections, we will provide a brief overview describing different examples of some 
reported chiral cryptophanes. We will mainly discuss the different approaches used to synthesize 
enantiopure cryptophane derivatives. Finally, we will describe the chiroptical properties of these 
cages and their complexes, which have been investigated by the different spectroscopic 
techniques mentioned above.  
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1. Examples on Chiral Cryptophanes 
To start with the chiral cryptophanes, it is worth first to discuss the anti-cryptophane 
derivatives, which are numerous, compared to the chiral syn-cryptophanes. The first reported 
cryptophane cage is the anti-cryptophane-A 58,18 which possesses a D3-symmetry. This particular 
arrangement results from a stereospecific replication of the parental CTB unit symmetry. With 
this example, a clear illustration of the inherent chirality was delivered. Apart from this example, 
other D3-cryptophane derivatives were also described such as anti-cryptophane-E, which 
possesses three propylenedioxy linkers and six methoxy groups. So generally, anti-cryptophane 
derivatives bearing the same CTB substituents and linkers possess a D3-symmetry.  
A decrease of the molecular symmetry from D3 to C3 is obtained when one of the two CTB units 
carry three different substituents. For example, substituting the three methoxy groups of 
cryptophane-A by three hydrogen atoms on one CTB unit results the anti-cryptophane-C, 59.29 
Other C3-symmetrical cages were also recently reported based on the cryptophane-A skeleton, 
like cryptophane-[222] (OCH2CO2H)3 (OH)3.
174 Further decrease in cryptophanes molecular 
symmetry from D3 to C2 is achieved by changing one of the three linkers but keeping the same 
CTB substituents. For example, anti-cryptophanes-[223] 60, [233] 61 or [224] 62 (OMe)6 are all 
chiral with C2-symmetry.
111 The crystal structure of compound PP-60 assures its anti-
configuration, Figure 88. 
 
Figure 88: crystal structure of PP-60. 
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In the first chapter of this manuscript, we also reported a chiral C2-cage with a [223] skeleton 
bearing a central alkenyl moiety on the propylenedioxy arm, compound 26.38 C1-symmetrical 
cryptophanes are also numerous and they are obtained if cryptophanes possess different linkers or 
substituents. Cryptophane-[222] monoacid 63, which is widely used for xenon-based biosensing 
applications has a C1-symmtery is one example, Figure 89.
75 It is noteworthy that all the 
cryptophanes described in the second chapter of the first part possess C1 symmetry except 
compound 26. 
 
 
Figure 89: symmetry of some anti-cryptophane derivatives. 
 
Syn-derivatives are less numerous but they constitute another interesting class of chiral 
cryptophanes. The first described chiral syn-cryptophane is cryptophane-D 64, the diastereomer 
of cryptophane-C, 59 described above. Similar to compound 59, this derivative has a C3-
symmetry. Other cages that bear the same symmetry are the thio-containing cryptophane 65 and 
the nona-methoxy cryptophane-[222], 66 derivatives shown in Figure 90.175,176 
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Figure 90: chiral syn-cryptophane derivatives. 
 
2. Synthesis of Enantiopure Cryptophane Derivatives 
Chiral cryptophane derivatives are usually obtained as a racemic mixture. Therefore, the 
study of their chiral properties requires the separation of the two enantiomers. Several approaches 
can be tested to separate these enantiomers. For instance, asymmetric synthesis of these 
derivatives starting from enantiopure starting materials is one of the readily used approaches. The 
separation of the two enantiomers via the formation of a diastereomeric mixture can also be 
employed. Then, the diastereomers can be separated by different techniques such as column 
chromatography or crystallization. Finally, HPLC using a chiral stationary phase can be used to 
obtain these enantiopure molecules. All these techniques possess their own advantages and 
drawbacks as will be discussed in the following sections.  
2.1. Enantiomerically Enriched Cryptophanes by Asymmetric Synthesis: 
Enantiopure CTB units have been prepared to synthesize enantiomerically enriched 
cryptophanes with high ee. Collet and co-workers have used extensively this approach to prepare 
enantiopure cryptophane derivatives with D3 or C3-symmetry.  This approach appears as an easy 
way to access these enantiopure molecules. Unfortunately, great care in the choice of the 
experimental conditions has to be considered since the CTB unit tends to easily racemize above 
C3
64
C3
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room temperature. Thus, under the experimental conditions required to perform the second ring 
closing reaction, a partial racemization is inevitable. Consequently, this approach only allows 
getting enantiomerically enriched cryptophane derivatives with a moderate to high ee (65 – 95%). 
Enantiopure CTB units, themselves can be synthesized from the trimerization of the properly 
functionalized enantiopure starting materials bearing a chiral auxiliary. This trimerization step 
results in the formation of two diastereomeric CTB units, which can be readily separated on silica 
gel. Recovery of the desired enantiopure CTB is then achieved by applying multistep reactions. 
For example, Collet and co-workers reported the synthesis of the two enantiopure 
cyclotriguaïcylene (CTG) (M and P), 72 units using α-bromo-propanoic acid as the chiral 
auxiliary.177 The first step involved the cyclization of the optically pure vanillic alcohol 
derivative 67, in HClO4 (65%). This step afforded a diastereomeric mixture of the two CTB units, 
compounds 68. An additional esterification step using diazomethane allowed the access of the 
two separated diastereomers, 69. These two diastereomers were subjected to subsequent reactions 
to give the desired enantiopure CTG, 72, Figure 91.  
 
 
Figure 91: synthesis of enantiopure 72 from optically pure vanillic alcohol derivative 67. 
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The second strategy overlies on reacting a readily trimerized CTB with a chiral auxiliary to form 
two diastereomers, which are separated by chromatography. For example, chiral auxiliaries like 
Ѡ-camphanic acid or R-(+)-2-phenoxypropanoic acids were employed and they were mildly 
removed after the separation.178,154   
Exploiting the resolved CTB units, enantiomerically enriched cryptophanes were synthesized, 
like the cryptophane-A, 58. The synthesis of PP-58 starts with the preparation of the M-CTG, 72 
followed by a substitution reaction to give the P-CTB template. Unlike the parental CTG units, 
cryptophanes are resistant to racemization at high temperature. Other enantiomerically enriched 
cryptophane derivatives with D3-symmetry were also reported, like cryptophane-E or 
cryptophane derivatives bearing unsaturated linkers like compounds 73, 74 and 75 shown in 
Figure 92.18, 33, 34  
 
Figure 92: structure of enantiomerically enriched MM-anti-cryptophane derivatives having D3-symmetry.  
 
Enantiopure cryptophane-C, 59 was specifically synthesized to encapsulate enantiomerically 
enriched chlorofluorobromomethane, one of the simplest chiral compounds. Collet and co-
workers reported the synthesis of this enantiopure cage by using a strategy similar to that reported 
for cryptophane-A. Thus, the enantiopure M-(+)-CTB (OH)3, compound 76 was alkylated with 
substituted vanillic alcohol derivative 77 to give the desired M-template 78. Cyclisation at 95 °C 
offered both the syn-MP-64, and anti-MM-59 in 5% and 20%, respectively. These two 
diastereomers were easily separated by column chromatography, Figure 93. 
73 74 75
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Figure 93: synthesis of enantioenriched 59 and 64.  
 
Recently, Crassous and co-workers have used this strategy to synthesize enantiomerically 
enriched thio-substituted cryptophanes 79, Figure 94. These compounds have been obtained from 
the corresponding functionalized enantiopure CTB units. It is noteworthy that in this case, the 
second ring closing reaction gives rise to a significant racemization since the two MM and PP 
cryptophane enantiomers were obtained in an ee 81.6 and 65.6 %, respectively. This cryptophane 
was later used to determine the ee of enantioenriched chlorofluoroiodomethane derivative. The 
recognition process was studied by 19F and 1H NMR spectroscopy.179,180  
 
Figure 94: structure of the enantioenriched compound 79. 
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It is worth to mention that the resolved cryptophanes obtained by enantioenriched CTB units 
have an ee between 65 and 99%. It is important to be aware for the unavoidable racemization of 
the enantiopure CTB units, which constitutes the main disadvantage of this method.  
Unlike the CTB units, tribenzotriquinacenes or the so-called TBTQ possess a more rigid skeleton. 
Although structurally similar, TBTQ are resistant to temperature-induced racemization practiced 
by the CTB units. This difference is due to the additional methyl bridge fusing the three 
methylene bridges together. Resolving the two enantiomers of TBTQ derivatives can be achieved 
by several strategies. One strategy reported is based on breaking their C3v-symmetry by mono-
functionalizing one or the three arene rings leading to either a C1 or C3 symmetrical molecule, 
respectively. These inherently chiral molecules can eventually be used to build chiral self-
assemblies. For example, the TBTQ derivative 80 bearing one functionalized aromatic ring was 
optically resolved using (R)-BINOL. The two obtained diastereomers (81 is one of them) were 
separated by column chromatography in 34% and 33% yields. The saponification of these esters 
allows the recovery of the enantiopure TBTQ, 80 with 97% and 95%, Figure 95. The chiroptical 
properties of these two derivatives were studied by polarimetry and ECD spectroscopy.45 
 
 
Figure 95: diastereoselective optical resolution of TBTQ derivative using R-BINOL.  
 
Stereoselective and enantioselective synthesis of TBTQ was also achieved by employing bio-
catalysis. Starting from four isomers of alcohol functionalized TBTQ 82, one pair of 
80 81 80
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diastereomers (M,R) and (P,R) was selectively acylated using commercially available Candida 
Antarctica lipase to give two diastereomeric ester derivatives 83. These compounds were then 
easily separated by column chromatography with a total yield of 48%. Enantioselective 
hydrolysis of the esters using lipase PS afforded the P-TBTQ derivative whereas using Candida 
Antarctica lipase the M-derivative was selectively hydrolyzed, Figure 96.181 
 
 
Figure 96: bio-catalyzed stereoselective optical resolution of TBTQ. 
 
In the first chapter, we have also described another method to obtain these compounds in their 
enantiopure form. Based on a previous work reported by Warmuth and co-workers, Kuck and co-
workers synthesized a TBTQ based cryptophane by thermodynamic dynamic resolution approach. 
Thus, reacting racemic TBTQ trialdehydes with (S,S)-diaminocyclohexane  offered three couples 
of cryptophane diastereomers (P,P,S,S,S) (M,M,S,S,S) (P,M,S,S,S) in 29%, 40% and 25% yields, 
respectively. These diastereomers were separated by chromatography and then hydrolyzed to 
give enantiopure TBTQ building blocks. Some derivatives of these molecules were used to build 
enantiomerically self-sorted nanotubes indicating their versatility to construct highly organized 
systems.46 Therefore, these compounds offer many interesting possibilities to design enantiopure 
cages. However, their synthesis and functionalization are tedious; hence these compounds cannot 
be easily used in their enantiopure form to design MRI tracers for 129Xe NMR applications.  
 
82 83
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2.2.  Synthesis of Cryptophanes by Dynamic Resolution: 
Using a thermodynamic dynamic resolution approach, Warmuth and co-workers have 
reported the resolution of CTB derivative 84 with high ee. The imination of a racemic mixture of 
CTB derivative functionalized by three aldehydes with two equivalents of (R,R)-
diaminocyclohexane, 85 offered a unique (P,P,R,R,R)-cryptophane enantiomer 86 in an excellent 
92% yield. In fact, the high reaction temperature and thermodynamic sink of the obtained 
cryptophane enantiomer were the main reasons behind this complete inversion. The hydrolysis of 
compound 86 in a mixture of trifluoroactetic acid and water gave the enantiopure (P)-84 in 92% 
with a high ee (99%), Figure 97.182 
 
Figure 97: synthesis of (P,P,R,R,R)-cryptophane. 
 
2.3.  Enantiopure Cryptophanes by Separation of Diastereomers: 
Synthesis of enantiopure cryptophane derivatives can also be achieved by reacting a 
cryptophane in its racemic form with a chiral auxiliary. This in turn leads to the formation of a 
diastereomeric mixture that can be separated by different techniques. Brotin and co-workers 
reported this approach in 2003, where they successfully obtained the two enantiomers of 
cryptophanol-A, 87. In this synthesis, the only available hydroxyl group on the cryptophane-
[222] skeleton was allowed to react with (1S)-(-)-camphanic acid chloride 88 leading to two 
84
85
86
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diastereomeric compound 89. Thanks to the large difference in solubility between these two 
compounds, the separation of these diastereomers was made possible by crystallization from hot 
toluene. This allowed to collect the first diastereomer in approximatively 15% yield (ee=98-
100%). The second enantiomerically enriched diastereomer was collected and then hydrolyzed 
under basic conditions. Reacting this compound with (1R)-camphanic acid chloride and applying 
the same procedure allowed to get the second diastereomer in 10% yield and ee = 98%-100%. 
Cleavage of the chiral auxiliary offered enantiopure cryptophanol-A, 87, Figure 98.183,78  
 
 
Figure 98: resolving cryptophanol-A by forming diastereomers with camphanic acyl chloride. 
 
The enantiopure compound 87 was subjected to various chemical transformations to give new 
enantiopure cryptophanes. The interest of this approach lies on the fact that no racemization takes 
place compared to the CTB based method. Thus, new enantiopure cryptophanes with different 
symmetry can be easily obtained by this way, whatever the experimental conditions (high 
temperature, solvents…). As an example, we can report the synthesis of some other enantiopure 
cages starting from PP and MM-cryptophanol-A. For example, enantiopure cryptophane-A was 
prepared from enantiopure cryptophanol-A. The latter was then demethylated with excess of 
LiPPh2 to give the enantiopure hexa-hydroxyl cryptophane, 90, with an excellent yield. 
87 89
88
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Subsequent alkylation and hydrolysis allowed the formation of an enantiopure cryptophane with 
six carboxylic acid functions.184,185 
Following the same approach, Dmochowski and co-workers synthesized enantiopure 
trisubstituted cryptophane-A derivatives. Racemic mixture of tri-hydroxyl cryptophane-A, 91 was 
resolved by esterification with (S)-Mosher’s acid, 92 to give two diastereomeric compounds 93, 
which were separated by column chromatography. The overall yield was 70% with 35% yield per 
each compound, Figure 99. The enantiomeric purity w 
as assessed by ECD. The chiral auxiliary was then removed by hydrolysis under basic conditions 
without any loss of optical activity. Further functionalization of the two isomers resulted new 
cryptophanes of various applications.186 
 
 
Figure 99: resolving tri-hydroxy cryptophane-[222] by Mosher’s acyl chloride. 
 
Although this strategy offers the cryptophane derivatives in excellent enantiomeric excess 
compared to the CTB-based method, this approach requires more synthetic steps and 
optimization of the separation step for each diastereomer. 
2.4.  Resolving Cryptophanes by HPLC: 
Resolving cryptophanes by HPLC has gained a great attention in the last few years since this 
approach does not necessarily require chemical transformations. The method solely lies on using 
91
92
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a suitable chiral stationary phase to separate the two enantiomers. The main inconvenience of this 
technique is its limitation to small-scale separation due to the high cost of semi-preparative 
columns, sensitivity and large volumes of mobile phase. This method also requires optimization 
of the separation conditions that can be difficult in some cases. Solubility issues of the racemic 
material have also to be taken into consideration.  
Collet and co-workers in 1989 reported the first use of HPLC on chiral stationary phase to 
separate various CTB and cryptophane derivatives.187  At that time, the increased applications of 
cryptophanes as chiral hosts rendered it important to develop a new analytical tool for their 
optical resolution. Chiralpak OT-(+) was used as the stationary phase to separate these 
compounds but this stationary phase suffers from low stability over time. Nevertheless, several 
CTB and cryptophanes were efficiently resolved as pointed previously. Table 4 summarizes the 
results obtained for few cryptophane derivatives. For instance, cryptophane-A, 58 was efficiently 
resolved into its enantiomers M-(+) and P-(-) using methanol as an eluent. The two enantiomers 
of cryptophane-A, PP-cryptophane-A and MM-cryptophane-A appear at 22.1 and 30.0 min, 
respectively.  
Symmetry R Bridges  Retention time (min) 
D3 OMe O(CH2)2O 22.1(+) 30.0(-) 
D3 OMe O(CH2)3O 27.4(+) 37.6(-) 
D3 OMe O(CH2)4O 30.3(+) 75.3(-) 
D3 OMe O(CH2)6O 38.9(+) 54.9(-) 
 
Table 4: analysis of D3-cryptophanes by chiral pack-OT (+), the (+) and (-) signs correspond to the SOR sign 
recorded at 589 nm. 
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Chiralpak OT-(+) was also employed to separate enantiopure cryptophane bearing aromatic 
bridged linkers. Thus, anti-cryptophane 94 bearing three ortho-substituted aromatic linkers was 
resolved using the latter chiral column. The two enantiomers appeared at 23.7 and 39.4 minutes, 
respectively. Same conditions were used to get cryptophane 95 with retention times 36.5 and 73.0 
minutes, Figure 100. These molecules were used to encapsulate various ammonium salts.35,188 
 
Figure 100: optically resolved cryptophane bearing benzyl substituted linkers. 
 
More recenly, enantiopure nona, 66 and dodecamethoxy 96 cryptophanes were resolved using 
new chiral HPLC columns. The anti and syn-isomers of cryptophane 66 show an inherently chiral 
structure (C3-symmetry). For anti-66-cryptophane, an efficient separation was obtained using 
Chiralpak IB with ee ≥ 99.5% for both enantiomers. On the other hand, the two enantiomers of 
the the syn-diastereomer have been separated by using a Chiralpak IA column chromatography 
(ee ≥ 98.5%). In the case of cryptophane 96, only the anti-diastereomer is chiral and has a D3 
symmetry. The two enantiomers of this derivative were separated by using Chiralpak ID column 
chromatography. Typically, a separation performed on a semi-preparative column allows to 
isolate few hundreds of mg of enantiopure compounds, which are sufficient to achieve a 
thourough study of chiroptical properties.176 
Cryptophane with C2-symmetry have also been separated by chiral column chromatography. For 
instance, compounds 60 and 61 bearing one and two propylenedioxy linkers have been separated 
94 95
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with chiralpak IA column. A detailed study of chiroptical properties has been reported by 
polarimetry, ECD, VCD and ROA and it  will be discussed later.189 
Interestingly, using a Chiralpak ID column, cryptophane derivatives with no substituents have 
been successfully separated. Thus, several hundreds of mg of the two enantiomers of 
cryptophane-[111] 97 and cryptophane-[222] 98 have been obtained. This allowed a detailed 
description of the chiroptical properties of these two derivatives, Figure 101.190, 191 
 
Figure 101: structure of cryptophane-[111] 97 and the corresponding retention time of each enantiomer. On the right 
shown the structure of cryptophane-[222] 98. 
 
Optical resolution of dually functionalized cryptophane 12 bearing a unique secondary alcohol on 
its propylenedioxy linker was also reported using chiral HPLC with high ee ≥ 99.5%. This cage 
showed a high affinity towards Cs+ and Tl+ cations, Figure 41.64 
Cryptophane-[222] (OH)5, 99 is an interesting molecular host capable of binding a large range of  
guest molecules. For this purpose, the two enantiomers of this molecule were separated in order 
to investigate how the presence of a guest molecule affects its chiroptical properties. Two 
different approaches have been used to get the two enantiomers of compound 99. The first 
approach lies on the separation of two diastereomeric compounds as described previously in the 
above section. This method is time consuming but it allows us to obtain these compounds with 
high ee and in fair quantities to perform the chiroptical studies. More recently, a simplified time 
saving approach was used instead, based on chiral HPLC separation of the penta-acetate 
97 98
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derivative 100. This derivative, which is the protected version of compound 99, was chosen due 
to its enhanced solubility. Thus, a Whelk-O1 column was used as the stationary chiral phase to 
offer the two enantiomers of the compound 100 with excellent ee ≥ 99%. The latter was then 
subjected to an alkaline hydrolysis to give the targeted enantiopure cryptophane derivative.61, 60 It 
is noteworthy that in this example the descriptors of compound 99 and 100 are inverted. Thus 
PP-100 gives rise to the MM-99, Figure 102. 
 
 
Figure 102: synthesis of enantiopure hepta-hydroxyl cryptophane-[222].  
 
2.5.  Synthesis of Chiral Metallo-Cryptophanes: 
The synthesis of multi-dimensional supramolecular structures can be achieved by different 
methods and coordination driven self-assembly is one of them. A particular interest is given to 
metallo-cages, which are made up of multi-dentate ligands and metal cations due to their 
potential applications in catalysis, separation, molecular recognition, and nanoscale vessels.192,193 
The first described self-assembled coordination driven cryptophane cage was reported in 2001 by 
Zhong and co-workers. In this paper, racemic pyridyl CTB derivative, 101 was self-assembled 
into [Pd31012]
6+ as the meso-syn cryptophane, 103 and chiral anti-cryptophanes 104 by the 
coordination with cis-protected palladium salts, 102. Inter conversion between these two syn and 
99
100 99
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anti-structures was observed and fastened by increasing the molar ratio of the 101 with respect to 
the metal source Figure 103. The tunable character of these cages is advantageous as they would 
change their properties in response to the guest molecule.194 
 
Figure 103: synthesis of Pd-based metallo cryptophanes. 
 
In another example Hardie and co-workers reported the synthesis of emissive Ir3+ metallo-
cryptophanes starting from CTB derived ligands 105 shown in Figure 104 and (L,D)-[Ir-
(ppy)2(MeCN)2]·X (X=PF6, BF4), 106 as the metal source. These molecules undergo homochiral 
self-sorting of the ligands in solution and in the solid state leading to chiral anti-cryptophanes 107, 
Figure 104. This process is enhanced in the presence of enantiopure chiral guest like R-
camphor.195 
101
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Figure 104: synthesis and crystal structure of emissive anti-cryptophane. 
 
Finally, Chambron and co-workers reported the synthesis of chiral trans-metallo-cages resulting 
from the reaction of nitrile-functionalized CTB, 108, with [Pd(dppp)][OTf]2. The reaction was 
completely stereoselective favoring the anti-[Pd3(dppp)3(108)2][OTf]6 as proved by proton and 
carbon NMR and crystal structure. The homochirality of these cages is due to the satisfaction of 
the square planar geometry of the palladium and the platinum centers by the coordination with 
the triply coordinated 108 derivatives, Figure 105.196 
 
Figure 105: nitrile-functionalized CTB unit and the synthesis of metallo anti-cryptophane derivative. 
 
105
106
107
108
[Pd3(dppp)3(108)2][OTf]6
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3. Chiroptical Properties of Cryptophane Derivatives and Their 
Complexes 
The access of enantiomerically pure cryptophanes allows us to investigate their chiroptical 
properties. These properties have been heavily exploited to assign the absolute configuration of 
cryptophanes and to gain insights about the conformation of these molecules in solution. Finally, 
the presence of a guest inside the cavity of the host might also modify the overall chiroptical 
properties of the host molecule. Interestingly, a large range of techniques such as ECD, VCD, 
ROA and ORD and X-ray crystallography can be used to study the chiroptical properties of these 
molecules. We will describe in the appendix section briefly the principle of these spectroscopic 
techniques. Through selected examples, which have been reported in the literature, we would like 
to show how these chiroptical techniques serve to characterize cryptophanes and their complexes. 
ECD spectroscopy is one of the earliest chiroptical methods used to study enantiopure 
cryptophane derivatives. Collet, Gotarelli and co-workers pioneered this work by studying 
enantiomerically enriched cryptophanes with D3 and C3-symmetry. Based on the Kuhn-
Kirkwood-coupled oscillator model, these authors were able to predict the shape of the ECD 
spectra of cryptophane-A and its congeners. For instance, in the case of the cryptophane-A 
derivative with D3-symmetry, this model predicts that each transitions 
1Lb, 
1La and 
1Bb (Platt’s 
notation) visible on the UV-visible spectrum (210-310 nm) can be decomposed into three excited 
states due to the resulting excitonic coupling. Each of these excited states possesses its own 
rotational strength that determines the intensity and the sign of the ECD bands. The obtained 
ECD spectrum is the result of the contribution of all these excited states. The ECD spectrum of 
PP-cryptophane-A has been reported in Figure 106. This ECD spectrum shows several Cotton 
bands with positive or negative signs. The two first bands observed between 260 and 310 nm can 
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be assigned to the Cotton bands of the 1Lb transition. Then, the negative-positive bisignate (230-
260 nm) corresponds to the ECD bands of 1La transition. It has been observed, by analogy, with 
other cryptophane-A congeners that this bisignate can be extremely useful to assign the absolute 
configuration of cryptophane derivative in organic solvents. Indeed, in contrast to the ECD bands 
of the 1Lb transitions, which are very sensitive to structural modifications and other external 
factors, the sign of this bisignate is robust and characteristic of the absolute configuration of the 
molecule. The negative-positive bisignate observed in Figure 106 allows us to assign the PP 
absolute configuration to the (+)-cryptophane-A derivative. Finally, the strong ECD band 
observed in the region of 220 nm corresponds to the 1Bb transition. 
 
 
Figure 106: ECD of (+)-cryptophane-A spectrum of 1,4-dioxane.  
 
Since the work of Collet and co-workers, numerous enantiopure cryptophane derivatives have 
been studied by ECD spectroscopy both in organic solvents and in aqueous solutions. Thus, 
numerous cryptophane derivatives having different symmetry have been investigated and in some 
(+)-Cryptophane-A
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cases their ECD spectra have been predicted thanks to the use of TD-DFT calculations.71 From a 
general point of view, it has been observed that ECD spectra recorded in organic solvents are not 
very sensitive to a change of the nature of the solvent.183 Spectral ECD modifications take place 
mainly in the 1Lb and 
1Bb regions of the ECD spectrum and a change in the nature of the organic 
solvent slightly affects the ECD spectra. Moreover, more pronounced changes are sometimes 
observed with the SOR values in terms of sign and magnitude. At first sight, this may appear 
surprising since the ECD and SOR values are strongly related. An interesting example is 
observed with cryptophane-[222], 98 devoid of any substituents whose ECD spectra recorded in 
several organic solvents are almost identical in shape and intensities. In contrast, the SOR values 
recorded in the same solvents show large variation in intensities. In addition, the sign of these 
SOR values can be different depending on the solvent and wavelength.191 This behavior has been 
attributed to tiny conformational changes that the molecule can adopt in solution. Interestingly, 
this unusual example reveals that in the case of cryptophane derivatives, polarimetry or ORD 
spectroscopy is much more sensitive to reveal small conformational changes in organic solvent. 
Another interesting example will be discussed in the next chapter that describes the unusual 
behavior of cryptophane derivatives subjected to self-encapsulation. 
It is noteworthy that this situation can be different in aqueous solution. For instance, it has been 
observed that the ECD spectra of enantiopure cryptophanes 90 bearing six phenol groups can be 
extremely sensitive to the nature of guest molecule and the nature of the aqueous solution.  An 
example is reported in Figure 107 that shows ECD modifications upon complexation in LiOH 
solution. In Figure 107, it can be noticed that large spectral modifications occur in 1Lb and the 
1Bb 
regions of the spectrum depending on the nature of the guest. For instance, in presence of CHCl3, 
the ECD spectrum shows between 270 and 330 nm a broad negative ECD band whereas several 
positive and negative Cotton bands are observed in absence of a solvent molecule or in presence 
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of CH2Cl2. Large spectroscopic changes are also observed in the 
1Bb region of the spectrum. 
These spectral changes are the consequences of conformational changes induced by the nature of 
the encapsulated guest. Indeed, the nature of the guest and in particular its molecular volume 
imposes the host molecule to change its molecular conformation to maximize interactions. 
Additional hydrophobic effect may contribute to these changes.184 
 
Figure 107: ECD spectra of empty free MM-90 and in the presence of CH2Cl2 and CHCl3 in LiOH (0.1 M) shown on 
the left. On right is shown the ECD spectra of MM-90 in solutions of LiOH, NaOH, KOH, and CsOH in H2O (0.1m). 
 
It has also been observed that a change of the nature of the solvent had a tremendous effect on the 
shape of these ECD spectra. Replacing, LiOH by CsOH solution resulted in important spectral 
changes. For instance, we observed a slight bathochromic shift of the whole ECD spectrum but 
we also noticed that this ECD spectrum remains unchanged upon addition of CH2Cl2 or CHCl3. 
Subsequent investigations have revealed that cationic species such as rubidium, cesium and even 
thallium are strongly encapsulated. For instance, ITC experiments allow us to measure very high 
binding constants K = 3.80 × 108 M-1 and K = 2.39 × 109 M-1 in LiOH (0.1 M) for cesium and 
thallium cations, respectively. 
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The strong affinity of host 99 bearing five hydroxyl groups for cesium and thallium cations can 
be assessed by ECD spectroscopy. Indeed, upon addition of these cationic species a strong 
change of the whole spectrum takes place. These spectral changes are strongly dependent on the 
experimental conditions. Figure 108 shows the differences observed when the initial cage is 
empty or when it contains a chloroform molecule inside the cavity. Particularly, upon addition of 
cesium cations to a free cryptophane cage, a bathochromic shift was observed along with an 
increase of the ECD component located at 315 nm and a decrease of the component located at 
300 nm in the 1Lb region is observed. A change in the 
1Bb transition is also detected. The obtained 
isobestic points indicate the formation of the cesium complexes. Addition of cesium to a 
chloroform saturated cage induces huge spectral changes especially in the 1Bb region, where the 
latter significantly decreased upon cesium complexation. This spectral region allows us to extract 
information about the conformational changes taking place upon the replacement of chloroform 
by the smaller cesium cation. Since then, this work has been extended to study the complexation 
of cationic species by other cryptophane derivatives.197,64,52 
 
 
Figure 108: ECD spectra recorded at 293 K of PP-99  (from 6.5 to 8.5 × 10−5 M): (a) in LiOH/H2O solution (0.1 M) 
in the presence of different amounts of a CsOH/H2O solution; (b) in a saturated solution of CHCl3 in LiOH/H2O in 
presence of different amounts of a CsOH/H2O solution. 197 
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Besides these studies involving cationic species, water-soluble enantiopure cryptophanes have 
been used to study the encapsulation of small chiral molecules. Due to their small molecular 
volume, small oxirane derivatives are well adapted to perform these studies. For instance, it has 
been shown that methyl oxirane and its congeners fit well the cavity of the penta-hydroxy 
derivative 99. Interestingly, it has been demonstrated that this cryptophane was able to achieve in 
basic aqueous solution enantioselective encapsulation. This enantioselective complexation can be 
easily detected by 1H NMR spectroscopy thanks to the high-shielding effect induced by the six 
aromatic rings surrounding the guest molecule. In addition, it has been observed that the different 
diastereomeric complexes give rise to different ECD spectra. Even though these differences are 
small they cannot be the consequence of artifact, Figure 109. 
 
 
Figure 109: structure of (S)-methyl oxirane@MM-cryptophane 99, and the corresponding ECD spectra of MM- 99 
and PP-99 in the presence of rac-oxirane, (S)-oxirane, and (R)-oxirane in NaOH/H2O solution (0.1 M) at 293 K. The 
concentration of MM-99 and PP-99 was taken in the range 5×10-5 and 5×10-4 M. 
 
Another example has been reported with cryptophane 99 and bioxirane. Bioxirane is an 
interesting example since this compound possesses two stereogenic centers; hence there exist 
three isomers, the RR, SS and meso-bioxirane. Thus, in presence of enantiopure compound 99, 
three different diastereomeric complexes can be formed in solution. As for the methyl oxirane 
99
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complexes, 1H NMR and ECD spectroscopies allows us to distinguish the three diastreomers 
formed in solution, Figure 110.61, 60 
 
 
Figure 110: structure of (S,S)@MM-99 complex, ECD spectra of (R,R)-bioxirane@PP-99 (red), (S,S)-
bioxirane@PP-99 (blue), meso-bioxirane@PP-99 (green), and guest-free PP-99 (black spectrum). ECD spectra of 
(S,S)- bioxirane@MM-99 (red dashes), (R, R)-bioxirane@MM-99 (blue dashes), meso-bioxirane@MM-99 (green 
dashes), and guest-free MM-99 (black dashes). The spectra were recorded at 278 K in NaOH/H2O (0.08 M) solution. 
[Host] = (6.2–8.8) × 10–5 M, [guest] = 0.06 M. 
 
Vibrational Circular Dichroism is another powerful technique that has raised considerable interest 
over the two last decades.198 This technique has been largely used to characterize enantiopure 
cryptophane derivatives. For instance, Brotin and co-workers reported in 2006 the first VCD 
spectra of the two enantiomers of cryptophane-A derivative, Figure 111. This study represented 
the first direct determination of the absolute configuration of this derivative thanks to the use of 
DFT calculations aimed at reproducing the experimental spectrum. Thus, from these experiments 
the MM absolute configuration could be attributed to the (-)589-cryptophane-A derivative. In turn, 
the PP absolute configuration could be attributed to the (+)589-cryptophane-A.
199 It is noteworthy 
that the absolute configuration of this derivative was previously determined indirectly from the 
knowledge of the absolute configuration of the corresponding CTB unit.34 Besides, this study 
allowed us to gain information about the conformation of the linkers in solution. This study was 
somehow complicated and time demanding considering all the possible conformations that the 
99
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three linkers can adopt in solution. In this example, our results reveal that the linkers of the 
CHCl3@cryptophane-A complex adopt mainly an all trans conformation. This conclusion is 
reasonable considering the large molecular volume of the guest (Vvdw = 72 Å
3). Cryptophane-
[111], 97 bearing three methylenedioxy bridges constitutes the simplest case and a model 
molecule to be studied by VCD spectroscopy. Indeed, this molecule offered many advantages 
because no solvent molecule can enter its cavity and this compound has limited number of 
conformations that simplifies the DFT analysis. Thus, this compound was very easy to analyze 
and the DFT calculation reproduces very well the experimental VCD spectrum.190       
 
Figure 111: VCD spectrum of cryptophane-A in CDCl3. 
 
Since then many other cryptophane derivatives have been studied by VCD spectroscopy. From a 
general point of view, the VCD spectra are not very sensitive to a structural change of the 
cryptophane skeleton. For instance, a series of cryptophane-A congener with C1-symmetry results 
in a very similar VCD spectra.200 The same trend was also observed with cryptophane derivatives 
with C2-symmetry such as cryptophane-[223] 60 and cryptophane-[233] 61 bearing different 
linkers. 189 Highly substituted cryptophane also resulted in a very similar spectra.71 To date, the 
only cryptophane derivative leading to pronounced VCD changes was the cryptophane-[222] 98 
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devoid of methoxy substituents. In this case, the authors have noticed large differences between 
the VCD spectrum of cryptophane-A and that of cryptophane-[222]. It is noteworthy that this 
cryptophane shows a very flexible skeleton that complicates the prediction of its conformation in 
solution by DFT calculation.191  
In aqueous solution the recording of VCD spectra is more complicated due to the strong 
absorption of infra-red radiation by water molecules. Nevertheless, good quality VCD spectra in 
aqueous solution can be recorded by reducing significantly the path-length of the cell. In the case 
of water-soluble cryptophane derivatives, VCD spectra have been recorded to study the 
encapsulation of solvent molecules, xenon or cationic species.  For instance, it has been shown in 
the case of cryptophane 90 that the encapsulation of guest molecules with different size resulted 
in large spectroscopic changes, Figure 112. These spectral modifications are characteristic of the 
conformational changes of the host molecule upon binding.184 
 
Figure 112: comparison of the VCD spectra of PP-compound 90 dissolved in D2O in the presence and the absence of 
a guest molecule. 
 
Raman Optical Activity (ROA) is another technique, which has been used extensively to 
characterize cryptophane derivatives. Readers interested in this chiroptical technique can refer to 
Chapter 1: Bibliography 
Page | 188  
 
some selected references.201, 202 ROA spectroscopy allows us to investigate the near infra-red 
region and typically ROA spectra can be recorded up to 100 cm-1. This represents an undeniable 
advantage compared to VCD spectroscopy. In the case of cryptophane derivative, ROA 
spectroscopy has been used as a complementary technique to determine the absolute 
configuration of cryptophane derivatives even though DFT calculations are more complicated to 
perform.  
An interesting example has recently been reported with cryptophane-[111], 97. In this example, 
Buffeteau and co-workers showed that ROA spectroscopy could be used to characterize the 
xenon@97 complex. Figure 113 shows the ROA spectra of cryptophane-[111] recorded in the 
absence and in the presence of xenon. It can be noted that these two spectra are superimposable 
over a very large spectral range except a 190 cm-1, where a clear difference can be observed. DFT 
calculations reveal that this vibration mode can be interpreted as the breathing mode of the host 
molecule. Upon the presence of xenon inside the cavity this mode is altered. This example clearly 
shows that ROA can be a useful complementary tool to characterize cryptophane molecules and 
their complexes.190  
 
Figure 113: comparison of experimental ROA spectra of [CD(+)254]-97 in CD2Cl2 solution in presence (red 
spectrum) or not (black spectrum) of xenon. 
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4. Objectives 
Cryptophanes chiroptical properties have enormously served to determine their absolute 
configuration, and study their different conformations. In particular, a better vision of 
cryptophanes conformations facilitates the understanding of their complexation properties. For 
example depending on the guests’ size and shape cryptophanes’ arms can adopt different 
conformations to maximize host-guest interactions.  
During our journey in the development of new cryptophane-[223] type derivatives bearing a 
functionalized propylenedioxy linker, we have evidenced a new conformation adopted by these 
cryptophanes. This phenomenon is referred to as “self-encapsulation”, in which the molecule 
tends to fill its cavity by its own functionalized propylenedioxy arm in the absence of a potential 
guest. This phenomenon is solvent dependent and takes place at room temperature, Figure 114. 
An in-depth investigation of the effect of this phenomenon on the cryptophanes chiroptical 
properties will be delivered using different chiroptical techniques. This will allow evaluating the 
robustness of these chiroptical techniques in response to this particular conformational change. 
 
Figure 114: solvent dependent self-encapsulation phenomenon of cryptophane-[223] derivatives.  
 
C2D2Cl4 , DMSO-d6
CDCl3 , CD2Cl2
S: CHCl3, CH2Cl2
R1: OMe, OAc
R: Acetate, Thio-Acetate
R1: OMe, OAc
R: Acetate, Thio-Acetate
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1. Evidencing a New Conformation of Cryptophanes 
Cryptophanes are flexible molecular cages that adopt different conformations depending on 
their structures and experimental conditions applied. In the introductory chapter of the first part, 
we have presented the several conformations that cryptophanes’ CTB units can take in solution or 
in the solid state. Most of these conformations form when the molecule is stored for a long time 
in the solid state or when heated at elevated temperature. These conformations are also easily 
obtained if the cage has sufficiently long linkers, which imposes higher flexibility. Surprisingly, 
we have also observed that the presence of bulky substituents (benzyl esters for instance) on the 
CTB units facilitates the formation of the imploded form known as crown-saddle. Most of 
cryptophanes conformations are heavily described by means of 1H NMR and X-ray 
crystallography, where a clear understanding of this arrangement is delivered, however, none of 
these studies investigated the impact of these conformational changes on their chiroptical 
properties.47,49   
Recently, our group reported the synthesis of a cryptophane-[223] derivatives with functionalized 
propylenedioxy arm for xenon biosensing applications.41 Particularly, a cryptophane-[223] 
platform bearing seven acetate groups, compound 109, showed an unusual behavior upon xenon 
complexation. Compared to its structural congener 13, compound 109 showed a broadened 129Xe 
NMR signal in 1,1,2,2-tetrachloroethane-d2. This strange behavior is characteristic of a fast in-out 
exchange kinetics of xenon and can be rationalized by the fact that cryptophane’s cavity is less 
accessible to xenon. This result seems to indicate that the cage is adopting a conformation that 
makes its cavity less accessible to xenon, Figure 115. 
 
Chapter 2: Self-Encapsulation: Chiroptical Aspects  
Page | 192  
 
 
Figure 115: one-scan 129Xe NMR spectra recorded at 298 K on solutions in C2D2Cl4 of cryptophane 13 (a) and 
cryptophane 109 (b). 
 
Particularly, compound 109 is vulnerable to undergo a self-encapsulation phenomenon, in which 
its central acetate group enters the cavity in the absence of a potential guest. This self-
encapsulation behavior have been previously described for other molecular hosts like 
cyclodextrins and pillar[5]arene, however it is the first time, we observe this phenomenon in 
cryptophane derivatives.203, 204, 205 This interesting finding triggered us to see first the effect of the 
self-encapsulation on the cryptophane’s physical properties in solution by 1H NMR. Since this 
cage is chiral, we wanted also to see the effect of this solvent-dependent conformation on the 
overall chiroptical properties. Investigating other cryptophane-[223] cages with similar structure, 
by 1H NMR spectroscopy, like cryptophane 110 bearing six methoxy groups and one central 
secondary acetate, compound 111 bearing a primary acetate or compound 29 bearing a thio-
acetate moiety, revealed that these molecules are also capable of performing self-encapsulation, 
Figure 116. It is worth mentioning that the properties of compound 29 has been only studied by 
1H NMR but other compounds were subjected to a full investigation. Having these molecules in 
hand, we were able then to separate their enantiomers and compare their chiroptical properties 
109
13
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with compound 109 to test whether we have a general trend in the chiroptical properties variation 
upon self-encapsulation. The physical properties of cryptophanes 109, 110 and 111 were then 
compared with cryptophane-[223] (OAc)6, 112, which has no function at the propylenedioxy arm 
and hence does not undergo self-encapsulation. In the following sections, we will deliver an in-
depth study of this phenomenon and its effect on the overall chiroptical properties. The majority 
of this work has been recently published in the Chirality journal. (Baydoun et al, Chirality, 2019, 
31, (7), 481-491. DOI: 10.1002/chir.23079) 
 
Figure 116: structure of cryptophane derivatives subjected to self-encapsulation phenomenon. 
 
2. Synthesis and Separation of Two Enantiomers of Cryptophanes 109, 
110, 111 and 112 
The synthesis of cryptophane 109 has been previously reported in literature,41 starting from 
cryptophane 12, where a hepta-acylation step in pyridine provided compound 109 in a good yield 
(74%). The two enantiomers of cryptophane 109 were then separated on a semi-preparative 
HPLC on a Chiralpak-IC column. A racemic mixture of 460 mg of cryptophane-109 provided the 
enantiomer [CD(-)254]-109 first (180 mg) and the [CD(+)254]-109 as a second fraction (200 mg). 
An enantiomeric excess ee > 99.5% and ee > 99% have been measured for [CD(-)254]-109 and 
[CD(+)254]-109, respectively.  
110 29111
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Cryptophane 110 has been obtained by a single acylation reaction of the central hydroxyl group 
of cryptophane 8 where it was obtained in a good yield (71%). Similar to compound 109, the two 
enantiomers of cryptophane 110 were also separated using semi-preparative chiral HPLC but this 
time using (S,S)-Whelk-O1 column as a stationary phase. This provided the [CD(-)254]-110 and 
[CD(+)254]-110.  
Similarly, cryptophane 111 was obtained by an acylation step of compound 27 and it was 
obtained in a good yield (70%). The two enantiomers of compound 111 were separated (S,S)-
Whelk-O1. 
Cryptophane 112 which has no central function on its propylenedioxy arm has been prepared 
using a known procedure and it was obtained in a good yield (71%). The two enantiomers were 
separated using a (S,S)-Whelk-O1 column.111 It is worth mentioning that compound 112 tends to 
partially implode upon separation.  
An additional purification step on silica gel was performed to ensure the purity of these 
compounds.  
3. 1H NMR Analysis of Cryptophanes 
The 1H NMR spectra of cryptophanes 109, 110, 111, 29 and 112 were recorded in different 
solvents that can either enter their cavities like CD2Cl2 and CDCl3 or solvents that have low 
affinity to cryptophanes like DMSO-d6, benzene-d6 and C2D2Cl4,. Table 5 shows the chemical 
shifts of the central acetate or thio-acetate groups in different solvents. 
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Solvent CD2Cl2 CDCl3 DMSO-d6, C2D2Cl4 Benzene-d6 
109 δ(ppm) 2.08 (s) 2 (v.b) 0.18 (b) -0.506 (b) - 
110 δ(ppm) 2.23 (s) 2.16 1.9 (b) -1.74 (b) -1.55 
111 δ(ppm) 2.08 (s) 2.07 (s) 2.07 (b) -1.35 -1.6 
29 δ(ppm) 2.35 (s) 2.34 2.4 -1.1 -1.3 
 
 
Table 5: chemical shift variation (ppm; ref: TMS) of the methyl function of the central acetate group in different 
solvents. 
 
 
In cryptophane 109 for example, the comparison of these spectra revealed large differences 
specifically in the signal corresponding to the methyl group of the central acetate moiety. For 
instance, the 1H NMR spectrum in CD2Cl2 clearly reveals a sharp signal at 2.08 ppm 
corresponding to the central acetate group grafted on the propylenedioxy arm. In CDCl3, 
however, this signal is replaced by another broadened signal, which can be barely seen. 
Interestingly in solvents that do not fit the cavity, like DMSO-d6, C2D2Cl4 the signal appearing at 
2.08 ppm is replaced by another shielded signal, which appears at 0.18 and -0.15 ppm, 
respectively with a chemical shift difference of about 2.59 ppm.  
Compounds 110, 111 and 29 showed a similar behavior, but interestingly, the signal appearing at 
almost 2 ppm is now more shielded (~3.9 ppm difference in CD2Cl2 and C2D2Cl4) and it appears 
at -1.74, -1.35 and -1.1 ppm, respectively for each compound. In Figure 117, we have specifically 
shown the 1H spectra of compound 110 in different solvents to clearly illustrate the chemical shift 
differences as a function of solvents. 
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Figure 117: 1H NMR spectra of compound 110 in different organic solvents. 
 
The 1H NMR spectra of compound 112 do not show any modification upon varying the solvents, 
this is because the molecule does not carry a central acetate moiety and thus does not seems to 
undergo a self-encapsulation phenomenon. 
4. Polarimetry and ECD spectroscopy 
The specific optical rotation (SOR) values of compounds 109, 110, 111 and 112 were 
recorded by polarimetry in different solvents (CD2Cl2, CDCl3, DMSO-d6, C2D2Cl4) at five 
different wavelengths (589, 577, 546, 435, and 365 nm). 
The SOR values of enantiopure compounds [CD(-)254]-109 and [CD(+)254]-109 show a solvent 
dependent behavior at these wavelength, different from that observed for compounds 110, 111 
and 112. For example, the SOR values of [CD(-)254]-109 in CH2Cl2 are positive and similar to 
-2,5-2-1,5-1-0,500,511,522,533,544,555,566,577,5
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that obtained in CHCl3 but the latter are lower in values. In contrast, a complete inversion of SOR 
values sign is observed in DMSO and C2H2Cl4, where they show low negative SOR values ([α]589 
= −7.6 × 10−1 deg cm2 g−1 and [α]589 = −10.4 × 10−1 deg cm2 g−1 at 25°C in DMSO and C2H2Cl4, 
respectively). It is worth mentioning that the [CD(+)254]-109 has the same SOR values with 
opposite signs, Figure 118.  
 
 
 
Figure 118: plot of the SOR values of [CD(+)254]-109 and [CD(-)254]-109 as a function of the nature of the solvent: 
black (CH2Cl2), orange (CHCl3), blue (DMSO), red (C2H2Cl4). 
 
In comparison to 109, compounds 110 and 111 show a usual behavior in which no change in the 
sign of the SOR values is observed as a function of solvent. For example, the [CD(+)254]-110 and 
[CD(+)254]-111 has positive SOR values in all these solvents. Interestingly, these values are 
higher in magnitude compared to the ones of compound 109, for example, the SOR value of 
[CD(+)254]-110 in C2H2Cl4  at 589 nm is equal to [α]589 = 199.0 × 10−1 deg cm2 g−1 and that of 
[CD(+)254]-111 is equal to [α]589 = 207 × 10−1 deg cm2 g−1. 
Similarly, the two enantiomers of compound 112 have the same sign of SOR values whatever the 
nature of the solvent. The magnitude of these values however is comparable to that observed with 
compound 109, Figure 119. 
100
50
0
-50
-100
-150
-200
-250 -100
-50
0
50
100
150
200
250
350 400 450 500 550350 400 450 500 550
S
p
e
c
i f
ic
O
p
ti
c
a
l
R
o
ta
ti
o
n
S
p
e
c
i f
ic
O
p
ti
c
a
l
R
o
ta
ti
o
n
l(nm)
l(nm)
CD(-) -254-109
CD(+)-254-109
Chapter 2: Self-Encapsulation: Chiroptical Aspects  
Page | 198  
 
 
Figure 119: plot of the SOR values of [CD(+)254]-110 and [CD(-)254]-112 as a function of the nature of the solvent: 
black (CH2Cl2), orange (CHCl3), blue (DMSO), red (C2H2Cl4). 
 
The ECD spectra of the enantiopure compounds 109, 110, 111 and 112 were recorded in different 
solvents like CH3CN, DMSO, C2H2Cl4, THF, CH2Cl2 and CHCl3. These molecules showed a 
good solubility in all solvents except CH3CN. Recording ECD spectra in CH3CN and THF allows 
us to access a large spectral range of the absorption spectrum reaching 210 nm, which includes 
the 1Bb, 
1La and 
1Lb transitions. In CH2Cl2 and CHCl3 the cut-off is around 230 nm, which allows 
the detection of the 1La and 
1Lb transitions. However, in DMSO and C2H2Cl4 only the 
1Lb 
transition is observed. 
The ECD spectra of [CD(+)254]-109 in CH2Cl2 revealed two negative-positive bisignate signals 
from low to high wavelength  (Figure 120, A). The first bisignate corresponds to the 1La 
transition,  which lies between 230 and 260 nm and the second lies between 260 and 310 
corresponds to the 1Lb transition. In THF, an ECD band of the 
1Bb transition is observed as a 
negative Cotton band. Upon varying the nature of the solvent, no spectral modifications were 
observed and the spectra are nearly superimposable except in the case of C2H2Cl4, where a 
decrease in the intensity of the ECD component at 290 nm is detected, Figure 120, B. Similarly, 
no detectable variation was observed in the ECD spectra of compound 112 in different solvents. 
-100
-50
0
50
100
150
200
250
350 400 450 500 550
S
p
e
c
if
ic
O
p
t i
c
a
l
R
o
t a
t i
o
n
l(nm)
CD(-) -254-109
350 400 450 500 550 l(nm)
200
400
600
800
1000
0
CD(+)-254-
350 400 450 500 550 l(nm)
CD(-) -254-112
20
40
60
160
100
140
0
120
80
180
200
( 1
0
- 1
d
e
g
c
m
2
g
- 1
) 110
Chapter 2: Self-Encapsulation: Chiroptical Aspects  
Page | 199  
 
For compounds 110 and 111, the ECD spectra are different from that recorded for compounds 
109 and 112. In particular, the 1Lb transition is now composed of three Cotton bands instead of 
two. Unlike the first two described compounds, the ECD bands of the 1Lb transition is more 
responsive to the change of the nature of the solvent, where modifications in its shape and 
intensity are observed especially in the ECD components between 285 and 310 nm, Figure 120, C 
and D. 
 
 
Figure 120: ECD spectra of [CD(+)254]-109 (black spectra) and [CD(-)254]-109 (red spectra) recorded in A) CH2Cl2 
B) C2H2Cl4 at 20 °C. ECD spectra of [CD(+)254]-110 (black spectra) and [CD(-)254]-110 (red spectra) recorded in 
C) CH2Cl2 D) C2H2Cl4 at 20 °C. 
 
5. IR and VCD spectroscopy 
The chiroptical properties of cryptophanes 109, 110 and 112 were also studied by VCD 
spectroscopy in different solvents, along with the infrared spectroscopy, which offered insight 
data about the self-encapsulation phenomenon. 
The IR spectra recorded in different solvents are relevant to that reported previously with 
cryptophane-[223] derivatives.111, 64 These spectra displayed at 1750 and 1160 cm-1 reflect the 
νC=O stretching vibration and the ester asymmetric and symmetric νC-O-C stretching vibrations. 
MM-110
BA
C D
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The νC=O stretching vibration is of particular interest because it reflects the environment and the 
behavior of the carbonyl groups in the molecules in different solvents. For example, the intensity 
of this signal is dependent on the number of the acetate groups in the molecule. In compounds 
109 and 112, for instance, this peak is more intense because they bear seven and six acetate 
groups, respectively. A closer look at this spectral region informs us a lot about the self-
encapsulation phenomenon. For example, the νC=O signal of compound 109 and 112 are equal to 
1762 cm-1 in CHCl3 and 1758 cm
-1 in C2H2Cl4. Thus, these peaks correspond to the six acetate 
groups grafted on the CTB units. In compound 109, however an additional shoulder is observed 
at 1746 cm-1 that might correspond to the central acetate group. In this compound, it is hard to 
extract data about self-encapsulation due to the contribution of the other six acetate available 
moieties, Figure 121, A and C. 
Interestingly, in compound 110 which bears a unique central acetate group, more information 
about the self-encapsulation process can be extracted from the νC=O IR band. In CHCl3 and 
CH2Cl2 for example, this stretching vibration appears as a single peak around 1740 cm
-1. In 
C2H2Cl4 where self-encapsulation takes place, a new signal appears at higher energy, 1752 cm
-1 
in addition to the initial signal appearing at 1738 cm-1. This new peak can be assigned to the 
acetate group pointing inside the cavity. It is worth mentioning that the new signal is double in 
intensity compared to the initially observed signal at 1739 cm-1. The new observed peak has a 
higher energy and this indicates that it interacts less with the surrounding environment. To 
confirm this result, additional experiment was performed in C2H2Cl4 with xenon, which is a 
competitive guest. Upon xenon addition, the intensity of the two peaks are reversed, in which the 
peak observed at 1739 cm-1 that corresponds to the acetate group out the cavity, is now 
predominant. This result can be explained by the fact that once xenon enters the cavity it expels 
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the acetate group out of it and hence clearly illustrates the self-encapsulation phenomenon, Figure 
121, B. 
 
Figure 121: IR spectra in the ester νC═O spectral range of (A) 109, (B) 110, and (C) 112 in CDCl3 (black spectra), 
CD2Cl2 (red spectra), and C2D2Cl4 (blue spectra) solvents (15 mM, 250 μm path length). Additional IR spectrum of 
110 in C2D2Cl4 in the presence of xenon (green spectrum in B). 
 
The VCD spectra of enantiopure compounds [CD(+)254]-109, [CD(+)254]-110, and [CD(+)254]-
112 were also recorded in different solvents. The comparison of the VCD spectra in these 
solvents is shown in Figure 122. Generally speaking, upon changing the nature of the solvent, the 
overall shape of the VCD spectra does not vary. However, a slight decrease in the intensity of the 
peaks is observed when using C2H2Cl4 as a solvent. Since this feature is observed in all the three 
compounds, which either undergo (109 and 110) or does not (112) self-encapsulation, then it 
seems that these modifications are not specific to this process but rather to the solvent effect. The 
latter behavior has been also observed previously for cryptophane-[222] with methoxy 
substituents, where it was related to the conformational changes of the linkers. When the 
cryptophane cage is complexing a guest molecule such as CHCl3, the trans conformation of the 
linkers is favored. However, in the absence of a suitable guest, the molecule tends to have 
different conformations and an overall conformational equilibrium is observed. This in turn gives 
rise to different VCD spectra. Additionally, a deep observation of the VCD spectra of compounds 
[CD(+)254]-109 and [CD(+)254]-112 revealed a negative positive bisignate signal from low to high 
BA C
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wavenumbers which is referred to as an excitonic coupling of the acetate groups. Specifically it 
arises from the coupling pair of oriented C═O dipoles and has been already observed for 
cryptophane derivative bearing six carboxylic acid groups Figure 122, A and C. 
 
 
Figure 122: VCD spectra in the 1850 to 1050 cm−1 spectral range of (A) [CD(+)254]‐109, (B) [CD(+)254]‐110, and 
(C) [CD(+)254]‐112 in CDCl3 (black spectra), CD2Cl2 (red spectra), and C2D2Cl4 (blue spectra) solvents (15 mM, 
250 μm path length). 
 
6. Determination of the Absolute Configuration of Cryptophane 109, 110, 
111 and 112 
Determination of cryptophane’s absolute configuration (AC) has been assessed using 
different chiroptical techniques and specifically polarimetry at 589 nm, which constitutes the 
simplest and the most used technique to determine the AC of cryptophanes.111,71  For example, 
PP-cryptophane-A and its derivatives have a positive SOR value at 589 nm regardless the nature 
of the solvent. This value is also associated with a positive CD band at 254 nm. In case of 
compound 109, a direct attribution of the AC using polarimetry is rendered impossible because 
the sign of the SOR values depends on the nature of the solvent. This is not the case for 
compounds 110, 111 and 112 and compound 109 is the first reported cryptophane that shows this 
behavior. 
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For the determination of the AC of compound 109, complementary chiroptical tools like ECD 
and VCD spectroscopy are thus necessary. ECD spectroscopy in organic solvents has proved its 
efficiency to attribute the AC of cryptophane derivatives. In particular, the ECD bands of the 1La 
transition can be exploited with confidence to attribute cryptophane’s AC. This is because, the 
ECD bands of the 1La transition are quite robust towards structural and experimental conditions 
like a change of the solvent. As discussed in the introductory chapter, the ECD bands of the PP-
cryptophane-A show a negative-positive bisignate 1La transition from high to low energy. The 
MM-cryptophane-A shows obviously opposite ECD Cotton bands. In case of an anti-cryptophane 
derivative bearing six acetate groups, the descriptors M and P will be inversed due to the change 
of priority of the groups (Prelog's rules). Based on this, and by analogy with the results observed 
with enantiopure cryptophane-A, enantiopure MM-109 will display a negative-positive bisignate 
for the ECD bands of the 1La transition. Consequently, the [CD(+)254]-109 corresponds to the 
MM-cryptophane-109, whereas the [CD(-)254]-109 corresponds to the PP-descriptor. The SOR 
value obtained at 589 nm is no longer reliable to determine the AC since it changes its sign in 
different solvents. Thus, in compound 109 it is important to specify the nature of the solvent to 
complete the assignment of the AC. Hence, we can conclude that the MM-109 is the (+)589-MM-
109 in C2H2Cl4 and  (-)589-MM-109 in CH2Cl2, Figure 123.  
 
Figure 123: comparison between the PP-cryptophane-A and PP-109. 
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For compounds 110, 111 and 112, the case is simpler, since no change in the SOR values is 
observed upon varying the nature of the solvents. For example, [CD(-)254]-110 and [CD(-)254]-
111 can be attributed to the MM-110 and MM-111 which have a negative SOR at 589 nm and a 
positive-negative bisignate 1La transition. The PP-112 is attributed to [CD(-)254]-112 and to 
(+)589-PP-112, Figure 124. 
 
Figure 124: attributed absolute configuration of cryptophanes 110, 111 and 112. 
 
To confirm the absolute configuration of cryptophanes derivatives, VCD spectroscopy combined 
with ab initio calculations at the DFT level have been performed for compounds 109 and 110. 
The geometries of PP-109 and MM-110 were optimized at the B3LYP/6‐31G** level, and 
harmonic vibrational frequencies were calculated at the same level. Calculations were performed 
assuming trans and gauche-gauche conformations for the ethylenedioxy and propylenedioxy 
linkers, respectively, and considering that the acetate group grafted on the propylenedioxy linker 
points toward or outward the cavity. The comparison of the experimental VCD spectrum of 
[CD(-)254]-109 and those calculated for PP-109 configuration are reported in Figure 125. The 
VCD spectra calculated for the PP configuration of 109, whatever the orientation of the acetate 
group grafted on the propylenedioxy linker, reproduce the sign of most of the bands observed in 
the experimental VCD spectrum for the [CD(-)254]-109 enantiomer, thus confirming the absolute 
configuration [CD(-)254]-PP for 109. Similarly, the comparison of the experimental VCD 
MM-110
[CD(-)254]
MM-111
[CD(-)254]
PP-112
[CD(-)254]
Chapter 2: Self-Encapsulation: Chiroptical Aspects  
Page | 205  
 
spectrum of [CD(-)254]-110 and those calculated for the MM-110 configuration, confirms the 
absolute configuration [CD(-)254]-MM for 110.  
 
Figure 125: Comparison of experimental VCD spectrum of [CD(−)254]‐109 in C2D2Cl4 solution (15 mM, 250 μm 
path length) and VCD spectra of PP‐109 calculated at the B3LYP/6‐31G** level (IEFPCM = C2H2Cl4) for the trans 
and gauche‐gauche conformations of the ethylenedioxy and propylenedioxy linkers, respectively, and for the acetate 
group grafted on the propylenedioxy linker pointing toward (blue spectrum) or outward (red spectrum) the cavity. 
 
7. Self-Encapsulation Confirmation by 1H NMR and IR 
Among the different spectroscopic methods used to characterize the self-encapsulation 
process, 1H NMR and IR confirmed with confidence this conformation. For instance, 1H NMR 
spectra revealed a clear chemical shift change of the central acetate or thio-acetate group in 
solvents that fill or do not fill the cavity. In large solvents like DMSO and C2H2Cl4, the central 
acetate group tends to fill cryptophanes cavity leading to high shielding. In the presence of a 
potential guest like CHCl3 and CH2Cl2, the acetate group will be expelled out and the guest 
molecule will occupy the cavity.  
Compound 109 shows a shielding of about 2.58 ppm in C2H2Cl4, this value suggests that the 
acetate group is not completely encapsulated. For compounds 110, 111 and 29, the acetate group 
is shielded by about 4 ppm. This value is comparable to that observed with cryptophane guests 
and it suggests a better complexation event.206,53 This can be explained by the fact that the acetate 
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groups bordering cryptophane-109 skeleton are now replaced by less hindered methoxy groups 
which in turn enhance the flexibility of the cage allowing better conformational rearrangement.  
Infrared spectroscopy has also served to confirm this phenomenon, specifically in compound 110 
that bears only one acetate group. For example, the peak observed at 1752 cm-1 in C2H2Cl4 can be 
clearly associated with the acetate group pointing inward the cavity. This stretching vibration 
appears at higher wavenumber compared to the acetate group pointing outward (1739 cm-1) 
because it interacts less with surrounding solvent environment. DFT calculations have also served 
to reproduce these IR spectra, in which an increase of the stretching vibration wavenumber by 
about 13 cm-1 is calculated for acetate pointing inward the cavity. This has been also confirmed 
by a competition experiment with xenon that expels the acetate group, thus restores the initial 
signal which appears at 1739 cm-1 and decrease the one at 1752 cm-1. 
It is worth mentioning, that self-encapsulation is a new conformation that is used by cryptophanes 
to fill their cavities in the absence of a guest. Normally, cryptophanes use imploded conformation 
as an alternative tool to occupy their cavities, but this conformation is energetically demanding or 
it forms when the cryptophane is stored for a long time in the solid state. The latter case is 
observed for compound 112 which even implodes in solution.  
8. Effect of Self-Encapsulation on Chiroptical Properties 
Self-encapsulation induces large conformational changes of cryptophane linkers. These 
changes were readily confirmed by 1HNMR and IR spectroscopy (see above). Different 
chiroptical tools were also employed to characterize this phenomenon. Despite the fact that 
compounds 109, 110 and 111 undergo self-encapsulation, they have completely different 
chiroptical properties in different solvents. Investigating the chiroptical properties by ECD 
spectroscopy revealed little variations in different solvents.183 This result is in agreement with our 
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previously reported results, which show that the Cotton bands are less responsive to 
conformational changes in organic solvents. This lack of sensitivity can be explained in part 
because the benzene chromophores are inserted into two independent rigid structures. Thus, the 
chromophores and their relative orientation seem to be moderately affected by the conformational 
rearrangement of the linkers. The ECD spectral results of enantiopure compound 109 are quite 
surprising, because the SOR are strongly modified under the same experimental conditions. It is 
also noteworthy that ECD and SOR (ORD) are related by Kramers-Kronigs relationships (see 
Appendix). Consequently, a change of the SOR (ORD) values must have an impact on the overall 
ECD spectrum.  
To explain this lack of sensitivity several hypotheses can be proposed. One of the proposed 
hypothesis is the contribution of high-energy excited states, which cannot be accessed in our case 
by conventional ECD spectrometer ( 220 nm). These high-energy excited states can contribute 
to the SOR values recorded for compound 109. This assumption is however difficult to check 
experimentally because we do not have access to the whole ECD spectrum of compound 109. 
Synchrotron Radiation Circular Dichroism (SRCD) allows extending the spectral range, but even 
in this case, it will be difficult to confirm this hypothesis. Such a study has been performed in the 
case of cryptophane-[222], 98, that shows a large variation of the SOR (ORD) values as a 
function of the nature of the solvent.191  
Another assumption to explain this unusual behavior will be to consider a participation of the 
solvent. Indeed, it has been shown in some cases that the solvent may contribute to the sign of the 
SOR values measured.207 Thus, a contribution of the solvent cannot be totally excluded, but this 
effect is also difficult to verify experimentally or by quantum calculations since the use of an 
explicit model would require large computation times, considering the molecular size of 
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compound 109, the number of possible conformations adopted and the number of solvent 
molecules surrounding the host molecule. Nevertheless, this surprising effect cannot be solely 
attributed to the self-encapsulation process since other compounds such as 110 and 111 show a 
different behavior.  
Compared to ECD, VCD spectroscopy revealed a higher sensitivity to conformational changes. 
For example, the VCD spectra of [CD(+)254]-109 and [CD(+)254]-110 enantiomers are dependent 
on the fact that the solvent can enter (CDCl3 or CD2Cl2) or not (C2D2Cl4) the cavity of the host. 
Particularly the spectral regions lying between 1480 and 1450 cm−1 associated with the δCH2 
bending vibration and in the 1300 to 1250 cm−1 related to the wagging and twisting modes of 
methylene groups are mostly affected by the nature of the solvent. However, these spectral 
modifications do not give any clue about self-encapsulation since they are also observed with 
compound 112, which does not undergo self-encapsulation.  
As observed with many different enantiopure cryptophane derivatives studied by our group, 
polarimetry appears to be the most sensitive technique to detect small conformational changes, 
when recorded in organic solvent. In contrast, ECD spectroscopy appears much less sensitive in 
studying these conformational changes due to the particular arrangement of the six benzene 
chromophores. VCD spectroscopy can also be useful to detect such type of conformational 
variations, with an additional advantage of being easily calculated using quantum mechanics 
equations. In addition, VCD spectroscopy combined with DFT calculations remain the methods 
of choice to determine, with confidence, the absolute configuration of these derivatives. This 
technique was proved to be efficient in the case of compound 109, where the direct determination 
of the absolute configuration was found complicated.   
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Through the run of this part, we have delivered a non-exhaustive description of some 
chiral cryptophane derivatives. The different chiroptical properties of these cages were also 
discussed to offer a better understanding of cryptophanes’ configurations and conformational 
variations of cryptophanes and their complexes. Importantly, we also highlighted the main 
chiroptical tools used in this domain and described the major functions of each tool, their 
advantages and inconveniences. Exploiting these tools along with 1H NMR spectroscopy, we 
were particularly interested in studying the behavior of the cryptophanes-[223] derivatives 
subjected to “self-encapsulation”. This phenomenon is characterized by a conformational change 
of the central group lying on the propylenedioxy arm, which points inward the inner cavity of the 
host in the absence of a competitor guest. The chiroptical properties of these cages revealed that 
compound 109 has a unique behavior, since its SOR values invert depending on the nature of the 
solvent. To our knowledge, this family of compounds gathers the first examples of cryptophane 
derivatives that give rise to a self-encapsulation phenomenon. The self-encapsulation process 
appears as a convenient way to fill the cavity in absence of guest molecules. This process occurs 
spontaneously in solution, and it requires less energy than the CTB implosion that is usually 
observed upon heating the compound in solution or in the solid state. In contrast, compound 112 
that does not possess appropriate substituent on the linker gives more easily the imploded form. 
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Experimental Details: 
Polarimetric, UV-Vis, and ECD measurements 
Optical rotations of the two enantiomers of 109, 110, 111 and 112 were measured in four solvents 
(CHCl3, CH2Cl2, DMSO, and C2H2Cl4) at 589, 577, 546, 435, and 365 nm using a polarimeter 
with a 10 cm path length cell, thermostated at 25°C. Concentrations used for the polarimetric 
measurements were typically in the range 0.22 to 0.3 g/100 mL. ECD spectra of the two 
enantiomers of 109, 110, 111 and 112 recorded on a Chirascan spectrometer (Applied 
Photophysics) in six solvents (CHCl3, CH2Cl2, THF, CH3CN, C2H2Cl4, and DMSO) at 20 °C 
with a 0.2 cm path length quartz cell (concentrations were in the range 0.1 to 1.0 × 10−4 M). 
Spectra were recorded between 210 and 350 nm (THF, CH3CN), 230 and 350 nm (CH2Cl2 and 
CHCl3), and 250 and 350 nm (DMSO, C2H2Cl4) with a 0.5 nm increment and a 1 second 
integration time. Spectra were processed with standard spectrometer software, baseline corrected, 
and slightly smoothed by using a third-order least square polynomial fit. UV-Vis spectra of 
compounds 109, 110, 111 and 112 were recorded in THF (210‐350 nm) at 25°C with a 1 cm path 
length quartz cell. 
IR and VCD measurements 
The IR and VCD spectra were recorded on a FTIR spectrometer equipped with a VCD optical 
bench. IR absorption and VCD spectra were recorded at a resolution of 4 cm−1, by coadding 50 
and 24000 scans (8 h acquisition time), respectively. Samples were held in a 250 μm path length 
cell with BaF2 windows. IR and VCD spectra of the two enantiomers of 109, 110 and 112 were 
measured in CDCl3, CD2Cl2, and C2D2Cl4 solvents at a concentration of 15 mM. Additional IR 
spectrum of 110 was measured in C2D2Cl4 in the presence of xenon. 
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DFT calculations 
The geometry optimizations, vibrational frequencies and absorption intensities were calculated by 
the Gaussian 09 program on the DELL cluster of the MCIA computing centre of the Bordeaux 
University. Calculations of the optimized geometry of PP-109 and MM-110 enantiomers were 
performed at the density functional theory (DFT) level using B3LYP functional and 6-31G** 
basis set with the use of IEFPCM model of solvent (C2H2Cl4 described with parameters ε = 7.096 
and ε∞ = 2.21). First, a conformational search of the two compounds was performed at the 
molecular mechanics level (MMFF94 force fields incorporated in compute VOA software, 8 kcal 
mol−1 limit) on the optimized structure of cryptophane-[223] as a starting point, on which acetate 
substituents were added. Two structures with, respectively, trans, trans, and gauche-gauche 
conformations for the two ethylenedioxy and propylenedioxy linkers, with the acetate group 
grafted on the latter pointing inward and outward the cavity, were optimized. Vibrational 
frequencies and IR intensities were calculated at the same level of theory. For comparison with 
experiments, the calculated frequencies were scaled by 0.968 and the calculated intensities were 
converted to Lorentzian bands with a half-width of 7 cm−1. 
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Synthesis of cryptophane 110: Acetic anhydride (0.7 mL, 7.4 
mmol, 10 equiv.) was added dropwise at 0 °C to a solution of 
cryptophane 8 (0.7 g, 0.75 mmol) in freshly distilled CH2Cl2 
(23 mL) and pyridine (3.5 mL). The reaction mixture was 
stirred for 48 hours at room temperature. The solution was then 
quenched at 0 °C with concentrated NaHCO3 (10 ml) for 10 
minutes and then poured in 20 mL of H2O. The aqueous layer was extracted 5 times with CH2Cl2 
and then dried over Na2SO4. After filtration the solvent was evaporated under reduced pressure. 
The crude product was subjected to column chromatography on silica gel (CH2Cl2/acetone: 
85/15) to give rise to compound 110 as a white product (0.52 g, 71%). 
1H NMR (400 MHz, CDCl3, 25 °C): 6.63-6.79 (12 s, 12 H), 4.58-4.62 (m, 6H), 4.02-4.2 (m, 
11H), 3.93 (m, 1 H), 3.73- 3.8 (6s, 18 H), 3.47 (m, 1H), 3.36-3.41 (m, 6 H), 2.17 (s, 3H).  
13C {1H} NMR (100.6 MHz, CDCl3, 25 °C): 170.6, 149.6 (2C), 149.55, 149.4, 148.8, 148.1, 
146.8, 146.7 (2 C), 146.6, 146.5 (2 C), 134.1, 134.1, 133.8, 133.8, 133.3, 132.8, 132.1, 131.9, 
131.5, 131.4, 131.35, 131.3, 120.3, 120.2 (3 C), 117.2, 115.1, 114.2 (2 C), 113.9, 113.7, 113.35, 
113.2, 70.8, 69.6, 69.5, 69.1, 68.9 (2 C), 66.6, 56.3, 56.3, 55.7, 55.65(2 C), 55.6, 36.5, 36.4; 36.2 
(4 C), 21.2.  
HRMS(ESI-TOF) m/z [M + Na]+ calcd for C57H58O14Na 989.3724, found 989.3719. 
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Synthesis of cryptophane 111: Acetic anhydride (0.3 mL, 
3.1 mmol, 5 equiv.) was added dropwise at 0 °C to a 
solution of cryptophane 27 (0.6 g, 0.63 mmol) in freshly 
distilled pyridine (8 mL). The reaction mixture was stirred 
for 48 hours at room temperature. The solution was then 
quenched at 0 °C with concentrated NaHCO3 (10 ml) for 10 
minutes and then poured in 20 mL of H2O. The aqueous layer was extracted 5 times with CH2Cl2 
and then dried over Na2SO4. After filtration the solvent was evaporated under reduced pressure. 
The crude product was subjected to column chromatography on silica gel (CH2Cl2/acetone: 95/5) 
to give rise to compound 111 as a white product (0.57 g, 70%). 
1H NMR (400 MHz, CDCl3, 25 °C): 6.76-6.52 (12 s, 12 H), 4.62-4.55 (m, 6H), 4.45-3.95 (m, 
11H), 3.79 (1s, 9 H), 3.76 (1s, 3H), 3.74 (1s, 3H), 3.44-3.35 (m, 6 H), 2.63 (s, 1H), 2.07 (s, 3H).  
13C {1H} NMR (100.6 MHz, CDCl3, 25 °C): 171.1, 149.5, 149.4 (2C), 149.3, 147.8, 147.5, 
147.0, 146.9, 146.7, 146.56, 146.54, 133.9 (2C), 133.8 (3C), 132.3, 132.2, 131.6, 131.5, 131.4, 
130 (2C), 120.4 (2C), 120.38, 120.1, 113.9 (2C), 113.6, 113.4, 112.9, 112.9, 112.3, 112.2, 69.65, 
69.5, 68.9 (2C), 64.92, 64.2, 62.56, 56.19, 55.7, 55.52 (2C), 55.4, 39.6 (2C), 36 (2C), 35.9 (2C), 
20.9.  
HRMS(ESI-TOF) m/z [M + Na]+ calcd for C58H60O14Na 1003.3880, found 1003.3875 
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Synthesis of cryptophane 112: Acetic anhydride (2.2 mL, 41 mmol) 
was added dropwise at 0 °C to a solution of cryptophane223 (OH)6 
(0.35g, 0.42 mmol) in Pyridine (5 mL). The reaction was stirred at 
room temperature for 16 hours under an argon atmosphere. Then, the 
reaction was quenched with a solution of sodium bicarbonate at 0 °C. 
The solution was then extracted 5 times with CH2Cl2. The combined organic layers were dried 
over sodium sulfate. A filtration, followed by evaporation of the solvents under reduced pressure, 
gives rise to compound 112 as a white product. The solid was then washed on a frit with an 
Et2O/CH2Cl2: 75/25 mixture to give compound 112 as a clean white solid (0.31g, 71%).  
1H NMR (400 MHz, CDCl3, 25 °C): 6.94 (s, 2 H), 6.91(2 H), 6.89 (2 H), 6.87 (2 H), 6.86(2 H), 
6.62 (2 H), 4.65-4.58 (m, 6 H), 4.28-4.286 (2 H, m), 4.16-4.15 (m, 2 H), 4.04 - 3.8 (m, 8 H), 3.5-
3.4 (m, 6H), 2.31 (s, 6 H), 2.29 (s, 6 H), 2.25 (s, 6 H), 2.09 (m, 2 H).  
13C {1H} NMR (100.6 MHz, CDCl3, 25 °C): 168.5 (4 C), 168.3 (2 C), 149.3 (2 C), 149.25 (2 C), 
149.0 (2 C), 140.5 (2 C), 140.3 (2 C), 138.7 (2 C), 138.6 (2 C), 137.8 (2 C), 136.7 (2 C), 133.6 (2 
C), 133.4 (2 C), 131.2 (2 C), 124.4 (2 C), 124.0 (2 C), 123.3 (2 C), 120.9 (2 C), 120.7 (2 C), 
113.6 (2 C), 69.8 (2 C), 69.1 (2 C), 63.7 (2 C), 36.4 (2 C), 36.1 (4 C), 20.7 (4 C), 20.6 (2 C).  
HRMS (ESI-TOF) m/z [M + Na]+ calcd for C61H56O18Na 1099.3364, found 1099.3359. 
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Analytical separation for compound 109 
 
 
 
Column Mobile Phase t1 k1 t2 k2  Rs 
Chiralpak IC heptane/EtOH/CH2Cl2 (50/10/40) 4.89 (-) 0.63 6.48 (+) 1.16 1.84 2.23 
 
 
 
Figure 126: chromatograms (Chiralpak IC, 250 x 4.6 mm, heptane/ethanol/CH2Cl2: 50/10/40, 1 mL/min at 25 °C) of 
the (rac)-109 before preparative separation on Chiralpak IC (250 x 10 mm, heptane/ethanol/CH2Cl2: 50/10/40, 5 
mL/min).  
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Semi-preparative separation for compound 109: 
Sample preparation: About 460 mg of compound (rac)-109 are dissolved in 18 mL of 
dichloromethane. Chromatographic conditions: Chiralpak IC (250 x 10 mm), 
hexane/ethanol/dichloromethane (5/1/4) as mobile phase, flow-rate = 5 ml/min, UV detection at 
230 nm. Injections (stacked): 180 times 100 µL, every 5 minutes. The first eluted enantiomer is 
collected between 4.2 and 5.2 minutes and the second one between 6 and 7.5 minutes. First 
fraction: 180 mg of the first eluted [CD(-)254]-109 with ee > 99.5% on Jasco CD-1595 circular 
dichroism detector at 254 nm. Second fraction: 200 mg of the second eluted [CD(+)254]-109 with 
ee > 99% on Jasco CD-1595 circular dichroism detector at 254 nm. 
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Figure 127: chromatograms (Chiralpak IC, 250 x 4.6 mm, heptane/ethanol/CH2Cl2: 50/10/40, 1 mL/min at 25 °C) of 
the collected [CD(-)254]-109 and [CD(+)254]-109 after preparative separation on Chiralpak IC (250 x 10 mm, 
heptane/ethanol/CH2Cl2: 50/10/40, 5 mL/min). Detection performed by UV-Vis spectroscopy at 230 nm (black 
chromatograms) and CD spectroscopy at 254 nm (red chromatograms). 
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Analytical separation for compound 110 
 
 
 
Column Mobile Phase t1 k1 t2 k2  Rs 
(S,S)-Whelk-O1 
heptane/EtOH/CH2Cl2  
20/40/40 
9.13 (-) 2.10  12.67 (+) 3.29 1.57 5.72 
 
 
Figure 128: chromatograms ((S,S)-Whelk-O1, 250 x 4.6 mm, heptane/ethanol/CH2Cl2: 20/40/40, 1 mL/min at 25 °C) 
of the (rac)-110 before preparative separation on (S,S)-Whelk-O1 (250 x 10 mm, heptane/ethanol/CH2Cl2: 20/40/40, 
5 mL/min).  
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Semi-preparative separation for compound 110: 
Sample preparation: About 580 mg of (rac)-110 are dissolved in 6 mL of dichloromethane. 
Chromatographic conditions: (S,S)-Whelk-O1 (250 x 10 mm), heptane/ethanol/ dichloromethane 
(20/40/40) as mobile phase, flow-rate = 5 mL/min, UV detection at 230 nm. Injections (stacked): 
20 times 300 µL, every 13.8 minutes. First fraction: 255 mg of the first eluted [CD(-)254]-110 
with ee > 99.5% on Jasco CD-1595 circular dichroism detector at 254 nm.  Second fraction: 240 
mg of the second eluted [CD(+)254]-2 with ee > 99.5% on Jasco CD-1595 circular dichroism 
detector at 254 nm. 
 
 
Figure 129: chromatograms ((S,S)-Whelk-O1, 250 x 4.6 mm, heptane/ethanol/CH2Cl2: 20/40/40, 1 mL/min at 25 °C) 
of the collected [CD(-)254]-110 and [CD(+)254]-110 after preparative separation on (S,S)-Whelk-O1 (250 x 10 mm, 
heptane/ethanol/CH2Cl2: 20/40/40, 5 mL/min). Detection performed by UV-Vis spectroscopy at 230 nm (black 
chromatograms) and CD spectroscopy at 254 nm (red chromatograms). 
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Analytical separation for compound 111 
 
 
 
Column Mobile Phase t1 k1 t2 k2  Rs 
(S,S)-Whelk-O1 
Heptane/EtOH/CH2Cl2  
20/40/40 
10.30 (-) 2.49 12.74 (+) 3.32 1.33 3.79 
 
 
 
Figure 130: chromatograms ((S,S)-Whelk-O1, 250 x 4.6 mm, heptane/ethanol/CH2Cl2: 20/40/40, 1 mL/min at 25 °C) 
of the (rac)-111 before preparative separation on (S,S)-Whelk-O1 (250 x 10 mm, heptane/ethanol/CH2Cl2: 20/40/40, 
5 mL/min).  
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Semi-preparative separation for compound 111: 
Sample preparation: About 530 mg of compound 111 are dissolved in 7 mL of dichloromethane. 
Chromatographic conditions: (S,S)-Whelk-O1 (250 x 10 mm), heptane/ethanol/dichloromethane 
(20/40/40) as mobile phase, flow-rate = 5 mL/min, UV detection at 260 nm. Injections (stacked): 
28 times 250 μL, every 14 minutes. First fraction: 220 mg of the first eluted ((-)-CD 254nm)-
enantiomer) with ee > 99.5%. Second fraction:  240 mg of the second eluted ((+)-CD 254nm)-
enantiomer) with ee > 99.5%. 
 
Figure 131: chromatograms ((S,S)-Whelk-O1, 250 x 4.6 mm, heptane/ethanol/CH2Cl2: 20/40/40, 1 mL/min at 25 °C) 
of the collected [CD(-)254]-111 and [CD(+)254]-111 after preparative separation on (S,S)-Whelk-O1 (250 x 10 mm, 
heptane/ethanol/CH2Cl2: 20/40/40, 5 mL/min). Detection performed by UV-Vis spectroscopy at 230 nm (black 
chromatograms) and CD spectroscopy at 254 nm (red chromatograms). 
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Analytical separation for compound 112 
 
 
 
 
Figure 132: chromatograms ((S,S)-Whelk-O1, 250 x 4.6 mm, ethanol/CH2Cl2: 50/50, 1 mL/min at 25 °C) of the (rac)-
112 before preparative separation on (S,S)-Whelk-O1 (250 x 10 mm, heptane/ethanol/CH2Cl2: 35/65, 5 mL/min). 
 
 
 
Column Mobile Phase t1 k1 t2 k2  Rs 
(S,S)-Whelk-O1 ethanol/CH2Cl2 50/50 5.30 (-) 0.80 6.86 (+) 1.32 1.67 4.81 
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Semi-preparative separation for compound 112 
Sample preparation: About 575 mg of compound (rac)-112 are dissolved in 170 mL of a 
mixture of ethanol/dichloromethane (30/70). Chromatographic conditions: (S,S)-Whelk-O1 (250 x 
10 mm), ethanol/dichloromethane (35/65) as mobile phase, flow-rate = 5 ml/min, UV detection at 
230 nm. Injections (stacked): 340 times 500 µL, every 4.4 minutes. First fraction: 235 mg of the 
first eluted [CD(-)254]-112 with ee > 99% on Jasco CD-1595 circular dichroism detector at 254 
nm. Second fraction: 200 mg of the second eluted [CD(+)254]-112 with ee > 99.5% on Jasco CD-
1595 circular dichroism detector at 254 nm. 
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Figure 133: chromatograms ((S,S)-Whelk-O1, 250 x 4.6 mm, ethanol/CH2Cl2: 50/50, 1 mL/min at 25 °C) of the 
collected [CD(-)254]-112 and [CD(+)254]-112 after preparative separation on (S,S)-Whelk-O1 (250 x 10 mm, 
ethanol/CH2Cl2: 50/50, 5 mL/min). Detection performed by UV-Vis spectroscopy at 230 nm (black chromatograms) 
and CD spectroscopy at 254 nm (red chromatograms). 
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Figure 134: 1H NMR spectrum (300 MHz) of (rac)-109 recorded in CD2Cl2 at 25 °C. The letters A,B,C,D,E show 
protons signals related to the imploded form.  
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Figure 135: 1H NMR spectrum (300 MHz) of (rac)-109 recorded in CDCl3 at 25 °C. The letters A,B,C,D show 
protons signals related to the imploded form. 
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Figure 136: 1H NMR spectrum (300 MHz) of (rac)-109 recorded in DMSO-d6 at 25 °C.  
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Figure 137: 1H NMR spectrum (300 MHz) of (rac)-109 recorded in 1,1,2,2-tetrachloroethane-d2 at 25 °C.  
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Figure 138: 1H NMR spectrum (300 MHz) of (rac)-110 recorded in CD2Cl2 at 25 °C.  
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Figure 139: 1H NMR spectrum (300 MHz) of (rac)-110 recorded in CDCl3 at 25 °C. 
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Figure 140: 1H NMR spectrum (300 MHz) of (rac)-110 recorded in 1,1,2,2-tetrachloroethane-d2 at 25 °C.  
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Figure 141: 1H NMR spectrum (300 MHz) of (rac)-110 recorded in benzene-d6 at 25 °C. 
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Figure 142: 1H NMR spectrum (300 MHz) of (rac)-111 recorded in different solvents at 25 °C. 
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Figure 143: 1H NMR spectrum (300 MHz) of (rac)-29 recorded in different solvents at 25 °C. 
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Solvent Conc.  []589 []577 []546 []435 []365 
CH2Cl2 0.21 -60.1 -62.3 -70.3 -123.4 -190.9 
CHCl3 0.23 -25.4 -28.3 -32.1 -48.5 -59.8 
DMSO 0.26 +7.2  +7.0 +8.0 +19.9 +61.4 
C2H2Cl4 0.26 +8.1 +9.1 +12.0 +23.4 +66.3 
 
Specific optical rotation values measured for [CD(+)254]-109 in different solvents at 25 °C. 
 
Solvent Conc.  []589 []577 []546 []435 []365 
CH2Cl2 0.21 +58.4 +62.0 +70.3 +121.2 +188.2 
CHCl3 0.25 +23.9 +24.9 +28.4 +46.9 +57.3 
DMSO 0.26 -7.6 -8.9 -9.7 -23.4 -66.1 
C2H2Cl4 0.29 -10.4 -9.8 -13.6 -26.2 -64.4 
 
Specific optical rotation values measured for [CD(-)254]-109 in different solvents at 25 °C. 
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Figure 144: plot of the SOR (10-1 deg cm2 g-1) values versus l (nm) for the [CD(+)254]-109  enantiomer in CH2Cl2 
(black), CHCl3 (orange), DMSO (blue) and C2H2Cl4 (red) at 25 °C.  
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Solvent Conc.  []589 []577 []546 []435 []365 
CH2Cl2 0.19 +159.0 +168.0 +194.5 +359.0 +664.5 
CHCl3 0.26 +201.0 +214.1 +246.5 +453.5 +845.1 
DMSO 0.31 +228.3  +241.1 +278.8 +510.4 +943.5 
C2H2Cl4 0.21 +199.0 +213.0 +244.5 +448.0 +835.5 
 
Specific optical rotation values measured for [CD(+)254]-110 in different solvents at 25 °C. 
 
 
 
Solvent Conc.  []589 []577 []546 []435 []365 
CH2Cl2 0.24 -155.0 -163.0 -189.0 -347.0 -652.0 
CHCl3 0.27 -200.2 -211.0 -245.0 -446.4 -823.4 
DMSO 0.30 -227.8 -239.0 -276.4 -505.0 -936.0 
C2H2Cl4 0.20 -192.5 -206.0 -236.5 -440.5 -820.0 
 
 
 
Specific optical rotation values measured for [CD(-)254]-110 in different solvents at 25 °C. 
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Figure 145: plot of the SOR (10-1 deg cm2 g-1) values versus l (nm) for the [CD(-)254]-110  enantiomer  in CH2Cl2 
(black), CHCl3 (orange), DMSO (blue) and C2H2Cl4 (red) at 25 °C. 
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Solvent Conc.  []589 []577 []546 []435 []365 
CH2Cl2 0.28 +150.0 +158.4 +183.8 +343.8 +656.2 
CHCl3 0.27 +214.4 +202.3 +235.2 +431.4 +804.1 
DMSO 0.25 +215.1  +226.26 +262.7 +480.8 +887.7 
C2H2Cl4 0.27 +207.1 +213.6 +251.6 +466.8 +872.7 
 
 
 
Specific optical rotation values measured for [CD(+)254]-111 in different solvents at 25 °C. 
 
 
 
 
 
Solvent Conc.  []589 []577 []546 []435 []365 
CH2Cl2 0.31 -148.8 -148.8 -180.6 -355.4 -639.1 
CHCl3 0.24 -190.4 -200.0 --230.2 -420.2 -775.4 
DMSO 0.31 -208.5 -218.5 -252.4 -463.6 -855.2 
C2H2Cl4 0.25 -204.4 -214.5 -249.18 -459.1 -850.0 
 
Specific optical rotation values measured for [CD(-)254]-111 in different solvents at 25 °C. 
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Solvent Conc.  []589 []577 []546 []435 []365 
CH2Cl2 0.26 -66.0 -70.1 -78.7 -131.6 -191.3 
CHCl3 0.24 -38.6 -40.9 -47.3 -74.5 -90.4 
DMSO 0.25 -50.0 -52.9 -60.5 -101.5 -145.0 
DMF 0.27 -53.9 -54.8 -61.8 -102.6 -142.3 
C2H2Cl4 0.30 -38.9 -38.3 -45.7 -75.6 -112.7 
 
Specific optical rotation values measured for [CD(+)254]-112 in different solvents at 25 °C. 
 
 
 
Solvent Conc.  []589 []577 []546 []435 []365 
CH2Cl2 0.25 +62.8 +64.5 +72.9 +122.0 +176.8 
CHCl3 0.29 +35.2 +38.0 +42.3 +68.0 +82.5 
DMSO 0.26 +47.0 +49.0 +54.8 +92.2 +127.5 
DMF 0.26 +45.3 +49.4 +55.0 +88.1 +118.5 
C2H2Cl4 0.31 +34.0 +35.1 +43.9 +68.2 +102.0 
 
Specific optical rotation values measured for [CD(-)254]-112 in different solvents at 25 °C. 
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Figure 146: plot of the SOR (10-1 deg cm2 g-1) values versus l (nm) for the [CD(+)254]-112  enantiomer.   
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Figure 147: ECD spectra of [CD(+)254]-109 (black spectra) and [CD(-)254]-109 (red spectra) recorded in CH2Cl2, 
CHCl3, THF, CH3CN, DMSO and C2H2Cl4 at 20 °C. (c = 10-4 – 10-5 M). UV-visible spectrum of 109 recorded in 
THF at 25 °C (c = 1.12 10-5 M). 
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Figure 148: ECD spectra of [CD(+)254]-110 (black spectra) and [CD(-)254]-110 (red spectra) recorded in CH2Cl2, 
CHCl3, THF, CH3CN, DMSO and C2H2Cl4 at 20 °C. (c = 10-4 – 10-5 M). UV-visible spectrum of 110 recorded in 
THF at 25 °C (c = 1.02 10-5 M). 
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Figure 149: 1Lb transition of the ECD spectra of [CD(+)254]-111 (black spectra) and [CD(-)254]-111 (red spectra) 
recorded in CH2Cl2, CHCl3, THF, CH3CN, DMSO and C2H2Cl4 at 20 °C. (c = 10-4 – 10-5 M).  
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Figure 150: ECD spectra of [CD(+)254]-112 (black spectra) and [CD(-)254]-112 (red spectra) recorded in CH2Cl2, 
CHCl3, THF, CH3CN, DMSO and C2H2Cl4 at 20 °C. (c = 10-4 – 10-5 M). UV-visible spectrum of 112 recorded in 
THF at 25 °C (c = 0.99 10-5 M). 
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Figure 151: IR spectra of a) [CD(+)254]-109, b) [CD(+)254]-110 and [CD(+)254]-112 c) in CDCl3 (black spectra), 
CD2Cl2 (red spectra) and C2D2Cl4 (blue spectra) solvents (0.015 mM, 250 µm  path length). 
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Figure 152: VCD spectra of [CD(+)254]-109 (black spectra) and [CD(-)254]-109 (red spectra) in a) CDCl3, b) CD2Cl2, 
and c) C2D2Cl4 solvents (0.015 mM, 250 µm  path length). 
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Figure 153: VCD spectra of [CD(+)254]-110 (black spectra) and [CD(-)254]-110 (red spectra) in a) CDCl3, b) CD2Cl2, 
and c) C2D2Cl4 solvents (0.015 mM, 250 µm  path length). 
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Figure 154: VCD spectra of [CD(+)254]-112 (black spectra) and [CD(-)254]-112 (red spectra) in a) CD2Cl2 and b) 
C2D2Cl4 solvents (0.015 mM, 250 µm  path length). 
 
-0.6
-0.4
-0.2
0.0
0.2
0.4
0.6
11001200130014001500160017001800
[CD(+)254]-3 in CD2Cl2
[CD()254]-3 in CD2Cl2

 
(L
.m
o
l-
1
.c
m
-1
)
Wavenumbers, cm
-1
A
-0.6
-0.4
-0.2
0.0
0.2
0.4
0.6
11001200130014001500160017001800
[CD(+)254]-3 in C2D2Cl4
[CD()254]-3 in C2D2Cl4

 
(L
.m
o
l-
1
.c
m
-1
)
Wavenumbers, cm
-1
B
Experimental part 
Page | 252  
 
 
Figure 155: comparison of experimental VCD spectrum of CD(-)254-110 in C2D2Cl4 solution (15 mM, 250 µm path 
length) and VCD spectra of MM-110 calculated at the B3LYP/6-31G** level (IEFPCM = C2H2Cl4) for the trans and 
gauche-gauche conformations of the ethylenedioxy and propylenedioxy linkers, respectively, and for the acetate 
group grafted on the propylenedioxy linker pointing inside (blue spectrum) or outside (red spectrum) the cavity. 
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B3LYP/6-31G** frequencies (scaled by 0.968) of the ester ν C=O stretching vibration of MM-110 (IEFPCM = 
CH2Cl2 and C2D2Cl4) for the acetate group pointing inward or outward the cavity. 
 
 
 
 
 
 IEFPCM = CH2Cl2 IEFPCM = C2D2Cl4 
Acetate pointing inward the 
cavity 
1753.58 1755.17 
Acetate pointing outward the 
cavity 
1741.42 1742.52 
  
 
 
 
 
 
 
 
 
 
General Conclusion 
General Conclusion 
Page | 255  
 
Cryptophanes have been first described by André Collet and widely developed in the 
laboratory of the ENS de Lyon. Since that time, the chemistry of cryptophanes has been limited 
to fundamental academic research, which focuses on the comprehension of supramolecular 
interactions. Since 2001, cryptophanes combined with hyperpolarized xenon have emerged as a 
breakthrough in molecular imaging dedicated for biological applications. Large number of 
xenon-cryptophane biosensors have been reported for in vitro and in cellulo imaging. The high 
sensitivity, fast responsiveness and exogenous nature of such sensors highlighted the chemistry of 
cryptophanes and triggered researchers to develop new faster routes for their synthesis in decent 
amounts. Most of these developed routes utilize cryptophane-[222] platform, which may suffer 
from low water solubility leading to non-specific interactions with cellular membranes and high 
symmetry making its functionalization and scaling up hard to achieve 
As a solution for these two problems, we have developed a new approach to synthesize water-
soluble easily functionalizable xenon cages based on cryptophane-[223] skeleton. Our platforms 
are dually functionalized that bear a lateral carboxylic acid moiety on their propelenedioxy arm 
and six ester groups as water-soluble precursors grafted on their CTB caps. With the available 
carboxylic acid group, successful functionalization of these platforms with different sensing arms 
like hydroxamic acid, APTRA unit and biotin derivative was made possible via amide coupling 
reaction. Elaboration of water soluble sensors was performed by an additional ester deprotection 
step. The obtained biosensors were produced in decent amounts and they showed acceptable 
solubility in water in the required concentration range. The ability of these cages to bind xenon 
was assessed with our collaborator Dr. Patrick Berthault in CEA, Saclay, Paris. These 
characterizations revealed that our molecules effectively bind xenon, as expected, with an in-out 
exchange dynamic suitable for performing hyper-CEST experiments. Unfortunately, the sensing 
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responsiveness of our sensors seems to be partially diminished compared to the reported 
cryptophane-[222] sensors. This is mainly due the position of the sensing unit, which is located 
on the propelendioxy arm. At this position, any change in the sensing units affects less the 
aromatic ring current, which in turn induces little changes in the magnetic field around xenon, 
hence will be translated as little change in xenon chemical shift. Nevertheless, our platforms can 
still be used as MRI tracers, when connected to a sensing unit whose affinity to the targeted 
analyte is very high, as seen with the biotin functionalized cage. With these results in hands, we 
can conclude that the position of the sensing unit is of particular importance to tune the 
responsiveness of xenon-biosensors. The next step in this subject involves the optimization of the 
some synthetic steps and functionalization of our platforms by different biologically active units 
to target biological events.  
Our cryptophane-[223] derivatives show a unique solvent-dependent self-encapsulation behavior 
of their central function. Unlike the imploded form, which is energetically demanding, self-
encapsulation takes place spontaneously at room temperature in the absence of a potential guest. 
This interesting phenomenon induces large conformational changes, which were successfully 
proved by 1H NMR and IR spectroscopy. The chiroptical study of these enantiopure cages, which 
were separated by our collaborator at Aix Marseilles University, Dr. Nicolas Vanthuyne, revealed 
that the overall chiroptical properties of these cages were modified under the effect of self-
encapsulation. Specifically, polarimetry appears to be the most sensitive technique to small 
conformational variations in organic solvents. Other spectroscopic techniques like ECD and VCD 
combined with DFT calculation, which were performed with our collaborators Dr. Thierry 
Buffeteau and Dr. Nicolas Daugey in Bordeaux, have mainly served in the determination of the 
AC of cryptophanes, where the direct determination of AC is hard to assess.           
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1. Nuclear Magnetic Resonance (NMR) Spectroscopy Principles 
Any nucleus with an odd number of protons and/or neutrons has a charge with a characteristic 
spin (I) of (mI) different orientations of (2I+1) values varying from –I, 2I+1  to +I states, all of 
which are degenerate (have the same energy). A proton, for example, has an (I) =1/2 which 
means, it has two allowed spin states (mI) of 1/2 and -1/2. The spinning of this nucleus creates a 
characteristic magnetic field with a magnetic moment (µ) which is related to (I) by an intrinsic 
constant, gyromagnetic ratio (γ), characteristic to each nucleus (eq. 1), Figure 156. 
                                                          µ= ℏ γ I                                                                         eq. 1 
ℏ: reduced planks constant  
In the presence of an external uniform magnetic field B0, the randomly orientated nuclei will 
align themselves in the direction of the applied magnetic field and they will lose their degeneracy 
due to the interaction of their magnetic moments with external applied field (Zeeman energy 
levels). Nuclei with lower energy, α state, orient themselves with the direction of the field, 
whereas nuclei with higher energy align in the opposite direction, β state. The energy values of 
each state are linear values to B0 and it is given in (eq. 2). 
                                                                E= -ℏ γ mIB0                                                               eq. 2 
The thermal population distribution between the two states is based on Boltzmann distribution 
coefficient given in (eq.3) where N represents the number of nuclei residing in the lower and 
higher energy states, Nα and Nβ, respectively, K is the Boltzmann constant and T is temperature. 
                                                      Nβ/ Nα= e ΔE/KT = e (-ℏ γ B0) /KT                                                                          eq.3                                                                                                                                                                                                   
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Figure 156: population distribution of spins at equilibrium state. 
 
For protons in 1.41 T magnet, the distribution coefficient between the two states is equal to 
0.9999382 which means that there is a slight excess on nuclei in the lower energy state directed 
parallel to the magnetic field. The difference in population between the two states is referred to as 
polarization (P) and it is expressed in (eq. 4).  
                                               P = Nα -Nβ/ Nα +Nβ ≈ (ℏ γ B0) /2KT                                             eq.4 
This will be expressed as a net longitudinal magnetization M0 in the direction of the applied field 
B0, (eq. 5) where Ns represents the excess of population residing in the α state. 
                                                      M0= (NS ℏ γ P)/2                                                        eq.5 
The nuclei at this stage are known to precess in the direction of B0 because they cannot be really 
oriented parallel or anti-parallel to it. The precession frequency is the known Larmor frequency 
Ѡ0 and it is expressed in (eq. 6). 
                                                              Ѡ0= γB0                                                                        eq. 6 
Once a radio frequency pulse is applied, excess of nuclei in the lower energy will be excited to a 
higher energy sate, and they will coherently precess, creating a transverse magnetization along 
Degenerate spin states 
α = 1/2
β = -1/2
Energy
Increasing field strength B0
ΔE= ℏ γB0
Thermal Boltzmann Distribution
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the y-axis. Once the pulse is removed the nuclei relax back to their initial state first by a spin-spin 
or transverse T2 relaxation resulting from the collision of the nuclei, and then a spin-lattice 
relaxation or longitudinal T1 relaxation resulting a dissipation of the thermal energy from one 
spin to the surrounding lattice environment and thus re-growing the initial longitudinal 
magnetization M0. The energy emitted after this process is detected as free induction decay (FID) 
and can be converted to a spectrum as a function of frequency by a Fourier transform, Figure 
157.208 
 
Figure 157: NMR principle. 
 
The key factor affecting the sensitivity of the NMR signals is the polarization of the nuclei 
between the two states. Higher polarization results in a higher longitudinal magnetization M0, 
enhancing thus the sensitivity. Back to (eq.4) enhancing the polarization can be reached by 
increasing the magnetic field (high costs) or by decreasing sample’s temperature (not suitable for 
biological samples). A last way to improve the sensitivity is to play by the nuclear polarization 
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itself, by disturbing the thermal Boltzmann equilibrium of nuclei between the different states into 
a non-equilibrated polarization or the so-called hyperpolarization which will be detailed 
throughout the introductory chapter of the first part. 
2. Optical Activity of Chiral Molecules and the Spectroscopic Tools 
The optical activity of chiral molecules originates from their differential interaction with 
contra-rotational components of the plane polarized light i.e. left and right circularly components. 
In other word, chiral molecules tend to affect the respective velocities and intensities of left and 
right polarized lights. These effects are the origin of what is known as the optical rotation and 
circular dichroism.  
2.1.Optical Rotatory Dispersion ORD and Polarimetry: 
When passed through a chiral sample, the two compartments of circularly polarized light are 
transmitted at different velocities. This will lead to a rotation of their resultant plane polarized 
light by an angle noted α. The difference in left and right circularly polarized light velocities 
originates from the difference in the refractive indices of these two components in a chiral sample. 
This phenomenon is the origin of optical rotation.  
α = 
𝟏𝟖𝟎𝒍 (𝒏𝑳−𝒏𝑹)
𝝀
 
Optical rotation angle α is expressed in the above equation where l is path length, n is the 
refractive index and λ is the wavelength. This equation shows that α is proportional to the 
difference in the refractive indices and it is inversely proportional to the wavelength. 
This angle can be measured by a polarimeter at a well-defined wavelength. The sodium D-line 
transition at 589 nm is the most common used. To characterize each sample a correction with 
respect to the concentration is needed. Thus, the Specific Optical Rotation (SOR) l (nm) 
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characterizes each enantiopure compound. Since 589 is also dependent on the temperature and 
concentration effect, these parameters have to be carefully mentioned. Concentration C is usually 
reported in g/100 mL of solvent and l’ is cell length which is usually equal to 1 dm.  
[α] λ  = 
𝜶
𝒍′𝑪
 
Another way to measure SOR values as a function of the wavelength is the Optical Rotation 
Dispersion (ORD) and it can be extended to the UV-visible spectral regions (on-resonance). Two 
different parts of the ORD spectrum can be discussed. In the off-resonant spectral region (the 
molecule does not absorb light), the ORD curves tend to show a monotonous behavior. In 
addition the SOR values tend to increase negatively or positively as we get close to an absorption 
wavelength. In some other cases a change of the sign of the SOR values can be sometimes 
observed. In the on-resonant spectral region (the molecule absorbs light), the ORD spectrum 
shows a dispersion band (bisignate). This effect is called the anomalous effect (AORD). This 
effect is translated by the appearance of maximal peaks and minimal troughs. A quantum 
theoretical description of ORD spectroscopy can be found in some reviews and articles, Figure 
158.209, 210  
 
Figure 158: plain and anomalous ORD curves.  
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2.2. Electronic Circular Dichroism ECD Spectroscopy: 
Circular dichroism results from a differential absorption of the left and right circularly 
polarized light by chiral molecules. In the classical approach, this difference affects the respective 
intensities of these two components creating an elliptical polarized light whose ellipticity is 
described by an angle θ which is characteristic of the chiral material studied. In an ECD spectrum, 
the difference in the absorptivity of the left and right circularly polarized light (Δɛ = ɛL - ɛR) is 
traced as a function of the wavelength. Each excited state visible on the ECD spectrum has a 
characteristic Rotational Strength Rij that determines its intensity and sign. The shape of the ECD 
spectrum is the result of the summation of all contributed rotational strengths of each electronic 
transition. It is worth mentioning that the sum of the rotational strengths extended to all the 
excited states is equal to zero. Nevertheless, it is important to note that the experimentalists do 
not have access to the whole ECD spectrum. Usually, the spectral range that is accessible 
depends on many different factors: the molecule it-self, the solvent, the concentration, and the 
spectrophotometer used. For instance, it is now possible to extend the spectral range by using 
Synchrotron Radiation circular Dichroism Spectroscopy.   
It is worth to note that ORD and ECD are strongly related via Kramers–Kronig relationship.211 
Thus, theoretically these two spectra can be deduced from each other but practically this is 
difficult to achieve since we cannot have access to the whole ECD or ORD spectra. In recent 
years, numerous studies have been undertaken to predict ORD curves from partial ECD spectra, 
Figure 159.  
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Figure 159: ORD curves and the corresponding ECD Cotton bands. 
 
The presence of more than one chromophore in cryptophane molecules, in close vicinity to each 
other and with proper orientations results in the interaction between them. This is called the 
excitonic coupling. This phenomenon is defined as the delocalization of the electronic excitation 
along the chromophores array, rather being confined on one chromophore. The process generates 
coupling interactions of the initial excited states to form new excitonic states, which are slightly 
shifted in frequency with respect to the initial excited state. Absorption of light in the ECD 
spectrum results in a bisignate band (positive-negative or negative-positive). For two 
chromophores interacting with each other, the sign of these ECD bands can be easily interpreted 
by the excitonic coupling method developed by Nakanishi and co-workers.212 It is noteworthy 
that in the case of cryptophane derivatives where six chromophore are involved a direct 
interpretation of their excitonic coupling is more complicated and can only understood by using 
quantum calculations, Figure 160. 
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Figure 160: Differential absorption of left and right polarized light by the exciton coupled chromophores and the 
corresponding excitonic couplets (black curve) which is a summation of the positive (blue curve) and negative (red 
curve) Cotton effects.  
 
Since, ECD spectroscopy depends on geometrical factors this technique is highly sensitive to 
conformational changes of the chiral molecules. Thus, a change of the conformation induced by 
external factors such as the nature of the solvent, temperature or in the case of the cryptophane 
derivatives the presence of a guest molecule inside its cavity can have a large impact on the ECD 
spectrum. ECD spectroscopy can also be used to determine the absolute configuration of chiral 
molecules. 
ECD spectra can be reproduced by quantum calculations by using TD-DFT. However, these 
theoretical spectra are quite difficult to reproduce because we need to consider many excited 
states. These simulated spectra give better results if we consider the role of the solvent (implicit 
or explicit model). However, this increases the complexity of such simulation and considerably 
increases the computational time. 
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2.3. Vibrational Circular Dichroism VCD Spectroscopy: 
Similar to the above described ECD spectroscopy, vibrational circular dichroism is the 
measurement of the differential absorption of left and right circularly polarized light in the 
infrared region. The obtained VCD spectra of two enantiomers are equal in magnitude but 
opposite in signs just like ECD spectra. In contrast to ECD spectroscopy, VCD spectra are more 
complicated in shape since each vibrational mode possess its own rotational strength. Thus 
numerous transitions can be detected on the VCD spectra of organic molecules. Nevertheless, 
solvent absorption often decreases the spectral window accessible. Thus the choice of the organic 
solvent is critical to record such spectra. Usually, CD2Cl2, CDCl3, 1,1,2,2-terachloroethane-d2 or 
even DMSO-d6 can be used to record spectra between 1800 cm
-1 and 1000 cm-1. Despite the 
strong absorption of water, VCD experiments can also be performed in deuterated water but these 
experiments usually require small path-length compared to organic solvents. This spectral region 
contains numerous bands and that can be useful to get information about the absolute 
configuration of the molecule of interest and its conformation in solution. Interestingly, this 
technique gives rise to VCD spectra, which are the sum of all conformations adopted by the 
molecule in solution. This may complicate the analysis of these spectra in the case of highly 
flexible molecules. VCD spectra can be reproduced by DFT calculation. A comparison of the 
experimental and calculated spectra allows the determination of the absolute configuration of the 
molecule.  In addition it gives insights about the conformation adopted by the molecule in 
solution. Sometimes, a weighted sum of theoretical VCD spectra is necessary to reproduce the 
experimental VCD spectrum. VCD spectroscopy only requires calculation performed on the 
ground state contrary to ECD spectroscopy. This represents an undeniable advantage to perform 
these calculations. VCD spectra are more difficult to record than ECD spectra. Consequently, 
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they require specific skills to obtain VCD spectra of good quality and avoid misinterpretation of 
the results. This is the reason why we have undertaken collaboration with Thierry Buffeteau and 
co-workers at the University of Bordeaux.198 
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